[
{"id":"1","chart":[{"values":[{"x":"1489156200","y":"12.435"},{"x":"1489156500","y":"12.6"},{"x":"1489156800","y":"12.6"},{"x":"1489157100","y":"12.65"},{"x":"1489157400","y":"12.75"},{"x":"1489157700","y":"12.75"},{"x":"1489158000","y":"12.8"},{"x":"1489158300","y":"12.725"},{"x":"1489158600","y":"12.755"},{"x":"1489158900","y":"12.775"},{"x":"1489159200","y":"12.75"},{"x":"1489159500","y":"12.825"},{"x":"1489159800","y":"12.825"},{"x":"1489160100","y":"12.85"},{"x":"1489160400","y":"12.85"},{"x":"1489160700","y":"12.85"},{"x":"1489161000","y":"12.85"},{"x":"1489161300","y":"12.85"},{"x":"1489161600","y":"12.775"},{"x":"1489161900","y":"12.725"},{"x":"1489162200","y":"12.725"},{"x":"1489162500","y":"12.8"},{"x":"1489162800","y":"12.85"},{"x":"1489163100","y":"12.9"},{"x":"1489163400","y":"12.875"},{"x":"1489163700","y":"12.9"},{"x":"1489164000","y":"12.9"},{"x":"1489164300","y":"12.875"},{"x":"1489164600","y":"12.9"},{"x":"1489164900","y":"12.9"},{"x":"1489165200","y":"12.9"},{"x":"1489165500","y":"12.9"},{"x":"1489165800","y":"12.876"},{"x":"1489166100","y":"12.875"},{"x":"1489166400","y":"12.875"},{"x":"1489166700","y":"12.85"},{"x":"1489167000","y":"12.85"},{"x":"1489167300","y":"12.825"},{"x":"1489167600","y":"12.825"},{"x":"1489167900","y":"12.85"},{"x":"1489168200","y":"12.85"},{"x":"1489168500","y":"12.85"},{"x":"1489168800","y":"12.9"},{"x":"1489169100","y":"12.85"},{"x":"1489169400","y":"12.875"},{"x":"1489169700","y":"12.9"},{"x":"1489170000","y":"12.9"},{"x":"1489170300","y":"12.9"},{"x":"1489170600","y":"12.775"},{"x":"1489170900","y":"12.775"},{"x":"1489171200","y":"12.8"},{"x":"1489171500","y":"12.8"},{"x":"1489171800","y":"12.825"},{"x":"1489172100","y":"12.85"},{"x":"1489172400","y":"12.825"},{"x":"1489172700","y":"12.875"},{"x":"1489173000","y":"12.875"},{"x":"1489173300","y":"12.9"},{"x":"1489173600","y":"12.875"},{"x":"1489173900","y":"12.9"},{"x":"1489174200","y":"12.9"},{"x":"1489174500","y":"12.9"},{"x":"1489174800","y":"12.9"},{"x":"1489175100","y":"12.9"},{"x":"1489175400","y":"12.9"},{"x":"1489175700","y":"12.875"},{"x":"1489176000","y":"12.825"},{"x":"1489176300","y":"12.775"},{"x":"1489176600","y":"12.775"},{"x":"1489176900","y":"12.8"},{"x":"1489177200","y":"12.85"},{"x":"1489177500","y":"12.875"},{"x":"1489177800","y":"12.9"},{"x":"1489178100","y":"12.875"},{"x":"1489178400","y":"12.9"},{"x":"1489178700","y":"12.9"},{"x":"1489179000","y":"12.875"},{"x":"1489179300","y":"12.85"},{"x":"1489179600","y":"12.85"},{"x":"1489180200","y":"13"}]
,"color":"#03a9f4"}],"list":"Market Movers","symbol": "ACCO","name": "ACCO Brands Corp","price": 12.9,"dollarChange": 0.66,"percentChange": 5.31,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/ACCO-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/ACCO-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/ACCO-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/ACCO-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/ACCO-1yr.php","open": 12.4,"high": 12.925,"low":12.4,"volume": 479220,"avgVol": 576885.553191,"sharesShort": 5252586,"shortPercent": 4.867389,"marketCap": 1446045456,"float": 107913840,"headlines":{"data":[{"title":"Briggs & Stratton Highlights New Products at Rental Show","publication_date":"2017-03-10 14:27:02 +0000","url":"http://finance.yahoo.com/news/briggs-stratton-highlights-products-rental-142702517.html","summary":"Briggs & Stratton Highlights New Products at Rental Show"},{"title":"Top Ranked Growth Stocks to Buy for March 10th","publication_date":"2017-03-10 11:54:11 +0000","url":"http://finance.yahoo.com/news/top-ranked-growth-stocks-buy-115411339.html","summary":"Top Ranked Growth Stocks to Buy for March 10th"},{"title":"Deere (DE) Upgraded to Strong Buy on Encouraging Outlook","publication_date":"2017-03-09 16:17:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PGYwBp_7qSo/deere-de-upgraded-to-strong-buy-on-encouraging-outlook-cm758490","summary":"On Mar 7 Zacks Investment Research upgraded Deere amp Company DE to a Zacks Rank 1 Strong Buy Going by the Zacks model companies sporting a Zacks Rank 1 have strong chances of outperforming the broader market over the next few quarters With positive earnings estimate revisions"},{"title":"Colfax Corporation (CFX) to Acquire Siemens' STE Business","publication_date":"2017-03-09 16:17:16 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v1JTlfocPjc/colfax-corporation-cfx-to-acquire-siemens-ste-business-cm758485","summary":"Colfax Corporation CFX signed a binding agreement to acquire Siemens AG s Siemens Turbomachinery Equipment GmbH STE business with a cash consideration of around 195 million The move would enhance Colfax s product portfolio as well as boost its position in the global industrial"},{"title":"AGCO Wins Equipment Purchasing Deal from State of Michigan","publication_date":"2017-03-09 14:35:02 +0000","url":"http://finance.yahoo.com/news/agco-wins-equipment-purchasing-deal-143502687.html","summary":"AGCO Wins Equipment Purchasing Deal from State of Michigan"},{"title":"Top Ranked Growth Stocks to Buy for March 8th","publication_date":"2017-03-08 15:23:03 +0000","url":"http://finance.yahoo.com/news/top-ranked-growth-stocks-buy-152303684.html","summary":"Top Ranked Growth Stocks to Buy for March 8th"},{"title":"Luxfer Holdings (LXFR) Misses on Q4 Earnings & Revenues","publication_date":"2017-03-08 15:17:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LVe-SwipDKg/luxfer-holdings-lxfr-misses-on-q4-earnings-revenues-cm757788","summary":"Luxfer Holdings PLC LXFR reported dismal fourth quarter 2016 results The quarterly top and bottom line performance was primarily affected by adverse foreign exchange impact and soft demand for magnesium based products Over the last one month Luxfer Holdings shares fell 2 12 as"},{"title":"Should You Add Kennametal (KMT) Stock to Your Portfolio?","publication_date":"2017-03-07 16:15:42 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zbwwtfW5Gnc/should-you-add-kennametal-kmt-stock-to-your-portfolio-cm757226","summary":"On Mar 7 we issued an updated research report on Kennametal Inc KMT What s Driving the Stock Over the last three months Kennametal s shares yielded a 13 28 return outperforming the gain of 6 55 generated by the Zacks categorized Machine Tools amp Related Products"},{"title":"MRC Global (MRC) Poised to Grow Despite Macro Headwinds","publication_date":"2017-03-06 16:17:33 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1V1hoIcx3eo/mrc-global-mrc-poised-to-grow-despite-macro-headwinds-cm756584","summary":"On Mar 6 we issued an updated research report on MRC Global Inc MRC Existing Scenario Over the last six months MRC Global s shares yielded a return of 38 64 outperforming the 17 15 gain provided by the Zacks classified Steel Pipe amp tubes industry The company intends"},{"title":"Top Ranked Growth Stocks to Buy for March 6th","publication_date":"2017-03-06 15:01:03 +0000","url":"http://finance.yahoo.com/news/top-ranked-growth-stocks-buy-150103858.html","summary":"Top Ranked Growth Stocks to Buy for March 6th"},{"title":"MRC Global (MRC) Poised to Grow Despite Macro Headwinds","publication_date":"2017-03-06 14:01:02 +0000","url":"http://finance.yahoo.com/news/mrc-global-mrc-poised-grow-140102929.html","summary":"MRC Global (MRC) Poised to Grow Despite Macro Headwinds"},{"title":"ACCO BRANDS CORP Financials","publication_date":"2017-03-03 18:04:10 +0000","url":"http://finance.yahoo.com/q/is?s=acco","summary":"ACCO BRANDS CORP Financials"},{"title":"Avery Dennison (AVY) Closes Hanita Coatings Acquisition","publication_date":"2017-03-03 16:16:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B76sH7_fB7U/avery-dennison-avy-closes-hanita-coatings-acquisition-cm755988","summary":"Avery Dennison Corporation AVY completed the acquisition of Hanita Coatings a pressure sensitive materials manufacturer of specialty films and laminates from Kibbutz Hanita and Tene Investment Funds In Dec 2016 Avery Dennison had agreed to acquire Hanita Coatings at a price of"},{"title":"Caterpillar (CAT) Faces Federal Tax Probe, Stock Down","publication_date":"2017-03-03 16:15:16 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m5w1LP7hm3I/caterpillar-cat-faces-federal-tax-probe-stock-down-cm755963","summary":"Caterpillar Inc s CAT shares were sent reeling after reports surfaced that Federal agents had raided the corporate headquarters of one of the world s largest makers of construction and other heavy equipment Consequently the company s shares dropped 4 8 to close at 94 36 yesterday In"},{"title":"Caterpillar (CAT) Faces Federal Tax Probe, Stock Down","publication_date":"2017-03-03 13:50:01 +0000","url":"http://finance.yahoo.com/news/caterpillar-cat-faces-federal-tax-135001778.html","summary":"Caterpillar (CAT) Faces Federal Tax Probe, Stock Down"},{"title":"Avery Dennison (AVY) Closes Hanita Coatings Acquisition","publication_date":"2017-03-03 13:42:01 +0000","url":"http://finance.yahoo.com/news/avery-dennison-avy-closes-hanita-134201237.html","summary":"Avery Dennison (AVY) Closes Hanita Coatings Acquisition"},{"title":"Middleby Corp. (MIDD) Poised to Grow Amid Macro Headwinds","publication_date":"2017-03-02 16:16:43 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KRl89N8vL9I/middleby-corp-midd-poised-to-grow-amid-macro-headwinds-cm755373","summary":"We issued an updated research report on the premium diversified machinery company Middleby Corp MIDD on Mar 2 2017 Over the last one month shares of this Zacks Rank 3 Hold yielded a 6 55 return outperforming the gain of 2 09 provided by the Zacks categorized Machinery"},{"title":"Why Altra Industrial (AIMC) Stock Might be a Great Pick?","publication_date":"2017-03-02 16:16:40 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zMy0EBML8I8/why-altra-industrial-aimc-stock-might-be-a-great-pick-cm755371","summary":"On Mar 1 2017 we issued an updated research report on premium industrial electrical equipment company Altra Industrial Motion Corp AIMC Over the last one month Altra Industrial Motion s shares yielded 6 05 return outperforming the 2 9 gain provided by the Zacks"},{"title":"Greif (GEF) Q1 Earnings Miss on Estimates, Revenues Beat","publication_date":"2017-03-02 16:16:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GzHsGxVn9RI/greif-gef-q1-earnings-miss-on-estimates-revenues-beat-cm755359","summary":"The provider of industrial packaging products and services Greif Inc GEF reported adjusted earnings of 45 cents per share in first quarter fiscal 2017 ended Jan 31 2017 which increased 12 5 year over year However earnings fell short of the Zacks Consensus Estimate of 50"},{"title":"Greif (GEF) Q1 Earnings Miss on Estimates, Revenues Beat","publication_date":"2017-03-02 14:29:02 +0000","url":"http://finance.yahoo.com/news/greif-gef-q1-earnings-miss-142902523.html","summary":"Greif (GEF) Q1 Earnings Miss on Estimates, Revenues Beat"},{"title":"Why Altra Industrial (AIMC) Stock Might be a Great Pick?","publication_date":"2017-03-02 14:24:02 +0000","url":"http://finance.yahoo.com/news/why-altra-industrial-aimc-stock-142402661.html","summary":"Why Altra Industrial (AIMC) Stock Might be a Great Pick?"},{"title":"Hyster-Yale (HY) Q4 Earnings Miss Estimates, Decline Y/Y","publication_date":"2017-03-01 23:13:53 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VcIq-FyRu8U/hyster-yale-hy-q4-earnings-miss-estimates-decline-yy-cm755100","summary":"Hyster Yale Materials Handling Inc s HY reported fourth quarter 2016 earnings of 74 cents per share a 30 decline year over year Further earnings missed the Zacks Consensus Estimate of 87 cents per share by 15 Operational Update Revenues in the quarter increased 7 year over"},{"title":"TriMas (TRS) Q4 Earnings In Line, Revenues Miss Estimates","publication_date":"2017-03-01 23:13:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jNDsstSdQA8/trimas-trs-q4-earnings-in-line-revenues-miss-estimates-cm755091","summary":"TriMas Corporation TRS posted adjusted earnings of 30 cents per share for fourth quarter 2016 in line with the Zacks Consensus Estimate However earnings increased 3 4 year over year On a reported basis including special items TriMas reported a loss of 1 48 per share in the"},{"title":"TriMas (TRS) Q4 Earnings In Line, Revenues Miss Estimates","publication_date":"2017-03-01 21:36:09 +0000","url":"http://finance.yahoo.com/news/trimas-trs-q4-earnings-line-213609539.html","summary":"TriMas (TRS) Q4 Earnings In Line, Revenues Miss Estimates"},{"title":"Middleby (MIDD) Beats on Q4 Earnings & Revenue Estimates","publication_date":"2017-03-01 15:15:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DuRvM0ILgwI/middleby-midd-beats-on-q4-earnings-revenue-estimates-cm754822","summary":"Machinery behemoth The Middleby Corporation MIDD reported better than expected fourth quarter 2016 results However over the last three months shares of this Zacks Rank 4 Sell stock yielded a return of 0 80 underperforming 6 67 gain provided by the Zacks categorized Machinery"},{"title":"Avery Dennison Hits 52-Week High: What's Driving the Stock?","publication_date":"2017-02-28 22:50:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SL87mfW5jjk/avery-dennison-hits-52-week-high-whats-driving-the-stock-cm754492","summary":"Shares of Avery Dennison Corporation AVY scaled a new 52 week high of 81 27 on Feb 27 before eventually closing the day s trading at 80 70 The stock price appreciation came on the back of strong fourth quarter results as well as an upbeat guidance This Pasadena CA based manufacturer"},{"title":"Avery Dennison Hits 52-Week High: What's Driving the Stock?","publication_date":"2017-02-28 21:04:09 +0000","url":"http://finance.yahoo.com/news/avery-dennison-hits-52-week-210409241.html","summary":"Avery Dennison Hits 52-Week High: What's Driving the Stock?"},{"title":"Top Ranked Growth Stocks to Buy for February 28th","publication_date":"2017-02-28 17:51:06 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8cDzyx7F5LY/top-ranked-growth-stocks-to-buy-for-february-28th-cm754320","summary":"Here are four stocks with Zacks Rank 1 Strong Buy and strong growth characteristics for investors to consider today February 28 th Gray Television Inc GTN This television broadcast company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 4 7"},{"title":"Top Ranked Growth Stocks to Buy for February 28th","publication_date":"2017-02-28 15:23:03 +0000","url":"http://finance.yahoo.com/news/top-ranked-growth-stocks-buy-152303497.html","summary":"Top Ranked Growth Stocks to Buy for February 28th"},{"title":"Kensington Celebrates 25 Years of Innovation and Leadership in Physical Security with the Introduction of NanoSaver Keyed Laptop Lock and Nano Security Slot for Ultra-thin Devices","publication_date":"2017-02-28 14:55:00 +0000","url":"http://finance.yahoo.com/news/kensington-celebrates-25-years-innovation-145500363.html","summary":"[PR Newswire] - SAN MATEO, Calif., Feb. 28, 2017 /PRNewswire/ -- Kensington ® , a worldwide leader of desktop computing and mobility solutions for IT, business and home office professionals and The Professionals' Choice, ..."},{"title":"Altra Industrial (AIMC) Beats on Q4 Earnings and Revenues","publication_date":"2017-02-28 13:50:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CPA54DQo5E0/altra-industrial-aimc-beats-on-q4-earnings-and-revenues-cm754029","summary":"Machinery company Altra Industrial Motion Corporation AIMC reported better than expected results for fourth quarter 2016 Over the last one month shares of this Zacks Rank 3 Hold stock yielded a return of 9 48 outperforming 2 77 gain provided by the Zacks categorized Machinery"},{"title":"Altra Industrial (AIMC) Beats on Q4 Earnings and Revenues","publication_date":"2017-02-28 12:29:12 +0000","url":"http://finance.yahoo.com/news/altra-industrial-aimc-beats-q4-122912173.html","summary":"Altra Industrial (AIMC) Beats on Q4 Earnings and Revenues"},{"title":"ACCO BRANDS CORP Files SEC form 10-K, Annual Report","publication_date":"2017-02-27 21:29:21 +0000","url":"http://biz.yahoo.com/e/170227/acco10-k.html","summary":"ACCO BRANDS CORP Files SEC form 10-K, Annual Report"},{"title":"Top Ranked Value Stocks to Buy for February 27th","publication_date":"2017-02-27 17:52:06 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KyvmRJXipw8/top-ranked-value-stocks-to-buy-for-february-27th-cm753721","summary":"Here are four stocks with Zacks Rank 1 Strong Buy and strong value characteristics for investors to consider today February 27 th ACCO Brands Corporation ACCO This manufacturer and distributor of office school and calendar products has seen the Zacks Consensus Estimate for"},{"title":"Avery Dennison (AVY) Prices 500 Million Euro Senior Notes","publication_date":"2017-02-27 16:53:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gny4z2kmZrU/avery-dennison-avy-prices-500-million-euro-senior-notes-cm753636","summary":"Avery Dennison Corporation AVY unveiled the pricing of 500 million 528 million of 1 250 Senior Notes due 2025 The underwritten public offering has been priced at 99 917 of the principal amount The offering is expected to close on Mar 3 The company will use approximately 200"},{"title":"Top Ranked Value Stocks to Buy for February 27th","publication_date":"2017-02-27 14:47:02 +0000","url":"http://finance.yahoo.com/news/top-ranked-value-stocks-buy-144702126.html","summary":"Top Ranked Value Stocks to Buy for February 27th"},{"title":"Avery Dennison (AVY) Prices 500 Million Euro Senior Notes","publication_date":"2017-02-27 14:30:02 +0000","url":"http://finance.yahoo.com/news/avery-dennison-avy-prices-500-143002959.html","summary":"Avery Dennison (AVY) Prices 500 Million Euro Senior Notes"},{"title":"New Strong Buy Stocks for February 24th","publication_date":"2017-02-24 16:54:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ThQdchjUT_Q/new-strong-buy-stocks-for-february-24th-cm752920","summary":"Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today ACCO Brands Corporation ACCO This manufacturer and distributor of office school and calendar products has witnessed the Zacks Consensus Estimate for its current year earnings soaring 9 9 over the last 30 days"},{"title":"New Strong Buy Stocks for February 24th","publication_date":"2017-02-24 14:10:02 +0000","url":"http://finance.yahoo.com/news/strong-buy-stocks-february-24th-141002608.html","summary":"New Strong Buy Stocks for February 24th"},{"title":"ACCO Brands Corp. :ACCO-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017","publication_date":"2017-02-23 17:26:33 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-acco-us-earnings-analysis-2016-by-the-numbers-february-23-2017/","summary":"ACCO Brands Corp. :ACCO-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017"},{"title":"ACCO Brands Corp. :ACCO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017","publication_date":"2017-02-23 15:13:06 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-acco-us-earnings-analysis-q4-2016-by-the-numbers-february-23-2017/","summary":"ACCO Brands Corp. :ACCO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017"},{"title":"ACCO Brands (ACCO) Catches Eye: Stock Jumps 9.7% in Session","publication_date":"2017-02-23 14:53:14 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2gtJOx6boH4/acco-brands-acco-catches-eye-stock-jumps-97-in-session-cm751966","summary":"ACCO Brands Corporation ACCO was a big mover last session as its shares rose almost 10 on the day The move came after the company reported encouraging fourth quarter 2016 results This led to far more shares changing hands than in a normal session This breaks the recent trend of the"},{"title":"ACCO Brands (ACCO) Catches Eye: Stock Jumps 9.7% in Session","publication_date":"2017-02-23 13:15:01 +0000","url":"http://finance.yahoo.com/news/acco-brands-acco-catches-eye-131501953.html","summary":"ACCO Brands (ACCO) Catches Eye: Stock Jumps 9.7% in Session"},{"title":"Edited Transcript of ACCO earnings conference call or presentation 22-Feb-17 1:30pm GMT","publication_date":"2017-02-22 20:27:29 +0000","url":"http://finance.yahoo.com/news/edited-transcript-acco-earnings-conference-202729132.html","summary":"Edited Transcript of ACCO earnings conference call or presentation 22-Feb-17 1:30pm GMT"},{"title":"Breadth And Taxes","publication_date":"2017-02-22 19:49:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/19LfImVYYo0/breadth-and-taxes-cm751587","summary":"By Scott Carmack ByScott Carmack Trump s phenomenal tax reform drives markets higher Trump s phenomenal tax reform drives markets higherTrump s phenomenal tax reform drives markets higher Donald Trump made headlines last week with his suggestion that a proposal for tax"},{"title":"ACCO Brands Corp Earnings Call scheduled for 8:30 am ET today","publication_date":"2017-02-22 13:30:00 +0000","url":"http://biz.yahoo.com/cc/2/155222.html","summary":"ACCO Brands Corp Earnings Call scheduled for 8:30 am ET today"},{"title":"Acco tops Street 4Q forecasts","publication_date":"2017-02-22 12:43:30 +0000","url":"http://sg.finance.yahoo.com/news/acco-tops-street-4q-forecasts-124330800.html","summary":"Acco tops Street 4Q forecasts"},{"title":"ACCO BRANDS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","publication_date":"2017-02-22 12:42:13 +0000","url":"http://biz.yahoo.com/e/170222/acco8-k.html","summary":"ACCO BRANDS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"},{"title":"7:08 am ACCO Brands beats by $0.02, beats on revs; guides FY17 EPS above consensus, revs in-line","publication_date":"2017-02-22 12:08:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#acco","summary":"7:08 am ACCO Brands beats by $0.02, beats on revs; guides FY17 EPS above consensus, revs in-line"},{"title":"ACCO Brands Corporation Reports Fourth Quarter 2016 Results","publication_date":"2017-02-22 12:00:00 +0000","url":"http://finance.yahoo.com/news/acco-brands-corporation-reports-fourth-120000720.html","summary":"[PR Newswire] - LAKE ZURICH, Ill., Feb. 22, 2017 /PRNewswire/ -- ACCO Brands Corporation (NYSE: ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, ..."},{"title":"ACCO April 21st Options Begin Trading","publication_date":"2017-02-21 16:08:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zJ9pMWg9wuM/acco-april-21st-options-begin-trading-cm750674","summary":"Investors in Acco Brands Corp Symbol ACCO saw new options begin trading today for the April 21st expiration At Stock Options Channel our YieldBoost formula has looked up and down the ACCO options chain for the new April 21st contracts and identified the following put contract of"},{"title":"ACCO BRANDS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement","publication_date":"2017-02-01 12:08:01 +0000","url":"http://biz.yahoo.com/e/170201/acco8-k.html","summary":"ACCO BRANDS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement"},{"title":"ACCO Brands Completes Acquisition Of Esselte Group Holdings AB","publication_date":"2017-02-01 12:00:00 +0000","url":"http://finance.yahoo.com/news/acco-brands-completes-acquisition-esselte-120000379.html","summary":"[PR Newswire] - LAKE ZURICH, Ill., Feb. 1, 2017 /PRNewswire/ -- ACCO Brands Corporation (ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, today announced that it has completed the acquisition of Esselte Group Holdings AB (\"Esselte\"). The combination improves ACCO Brands' scale and enhances its position as an industry leader in Europe. \"We are excited to add Esselte, its talented employees and its portfolio of products and brands to the ACCO Brands family,\" said Boris Elisman, Chairman, President and Chief Executive Officer of ACCO Brands."},{"title":"ACCO Brands Corp. breached its 50 day moving average in a Bullish Manner : ACCO-US : January 26, 2017","publication_date":"2017-01-26 13:11:13 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-breached-its-50-day-moving-average-in-a-bullish-manner-acco-us-january-26-2017/","summary":"ACCO Brands Corp. breached its 50 day moving average in a Bullish Manner : ACCO-US : January 26, 2017"},{"title":"Coverage initiated on ACCO Brands by BWS Financial","publication_date":"2017-01-25 14:47:50 +0000","url":"http://finance.yahoo.com/q/ud?s=ACCO","summary":"Coverage initiated on ACCO Brands by BWS Financial"},{"title":"Consumer Sector Update for 01/20/2017: ACCO,AAN,HLF","publication_date":"2017-01-20 21:38:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rDui9sxt7qE/consumer-sector-update-for-01202017-accoaanhlf-cm736231","summary":"Top Consumer StocksTop Consumer Stocks WMT 0 81 WMT 0 81 MCD 0 09 MCD 0 09 DIS 0 31 DIS 0 31 CVS 1 39 CVS 1 39 KO 0 19 KO 0 19 Consumer stocks were ending with narrow gains this afternoon with shares of consumer staples companies in the S amp P 500 increasing almost 0 4"},{"title":"ACCO Brands to Report Fourth Quarter 2016 Results Wednesday, February 22, 2017","publication_date":"2017-01-20 18:25:35 +0000","url":"http://finance.yahoo.com/news/acco-brands-report-fourth-quarter-182535918.html","summary":"[GlobeNewswire] - LAKE ZURICH, Ill., Jan. 20, 2017-- ACCO Brands Corporation will release fourth quarter 2016 financial results at approximately 7:00 a.m. Eastern Time on Wednesday, February 22, 2017.. At 8:30 a.m. Eastern ..."},{"title":"ACCO Brands Receives Clearance From Competition Authorities For Acquisition Of Esselte","publication_date":"2017-01-20 17:44:00 +0000","url":"http://finance.yahoo.com/news/acco-brands-receives-clearance-competition-174400323.html","summary":"[PR Newswire] - LAKE ZURICH, Ill., Jan. 20, 2017 /PRNewswire/ -- ACCO Brands Corporation (ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, today announced that it has received clearance from the relevant competition authorities related to the pending acquisition of Esselte Group Holdings AB (\"Esselte\")."},{"title":"ACCO Brands Corp. – Value Analysis (NYSE:ACCO) : January 18, 2017","publication_date":"2017-01-18 18:01:30 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-value-analysis-nyseacco-january-18-2017/","summary":"ACCO Brands Corp. – Value Analysis (NYSE:ACCO) : January 18, 2017"},{"title":"ETFs with exposure to ACCO Brands Corp. : January 17, 2017","publication_date":"2017-01-17 15:32:59 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acco-brands-corp-january-17-2017/","summary":"ETFs with exposure to ACCO Brands Corp. : January 17, 2017"},{"title":"ACCO Brands Corp. breached its 50 day moving average in a Bearish Manner : ACCO-US : January 13, 2017","publication_date":"2017-01-13 13:42:56 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-breached-its-50-day-moving-average-in-a-bearish-manner-acco-us-january-13-2017/","summary":"ACCO Brands Corp. breached its 50 day moving average in a Bearish Manner : ACCO-US : January 13, 2017"},{"title":"Kensington Unveils SD5000T Thunderbolt™ 3 Docking Station at ShowStoppers @ CES 2017","publication_date":"2017-01-05 13:00:00 +0000","url":"http://finance.yahoo.com/news/kensington-unveils-sd5000t-thunderbolt-3-130000092.html","summary":"[PR Newswire] - LAS VEGAS, Jan. 5, 2017 /PRNewswire/ -- Kensington ® , a worldwide leader of desktop computing and mobility solutions for IT, business and home office professionals and The Professionals' Choice, today ..."},{"title":"Kensington Fortifies Device and Data Security - Launches Laptop Locking Station 2.0 and VeriMark Fingerprint Key at ShowStoppers @ CES 2017","publication_date":"2017-01-05 13:00:00 +0000","url":"http://finance.yahoo.com/news/kensington-fortifies-device-data-security-130000795.html","summary":"[PR Newswire] - LAS VEGAS, Jan. 5, 2017 /PRNewswire/ -- Kensington®, a worldwide leader of desktop computing and mobility solutions for IT, business and home office professionals and The Professionals' Choice, today announced the launch of its Laptop Locking Station 2.0, a powerful locking solution for thin laptops such as the MacBook and MacBook Air, and the VeriMark™ Fingerprint Key, the world's first fingerprint security key to support Fast IDentity Online (FIDO) universal 2nd-factor authentication (U2F), as well as Windows Hello biometric login. Kensington will display both new security products at ShowStoppers @ CES 2017, January 5, at table D-15 in the Lafite Ballroom, Wynn Hotel, Las Vegas."},{"title":"Altra Industrial (AIMC) Poised to Grow Amid Macro Headwinds","publication_date":"2016-12-30 15:02:40 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UiVu9o_QcMs/altra-industrial-aimc-poised-to-grow-amid-macro-headwinds-cm727779","summary":"On Dec 30 2016 we issued an updated research report on premium industrial electrical equipment company Altra Industrial Motion Corp AIMC Altra Industrial Motion s stock is currently engulfed with both optimistic and pessimistic aspects Post third quarter 2016 earnings release shares"},{"title":"Altra Industrial (AIMC) Poised to Grow Amid Macro Headwinds","publication_date":"2016-12-30 13:01:01 +0000","url":"http://finance.yahoo.com/news/altra-industrial-aimc-poised-grow-130101983.html","summary":"Altra Industrial (AIMC) Poised to Grow Amid Macro Headwinds"},{"title":"Post Earnings Coverage as Ennis Q3 Results Outperformed Expectations","publication_date":"2016-12-29 13:15:00 +0000","url":"http://finance.yahoo.com/news/post-earnings-coverage-ennis-q3-131500134.html","summary":"[Accesswire] - Upcoming AWS Coverage on ACCO Brands LONDON, UK / ACCESSWIRE / December 29, 2016 / Active Wall St. announces its post-earnings coverage on Ennis, Inc. (NYSE: EBF ). The Company posted its financial results ..."},{"title":"Actuant (ATU) Stock Looks Bullish on Robust Q1 Earnings","publication_date":"2016-12-24 00:56:37 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n8Njc8W3xsk/actuant-atu-stock-looks-bullish-on-robust-q1-earnings-cm725915","summary":"On Dec 23 2016 we issued an updated research report on Actuant Corporation ATU Existing Scenario At the moment Actuant s stock is a good catch for your portfolio Over the last 30 days the Zacks Rank 2 Buy stock recorded a return of 4 62 as against the negative return of 1"},{"title":"Actuant (ATU) Stock Looks Bullish on Robust Q1 Earnings","publication_date":"2016-12-23 23:20:11 +0000","url":"http://finance.yahoo.com/news/actuant-atu-stock-looks-bullish-232011422.html","summary":"Actuant (ATU) Stock Looks Bullish on Robust Q1 Earnings"},{"title":"ACCO BRANDS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive","publication_date":"2016-12-22 21:06:25 +0000","url":"http://biz.yahoo.com/e/161222/acco8-k.html","summary":"ACCO BRANDS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive"},{"title":"Lindsay (LNN) Misses Earnings & Revenue Estimates in Q1","publication_date":"2016-12-22 16:59:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vOVq7lqMUaU/lindsay-lnn-misses-earnings-revenue-estimates-in-q1-cm725094","summary":"Lindsay Corporation LNN reported first quarter fiscal 2017 ended Nov 30 2016 adjusted earnings of 8 cents per share plunging 87 from 62 cents per share in the prior year quarter Further earnings fell short of the Zacks Consensus Estimate of 63 cents a negative earnings surprise of"},{"title":"Top Ranked Value Stocks to Buy for December 22nd","publication_date":"2016-12-22 16:02:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aipLWDl34uw/top-ranked-value-stocks-to-buy-for-december-22nd-cm725186","summary":"Here are four stocks with Zacks Rank 1 Strong Buy and strong value characteristics for investors to consider today December 22 nd TTM Technologies Inc TTMI This manufacturer of printed circuit boards has seen the Zacks Consensus Estimate for its current year earnings increasing 15"},{"title":"Actuant (ATU) Beats Q1 Earnings, Raises FY17 EPS Guidance","publication_date":"2016-12-22 16:00:50 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kv_5ZdMSykc/actuant-atu-beats-q1-earnings-raises-fy17-eps-guidance-cm725047","summary":"Diversified machinery company Actuant Corporation ATU reported its first quarter fiscal 2017 ended Nov 30 2016 earnings Amid dismal market conditions the Zacks Rank 3 Hold stock is poised to grow on the back of prompt restructuring moves The stock has been performing better than"},{"title":"Top Ranked Value Stocks to Buy for December 22nd","publication_date":"2016-12-22 13:14:01 +0000","url":"http://finance.yahoo.com/news/top-ranked-value-stocks-buy-131401461.html","summary":"Top Ranked Value Stocks to Buy for December 22nd"},{"title":"Caterpillar (CAT) Hurt by Weak Markets, Sales Fall Yet Again","publication_date":"2016-12-22 00:56:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YCgNDM_hppU/caterpillar-cat-hurt-by-weak-markets-sales-fall-yet-again-cm724872","summary":"Caterpillar Inc s CAT global retail sales for the three month period ending Nov 2016 plunged 17 So far this year Caterpillar s monthly sales have posted an average decline of 15 The company s sales growth has been in the red for an unprecedented stretch of 48 consecutive months The"},{"title":"Top Ranked Value Stocks to Buy for December 20th","publication_date":"2016-12-20 17:01:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OV5KMO7AAxA/top-ranked-value-stocks-to-buy-for-december-20th-cm724103","summary":"Here are four stocks with Zacks Rank 1 Strong Buy and strong value characteristics for investors to consider today December 20 th ACCO Brands Corporation ACCO This manufacturer and distributor of office school and calendar products has seen the Zacks Consensus Estimate for"},{"title":"Emerson Unveils Roxar API, Boosts Reservoir Modeling Skills","publication_date":"2016-12-20 16:01:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YQoQCGXDlVU/emerson-unveils-roxar-api-boosts-reservoir-modeling-skills-cm723934","summary":"Emerson Electric Co s EMR business arm Emerson Automation Solutions launched the Roxar API Application Programming Interface an extensibility solution used for reservoir modelling especially for the industry renowned software Roxar RMS The move reflects Emerson s commitment"},{"title":"Top Ranked Value Stocks to Buy for December 20th","publication_date":"2016-12-20 14:29:02 +0000","url":"http://finance.yahoo.com/news/top-ranked-value-stocks-buy-142902883.html","summary":"Top Ranked Value Stocks to Buy for December 20th"},{"title":"Should RBC Bearings (ROLL) Be in Your Portfolio Right Now?","publication_date":"2016-12-19 15:59:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-WqOoRmISqU/should-rbc-bearings-roll-be-in-your-portfolio-right-now-cm723194","summary":"On Dec 19 2016 Zacks Investment Research upgraded RBC Bearings Inc ROLL to a Zacks Rank 3 Hold from a Zacks Rank 4 Sell Going by the Zacks model companies with a Zacks Rank 3 have chances of delivering in line performances with the broader market over the upcoming quarters Why"},{"title":"ACCO Brands Hits 52-Week High on Raised View, Acquisitions","publication_date":"2016-12-19 13:58:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i0kx_KyJm2s/acco-brands-hits-52-week-high-on-raised-view-acquisitions-cm723089","summary":"Shares of ACCO Brands Corporation ACCO reached a new 52 week high of 14 00 during its trading session on Dec 16 This apex improved upon the last 52 week high of 13 70 on Dec 15 Year to date shares of the company yielded 87 9 return outperforming the return of 19 6 generated by the"},{"title":"ACCO Brands Hits 52-Week High on Raised View, Acquisitions","publication_date":"2016-12-19 11:44:11 +0000","url":"http://finance.yahoo.com/news/acco-brands-hits-52-week-114411961.html","summary":"ACCO Brands Hits 52-Week High on Raised View, Acquisitions"},{"title":"Middleby (MIDD) Looks Bullish on Robust Growth Drivers","publication_date":"2016-12-16 21:57:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DRholi9EhwA/middleby-midd-looks-bullish-on-robust-growth-drivers-cm722740","summary":"We issued an updated research report on the premium diversified machinery company Middleby Corp MIDD on Dec 16 2016 Middleby s stock looks bullish at the moment Post third quarter 2016 earnings release Nov 8 2016 the company s shares recorded a e return of 12 26 outperforming 9"},{"title":"Middleby (MIDD) Looks Bullish on Robust Growth Drivers","publication_date":"2016-12-16 19:36:07 +0000","url":"http://finance.yahoo.com/news/middleby-midd-looks-bullish-robust-193607399.html","summary":"Middleby (MIDD) Looks Bullish on Robust Growth Drivers"},{"title":"Stock Market Roundup Dec. 14: Fed Raises Rates for Second Time in Decade","publication_date":"2016-12-14 23:56:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FdB38xzYrHg/stock-market-roundup-dec-14-fed-raises-rates-for-second-time-in-decade-cm721630","summary":"It turned out to be a choppy day of trading on Wall Street Wednesday as the news of the Federal Reserve s decision to raise the benchmark interest rate by a quarter percentage point sank in The Dow Jones the S amp P 500 and the Nasdaq all dropped considerable points while utilities and"},{"title":"MRC Global's (MRC) Stock Looks Bullish on Growth Drivers","publication_date":"2016-12-12 16:00:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JVf2A7TIGDI/mrc-globals-mrc-stock-looks-bullish-on-growth-drivers-cm720018","summary":"On Dec 12 2016 we issued an updated research report on MRC Global Inc MRC Growth Drivers MRC Global s stock looks promising at the moment Post third quarter 2016 earnings release the Zacks Rank 2 Buy stock recorded an average return of 55 00 outperforming 26 83 returns"},{"title":"MRC Global's (MRC) Stock Looks Bullish on Growth Drivers","publication_date":"2016-12-12 14:14:02 +0000","url":"http://finance.yahoo.com/news/mrc-globals-mrc-stock-looks-141402525.html","summary":"MRC Global's (MRC) Stock Looks Bullish on Growth Drivers"},{"title":"ACCO BRANDS CORP Files SEC form 8-K, Other Events","publication_date":"2016-12-08 21:49:31 +0000","url":"http://biz.yahoo.com/e/161208/acco8-k.html","summary":"ACCO BRANDS CORP Files SEC form 8-K, Other Events"},{"title":"ACCO Brands Corporation Prices Offering Of $400 Million 5.25% Senior Unsecured Notes","publication_date":"2016-12-08 21:38:00 +0000","url":"http://finance.yahoo.com/news/acco-brands-corporation-prices-offering-213800255.html","summary":"[PR Newswire] - LAKE ZURICH, Ill., Dec. 8, 2016 /PRNewswire/ -- ACCO Brands Corporation (ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, today announced that it priced a private offering of $400 million in aggregate principal amount of 5.25% Senior Unsecured Notes due 2024 (\"the Notes\"). The price to investors will be 100% of the aggregate principal amount of the Notes. The company intends to use the proceeds from the offering, together with borrowings under its revolving credit facility and cash on hand, to redeem all of its 6.75% Senior Unsecured Notes due April 2020 and to pay fees and expenses related to the offering."},{"title":"Top Ranked Value Stocks to Buy for December 8th","publication_date":"2016-12-08 17:01:18 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YtyFba-xgH0/top-ranked-value-stocks-to-buy-for-december-8th-cm718778","summary":"Here are four stocks with Zacks Rank 1 Strong Buy and strong value characteristics for investors to consider today December 8 th ACCO Brands Corporation ACCO This manufacturer and distributor of office school and calendar products has seen the Zacks Consensus Estimate for its"},{"title":"Top Ranked Value Stocks to Buy for December 8th","publication_date":"2016-12-08 14:09:02 +0000","url":"http://finance.yahoo.com/news/top-ranked-value-stocks-buy-140902382.html","summary":"Top Ranked Value Stocks to Buy for December 8th"},{"title":"ACCO Brands Corporation Announces Private Offering Of $400 Million Senior Unsecured Notes","publication_date":"2016-12-08 13:08:00 +0000","url":"http://finance.yahoo.com/news/acco-brands-corporation-announces-private-130800205.html","summary":"[PR Newswire] - LAKE ZURICH, Ill., Dec. 8, 2016 /PRNewswire/ -- ACCO Brands Corporation (ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, today announced a private offering of $400 million of senior unsecured notes due 2024. The company intends to use the proceeds from the offering, together with borrowings under its revolving credit facility and cash on hand, to redeem all of its 6.75% Senior Unsecured Notes due April 2020 and to pay fees and expenses related to the offering. The redemption of the existing notes is conditioned on completion of the offering of the new notes. The notes will be offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended, and outside of the United States, only to non-U.S. investors pursuant to Regulation S. The notes will not be registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from registration requirements or a transaction not subject to the registration requirements of the Securities Act or any state securities laws."},{"title":"5 Reasonable Breakout Stocks for Exceptional Returns","publication_date":"2016-12-08 12:58:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-VK2P5NYaG8/5-reasonable-breakout-stocks-for-exceptional-returns-cm718461","summary":"Utilizing a breakout investment strategy is a natural choice for active investors who settle for nothing less than superlative returns This involves zeroing in on stocks trading within a tight range and buying them when they step out of this band In keeping with this approach they are"},{"title":"5 Reasonable Breakout Stocks for Exceptional Returns","publication_date":"2016-12-08 10:55:10 +0000","url":"http://finance.yahoo.com/news/5-reasonable-breakout-stocks-exceptional-105510777.html","summary":"5 Reasonable Breakout Stocks for Exceptional Returns"},{"title":"Powell Industries (POWL) Beats on Q4 Earnings & Revenues","publication_date":"2016-12-07 15:59:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NouyHhfn-Xo/powell-industries-powl-beats-on-q4-earnings-revenues-cm717941","summary":"Powell Industries Inc POWL reported adjusted earnings per share of 54 cents in the fourth quarter of fiscal 2016 outpacing the Zacks Consensus Estimate of 3 cents by a whopping 1700 Reported earnings also surged 20 year over year The bottom line improvement came on the back of"},{"title":"Powell Industries (POWL) Beats on Q4 Earnings & Revenues","publication_date":"2016-12-07 14:07:02 +0000","url":"http://finance.yahoo.com/news/powell-industries-powl-beats-q4-140702235.html","summary":"Powell Industries (POWL) Beats on Q4 Earnings & Revenues"},{"title":"Packaging Corporation Hits 52-Week High: What's Driving It?","publication_date":"2016-12-06 23:56:50 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QaenMs8_zr8/packaging-corporation-hits-52-week-high-whats-driving-it-cm717733","summary":"Shares of containerboard and packaging products manufacturer Packaging Corporation of America PKG scaled a new 52 week high of 88 29 on Dec 5 before ending the day at 87 15 The shares touched a new high following the completion of its recent acquisition of Columbus Container This"},{"title":"Sonoco (SON) Provides 2017 Guidance, Reaffirms 2016 View","publication_date":"2016-12-05 14:33:02 +0000","url":"http://finance.yahoo.com/news/sonoco-son-provides-2017-guidance-143302071.html","summary":"Sonoco (SON) Provides 2017 Guidance, Reaffirms 2016 View"},{"title":"Hedge Funds Are Banking On ACCO Brands Corporation (ACCO)","publication_date":"2016-12-01 16:59:51 +0000","url":"http://www.insidermonkey.com/blog/hedge-funds-are-banking-on-acco-brands-corporation-acco-495750/","summary":"Hedge Funds Are Banking On ACCO Brands Corporation (ACCO)"},{"title":"Berry Plastics (BERY) Beats on Q4 Earnings, Lags Revenues","publication_date":"2016-11-30 16:59:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hixF5Ikpv1w/berry-plastics-bery-beats-on-q4-earnings-lags-revenues-cm715762","summary":"Berry Plastics Group Inc BERY posted fourth quarter fiscal 2016 ended Oct 1 2016 results with adjusted earnings per share of 73 cents improving around 46 year over year Earnings comfortably beat the Zacks Consensus Estimate of 59 cents per share Including one time items the"},{"title":"Should Actuant (ATU) Stock Be Part of Your Portfolio Now?","publication_date":"2016-11-29 23:54:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T5aK9xsOlvE/should-actuant-atu-stock-be-part-of-your-portfolio-now-cm715419","summary":"On Nov 29 2016 Zacks Investment Research upgraded Actuant Corporation ATU to a Zacks Rank 3 Hold from a Zacks Rank 4 Sell Going by the Zacks model companies holding a Zacks Rank 3 have chances of performing in line with the broader market Why Hold Actuant aims to enhance"},{"title":"The Zacks Analyst Blog Highlights: EnerSys, Worthington Industries, ACCO Brands, Broadwind Energy and Net 1 Ueps Technologies","publication_date":"2016-11-29 16:58:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yhxZv7G6UgQ/the-zacks-analyst-blog-highlights-enersys-worthington-industries-acco-brands-broadwind-energy-and-net-1-ueps-technologies-cm715160","summary":"For Immediate Release Chicago IL November 29 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog"},{"title":"The Zacks Analyst Blog Highlights: EnerSys, Worthington Industries, ACCO Brands, Broadwind Energy and Net 1 Ueps Technologies","publication_date":"2016-11-29 14:30:02 +0000","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-enersys-143002570.html","summary":"The Zacks Analyst Blog Highlights: EnerSys, Worthington Industries, ACCO Brands, Broadwind Energy and Net 1 Ueps Technologies"},{"title":"5 Stocks to Buy on Record Gain in Durable Orders","publication_date":"2016-11-28 21:54:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l1wU6mY_OQA/5-stocks-to-buy-on-record-gain-in-durable-orders-cm714718","summary":"Durable orders increased significantly in October indicating that the U S manufacturing sector was attaining stability This report adds further weight to a raft of data released recently which suggest that the economy has strengthened Further markets and industry have been buoyed by"},{"title":"Top Ranked Value Stocks to Buy for November 28th","publication_date":"2016-11-28 19:56:33 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0yhL1wHnvmE/top-ranked-value-stocks-to-buy-for-november-28th-cm714679","summary":"Here are four stocks with Zacks Rank 1 Strong Buy and strong value characteristics for investors to consider today November 28 th The Children s Place Inc PLCE This children s specialty apparel retailer has seen the Zacks Consensus Estimate for its current year earnings"},{"title":"5 Stocks to Buy on Record Gain in Durable Orders","publication_date":"2016-11-28 19:35:07 +0000","url":"http://finance.yahoo.com/news/5-stocks-buy-record-gain-193507051.html","summary":"5 Stocks to Buy on Record Gain in Durable Orders"},{"title":"Caterpillar Hits 52-Week High: What's Driving the Stock?","publication_date":"2016-11-28 15:33:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uCddlEPiLsE/caterpillar-hits-52-week-high-whats-driving-the-stock-cm714445","summary":"Caterpillar Inc CAT shares attained a 52 week high of 96 44 during intraday trading on Nov 25 finally closing lower at 95 81 The company has delivered a year to date return of about 40 98 Caterpillar has a market cap of 56 06 billion Average volume of shares traded in the last"},{"title":"Top Ranked Value Stocks to Buy for November 28th","publication_date":"2016-11-28 15:10:03 +0000","url":"http://finance.yahoo.com/news/top-ranked-value-stocks-buy-151003769.html","summary":"Top Ranked Value Stocks to Buy for November 28th"},{"title":"Casella Waste Hits New 52-Week High on Robust '16 Outlook","publication_date":"2016-11-28 14:33:46 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KVta1zlItWA/casella-waste-hits-new-52-week-high-on-robust-16-outlook-cm714359","summary":"Shares of Casella Waste Systems Inc CWST reached a new 52 week high of 12 85 during its trading session on Nov 25 This apex improved upon the last 52 week high of 12 75 on Nov 23 Casella Waste Systems closed its trading session a tad lower at 12 77 yielding a solid year to date"},{"title":"Caterpillar Hits 52-Week High: What's Driving the Stock?","publication_date":"2016-11-28 13:24:01 +0000","url":"http://finance.yahoo.com/news/caterpillar-hits-52-week-high-132401160.html","summary":"Caterpillar Hits 52-Week High: What's Driving the Stock?"},{"title":"Casella Waste Hits New 52-Week High on Robust '16 Outlook","publication_date":"2016-11-28 12:42:12 +0000","url":"http://finance.yahoo.com/news/casella-waste-hits-52-week-124212878.html","summary":"Casella Waste Hits New 52-Week High on Robust '16 Outlook"},{"title":"The Zacks Analyst Blog Highlights: TTM Technologies, USD Partners, Kemet, Fibria Celulose and ACCO Brands","publication_date":"2016-11-25 16:04:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s0j5U59_uXY/the-zacks-analyst-blog-highlights-ttm-technologies-usd-partners-kemet-fibria-celulose-and-acco-brands-cm713921","summary":"For Immediate Release Chicago IL November 25 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog"},{"title":"Manitowoc (MTW) Hit by Low Crane Demand: Time to Dump?","publication_date":"2016-11-24 14:06:12 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3XpHSCN9d_s/manitowoc-mtw-hit-by-low-crane-demand-time-to-dump-cm713631","summary":"On Nov 23 2016 we issued an updated research report on The Manitowoc Company Inc MTW a leading global manufacturer of cranes and lift solutions The current global economic environment is severely affecting Manitowoc s customer demand for cranes Manitowoc reported adjusted loss"},{"title":"Deere (DE) Q4 Earnings & Revenues Beat but Decline Y/Y","publication_date":"2016-11-23 17:07:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9F8PdtfYgiA/deere-de-q4-earnings-revenues-beat-but-decline-yy-cm713310","summary":"Deere amp Company s DE fourth quarter fiscal 2016 ended Oct 31 2016 earnings declined 17 year over year to 90 cents per share However earnings beat the Zacks Consensus Estimate of 36 cents by a wide margin of 150 Global farm recession and weak construction equipment markets"},{"title":"5 Bargain Stocks to Grab for Black Friday","publication_date":"2016-11-23 16:07:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/73A54W-rZ4w/5-bargain-stocks-to-grab-for-black-friday-cm713275","summary":"The biggest bargain hunt of the year is about to commence As Friday approaches shoppers are preparing to pick up the best shopping deals of the year Known as Black Friday since the early 1930s this is the day which accounts for nearly 30 of retailers annual revenues Encouraging"},{"title":"Deere (DE) Q4 Earnings & Revenues Beat but Decline Y/Y","publication_date":"2016-11-23 15:13:03 +0000","url":"http://finance.yahoo.com/news/deere-q4-earnings-revenues-beat-151303018.html","summary":"Deere (DE) Q4 Earnings & Revenues Beat but Decline Y/Y"},{"title":"iRobot (IRBT) to Buy SODC's Distribution Business in Japan","publication_date":"2016-11-23 00:18:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WRn7E5sQAdc/irobot-irbt-to-buy-sodcs-distribution-business-in-japan-cm713027","summary":"iRobot Corporation IRBT expanded its commercial growth opportunities in Japan by signing a definitive contract to acquire the distribution business of Sales On Demand Corporation SODC a privately held company in Tokyo Since 2004 SODC has been a prominent distribution partner of iRobot"},{"title":"iRobot (IRBT) to Buy SODC's Distribution Business in Japan","publication_date":"2016-11-22 22:38:10 +0000","url":"http://finance.yahoo.com/news/irobot-irbt-buy-sodcs-distribution-223810674.html","summary":"iRobot (IRBT) to Buy SODC's Distribution Business in Japan"},{"title":"Caterpillar's 47-Month Low Continues, October Sales Dip 12%","publication_date":"2016-11-21 15:53:37 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bw8G9Ioa32Y/caterpillars-47-month-low-continues-october-sales-dip-12-cm711930","summary":"Caterpillar Inc s CAT global retail sales for the three month period ending Oct 2016 plunged 12 Despite remaining in the negative territory the decline rate has somewhat improved from the 18 dip in September 17 in August and 19 in July So far this year Caterpillar s monthly sales"},{"title":"Caterpillar's 47-Month Low Continues, October Sales Dip 12%","publication_date":"2016-11-21 13:34:01 +0000","url":"http://finance.yahoo.com/news/caterpillars-47-month-low-continues-133401005.html","summary":"Caterpillar's 47-Month Low Continues, October Sales Dip 12%"},{"title":"ETFs with exposure to ACCO Brands Corp. : November 18, 2016","publication_date":"2016-11-18 17:55:07 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acco-brands-corp-november-18-2016/","summary":"ETFs with exposure to ACCO Brands Corp. : November 18, 2016"},{"title":"Avery Dennison (AVY) Strategic Deals Impress: Time to Buy?","publication_date":"2016-11-18 15:51:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C_xSjh-31SY/avery-dennison-avy-strategic-deals-impress-time-to-buy-cm711179","summary":"On Nov 17 we issued an updated research report on Avery Dennison Corporation AVY a producer of pressure sensitive materials PSM and a variety of tickets tags labels and other converted products In the third quarter of 2016 Avery Dennison reported a 16 year over year increase"},{"title":"Avery Dennison (AVY) Strategic Deals Impress: Time to Buy?","publication_date":"2016-11-18 13:44:01 +0000","url":"http://finance.yahoo.com/news/avery-dennison-avy-strategic-deals-134401398.html","summary":"Avery Dennison (AVY) Strategic Deals Impress: Time to Buy?"},{"title":"ACCO Brands Corp. :ACCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016","publication_date":"2016-11-17 16:05:55 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-acco-us-earnings-analysis-q3-2016-by-the-numbers-november-17-2016/","summary":"ACCO Brands Corp. :ACCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016"},{"title":"Terex to Gain from Portfolio Restructuring; Risks Remain","publication_date":"2016-11-16 14:52:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HqjrbPONua8/terex-to-gain-from-portfolio-restructuring-risks-remain-cm710024","summary":"We have issued an updated research report on Terex Corporation TEX on Nov 15 Performance of this Zacks Rank 3 Hold global equipment manufacturer is likely to be hurt by lower demand for replacement of machines and weak mining market Nevertheless the company will benefit from the"},{"title":"Terex to Gain from Portfolio Restructuring; Risks Remain","publication_date":"2016-11-16 13:11:01 +0000","url":"http://finance.yahoo.com/news/terex-gain-portfolio-restructuring-risks-131101767.html","summary":"Terex to Gain from Portfolio Restructuring; Risks Remain"},{"title":"DXP Enterprises (DXPE) Reports Q3 Earnings, Sales Fall Y/Y","publication_date":"2016-11-15 16:30:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VRFC9deMB3Q/dxp-enterprises-dxpe-reports-q3-earnings-sales-fall-yy-cm709394","summary":"DXP Enterprises Inc DXPE reported mixed third quarter 2016 results with earnings beating expectations and revenues missing estimates The company s earnings of 2 cents per share compared favorably with the year ago loss of 3 64 The Zacks Consensus Estimate was of a loss of 2"},{"title":"DXP Enterprises (DXPE) Reports Q3 Earnings, Sales Fall Y/Y","publication_date":"2016-11-15 14:35:02 +0000","url":"http://finance.yahoo.com/news/dxp-enterprises-dxpe-reports-q3-143502769.html","summary":"DXP Enterprises (DXPE) Reports Q3 Earnings, Sales Fall Y/Y"},{"title":"Cognizant (CTSH) Cloud Facilitates Digitization of ACCO","publication_date":"2016-11-11 11:51:11 +0000","url":"http://finance.yahoo.com/news/cognizant-ctsh-cloud-facilitates-digitization-115111760.html","summary":"Cognizant (CTSH) Cloud Facilitates Digitization of ACCO"},{"title":"Astec Industries (ASTE) Catches Eye: Stock Jumps 16.1%","publication_date":"2016-11-10 15:57:01 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jjmdk81xqM4/astec-industries-aste-catches-eye-stock-jumps-161-cm707091","summary":"Astec Industries Inc ASTE was a big mover last session as the company saw its shares rise over 16 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above the"},{"title":"Cognizant Cloud-Enables Office Product Leader ACCO Brands' IT Infrastructure and Builds the Foundation for Digital Enterprise","publication_date":"2016-11-10 11:11:08 +0000","url":"http://www.publicnow.com/view/A80259A08AD28A5639EA718F6C71C161F58972A2","summary":"[at noodls] - TEANECK, N.J., Nov. 10, 2016/PRNewswire / -- Cognizant (NASDAQ: CTSH) today announced it has enabled ACCO Brands Corporation (NYSE: ACCO), one of the world's largest suppliers of branded school, office ..."},{"title":"The Zacks Analyst Blog Highlights: ACCO Brands, Norbord, Sanderson Farms, Standard Motor Products and TTM Technologies","publication_date":"2016-11-09 14:30:02 +0000","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-acco-143002650.html","summary":"The Zacks Analyst Blog Highlights: ACCO Brands, Norbord, Sanderson Farms, Standard Motor Products and TTM Technologies"},{"title":"Top Ranked Growth Stocks to Buy for November 9th","publication_date":"2016-11-09 14:19:02 +0000","url":"http://finance.yahoo.com/news/top-ranked-growth-stocks-buy-141902533.html","summary":"Top Ranked Growth Stocks to Buy for November 9th"},{"title":"Middleby (MIDD) Beats Q3 Earnings on Acquisition Benefits","publication_date":"2016-11-09 12:54:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jtVww0uIx10/middleby-midd-beats-q3-earnings-on-acquisition-benefits-cm706173","summary":"Machinery behemoth The Middleby Corporatio n MIDD reported mixed third quarter 2016 results Though the company s top line lagged the Zacks Consensus Estimate the bottom line surpassed expectations The company s quarterly earnings of 1 33 cents per share surpassed the Zacks"},{"title":"Sun Hydraulics (SNHY) Q3 Earnings Miss, Outlook Positive","publication_date":"2016-11-08 23:36:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b8JzbqZUC6A/sun-hydraulics-snhy-q3-earnings-miss-outlook-positive-cm705993","summary":"Sun Hydraulics Corporation SNHY reported weak third quarter 2016 results The company claimed that the soft global demand and a stronger U S dollar have primarily weighed over the quarterly top and bottom line results The company s adjusted earnings came in at 19 cents per share a"},{"title":"3 Reasons Value Stock Investors Will Love ACCO Brands (ACCO)","publication_date":"2016-11-08 14:56:02 +0000","url":"http://finance.yahoo.com/news/3-reasons-value-stock-investors-145602325.html","summary":"3 Reasons Value Stock Investors Will Love ACCO Brands (ACCO)"},{"title":"5 Best Stocks to Buy After the Presidential Election","publication_date":"2016-11-08 12:58:12 +0000","url":"http://finance.yahoo.com/news/5-best-stocks-buy-presidential-125812891.html","summary":"5 Best Stocks to Buy After the Presidential Election"},{"title":"Rockwell Automation (ROK) Beats Q4 Earnings Estimates","publication_date":"2016-11-07 22:54:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uh5rlLwHDQE/rockwell-automation-rok-beats-q4-earnings-estimates-cm705283","summary":"Rockwell Automation Inc ROK reported adjusted earnings per share of 1 52 in fourth quarter fiscal 2016 ended Sep 30 2016 down 3 from 1 57 earned in the prior year quarter However earnings outpaced the Zacks Consensus Estimate of 1 49 and recorded a positive earnings surprise of"},{"title":"Rockwell Automation (ROK) Beats Q4 Earnings Estimates","publication_date":"2016-11-07 20:53:08 +0000","url":"http://finance.yahoo.com/news/rockwell-automation-rok-beats-q4-205308504.html","summary":"Rockwell Automation (ROK) Beats Q4 Earnings Estimates"},{"title":"GBC® Introduces its New Discovery™ Line of Document Cameras.","publication_date":"2016-11-07 14:22:00 +0000","url":"http://finance.yahoo.com/news/gbc-introduces-discovery-line-document-142200394.html","summary":"[PR Newswire] - Portable and easy to use, GBC Discovery document cameras are a perfect solution to help educators make their lectures or classroom instruction visually comprehensive and interactive. All three Discovery models are equipped with an 8 Mega Pixel sensor -- the best sensor available on any document camera in the market. A superior sensor captures more detail while offering greater resolution and light sensitivity. This allows instructors to generate brilliant visuals that capture students' attention, engage them in teaching lessons and enhance their learning experiences. All three GBC Discovery document cameras – models 1100, 3000, and 3100 – operate as stand-alone devices and connect directly via VGA or HDMI to an overhead projector or flat screen television. Some similar models require interface to a computer."},{"title":"5 Attractively Priced Breakout Stocks for Strong Returns","publication_date":"2016-11-07 13:01:01 +0000","url":"http://finance.yahoo.com/news/5-attractively-priced-breakout-stocks-130101944.html","summary":"5 Attractively Priced Breakout Stocks for Strong Returns"},{"title":"RBC Bearings' (ROLL) Q2 Earnings Beat, Revenues Up Y/Y","publication_date":"2016-11-04 15:12:21 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nprwFRE-Ilk/rbc-bearings-roll-q2-earnings-beat-revenues-up-yy-cm703948","summary":"Premium machine tools amp accessories company RBC Bearings Inc ROLL reported better than expected second quarter fiscal 2017 results Adjusted earnings for the quarter came in at 78 cents per share a penny above than the Zacks Consensus Estimate The bottom line also surpassed the year"},{"title":"MRC Global (MRC) Reports Narrower-than-Expected Q3 Loss","publication_date":"2016-11-04 14:15:01 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/syrsyVgbKHw/mrc-global-mrc-reports-narrower-than-expected-q3-loss-cm704066","summary":"MRC Global Inc MRC posted third quarter 2016 loss of 48 cents per share or loss of 6 cents excluding severance non cash inventory and restructuring after tax charges of 42 cents The adjusted loss was narrower than the Zacks Consensus Estimate of a loss of 15 cents The company had"},{"title":"Watts Water (WTS) Beats Q3 Earnings, Lags on Revenues","publication_date":"2016-11-03 17:10:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G88z1r_74Yk/watts-water-wts-beats-q3-earnings-lags-on-revenues-cm703431","summary":"Watts Water Technologies Inc WTS reported third quarter 2016 adjusted earnings of 71 cents per share a 6 improvement year over year Earnings surpassed the Zacks Consensus Estimate of 69 cents Despite a lower top line the company witnessed growth in earnings owing to its transformation"},{"title":"Ball Corporation (BLL) Q3 Earnings Beat, Revenues Miss","publication_date":"2016-11-03 17:10:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eHP4doXdpuQ/ball-corporation-bll-q3-earnings-beat-revenues-miss-cm703384","summary":"Ball Corporation BLL reported third quarter 2016 adjusted earnings of 96 cents per share surpassing the Zacks Consensus Estimate of 92 cents Earnings decreased 4 on a year over year basis Earnings per share figure for the third quarter of 2016 reflects the impact of higher shares issued"},{"title":"Milacron (MCRN) Misses Q3 Earnings, Revenues; Shares Fall","publication_date":"2016-11-03 16:10:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aofdSlI35sY/milacron-mcrn-misses-q3-earnings-revenues-shares-fall-cm703333","summary":"Milacron Holdings Corp MCRN reported third quarter fiscal 2016 adjusted earnings per share of 36 cents a 3 decline from 37 cents in the year ago quarter Further earnings fell short of the Zacks Consensus Estimate of 38 cents Including one time items the company reported earnings"},{"title":"Top Ranked Growth Stocks to Buy for November 3rd","publication_date":"2016-11-03 14:18:02 +0000","url":"http://finance.yahoo.com/news/top-ranked-growth-stocks-buy-141802176.html","summary":"Top Ranked Growth Stocks to Buy for November 3rd"},{"title":"Xylem's (XYL) Sales Guidance Up on Solid Growth Prospects","publication_date":"2016-11-03 14:11:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ynz27tT9tA/xylems-xyl-sales-guidance-up-on-solid-growth-prospects-cm703186","summary":"On Nov 3 2016 we issued an updated research report on premium diversified machinery company Xylem Inc XYL Bullish Factors Xylem s public utility sector s business has been gaining strength over time This improvement is largely attributable to the rise in demand for its wastewater"},{"title":"Xylem (XYL) Beats Q3 Earnings, Trims 2016 EPS Guidance","publication_date":"2016-11-01 21:16:14 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dU9NNRD4TsY/xylem-xyl-beats-q3-earnings-trims-2016-eps-guidance-cm702046","summary":"Premium water solutions provider Xylem Inc XYL reported mixed third quarter 2016 results The company claimed that strong public utility sectors business during the quarter had partially offset the impact of weak conditions prevailing in the broader industrial sector 160 160"},{"title":"Columbus McKinnon (CMCO) in Focus: Stock Moves 9.1% Higher","publication_date":"2016-11-01 12:40:12 +0000","url":"http://finance.yahoo.com/news/columbus-mckinnon-cmco-focus-stock-124012716.html","summary":"Columbus McKinnon (CMCO) in Focus: Stock Moves 9.1% Higher"},{"title":"Astec (ASTE) Earnings Miss Estimates in Q3, Revenues Beat","publication_date":"2016-10-28 06:43:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nxK1DdJsMrw/astec-aste-earnings-miss-estimates-in-q3-revenues-beat-cm699836","summary":"Astec Industries Inc ASTE posted earnings of 30 cents per share in third quarter 2016 a 200 increase year over year but fell short of the Zacks Consensus Estimate of 37 cents Despite its strong overall performance low oil and natural gas prices continue to hurt its Energy Group"},{"title":"Sealed Air (SEE) Tops Q3 Earnings, Guides a Strong Q4","publication_date":"2016-10-27 21:42:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rKAxCtC6KMA/sealed-air-see-tops-q3-earnings-guides-a-strong-q4-cm699775","summary":"Sealed Air Corporation s SEE third quarter 2016 adjusted earnings per share of 71 cents increased 1 year over year The figure beat the Zacks Consensus Estimate by a penny Including special items earnings came in at 83 cents per share soaring 98 from the year ago quarter Total"},{"title":"Sealed Air (SEE) Tops Q3 Earnings, Guides a Strong Q4","publication_date":"2016-10-27 20:07:08 +0000","url":"http://finance.yahoo.com/news/sealed-air-see-tops-q3-200708138.html","summary":"Sealed Air (SEE) Tops Q3 Earnings, Guides a Strong Q4"},{"title":"Kensington Exclusively Launches Security Solution for the New Microsoft Surface Studio","publication_date":"2016-10-27 17:13:00 +0000","url":"http://finance.yahoo.com/news/kensington-exclusively-launches-security-solution-171300879.html","summary":"[PR Newswire] - SAN MATEO, Calif., Oct. 27, 2016 /PRNewswire/ -- Kensington ® , a worldwide leader of desktop productivity and mobility solutions for IT, business and home office professionals and The Professionals' ..."},{"title":"ACCO Brands (ACCO) Shares March Higher, Can It Continue?","publication_date":"2016-10-27 13:43:14 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GpEYh7TfmZg/acco-brands-acco-shares-march-higher-can-it-continue-cm699245","summary":"As of late it has definitely been a great time to be an investor in ACCO Brands Corporation ACCO The stock has moved higher by 16 5 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest that the"},{"title":"ACCO Brands (ACCO) Shares March Higher, Can It Continue?","publication_date":"2016-10-27 12:51:12 +0000","url":"http://finance.yahoo.com/news/acco-brands-acco-shares-march-125112016.html","summary":"ACCO Brands (ACCO) Shares March Higher, Can It Continue?"},{"title":"ACCO BRANDS CORP Files SEC form 10-Q, Quarterly Report","publication_date":"2016-10-26 19:25:18 +0000","url":"http://biz.yahoo.com/e/161026/acco10-q.html","summary":"ACCO BRANDS CORP Files SEC form 10-Q, Quarterly Report"},{"title":"ACCO Brands Corp.: Strong price momentum but will it sustain?","publication_date":"2016-10-25 20:23:47 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-strong-price-momentum-but-will-it-sustain/","summary":"ACCO Brands Corp.: Strong price momentum but will it sustain?"},{"title":"ACCO Brands Corp. breached its 50 day moving average in a Bullish Manner : ACCO-US : October 25, 2016","publication_date":"2016-10-25 12:56:25 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-breached-its-50-day-moving-average-in-a-bullish-manner-acco-us-october-25-2016/","summary":"ACCO Brands Corp. breached its 50 day moving average in a Bullish Manner : ACCO-US : October 25, 2016"},{"title":"Edited Transcript of ACCO earnings conference call or presentation 24-Oct-16 12:30pm GMT","publication_date":"2016-10-24 20:15:08 +0000","url":"http://finance.yahoo.com/news/edited-transcript-acco-earnings-conference-201508650.html","summary":"Edited Transcript of ACCO earnings conference call or presentation 24-Oct-16 12:30pm GMT"},{"title":"Why Acco Brands (ACCO) Stock Is Soaring Today","publication_date":"2016-10-24 18:50:00 +0000","url":"https://www.thestreet.com/story/13864422/1/why-acco-brands-acco-stock-is-soaring-today.html?puc=yahoo&cm_ven=YAHOO","summary":"Why Acco Brands (ACCO) Stock Is Soaring Today"},{"title":"ACCO Brands Corp Earnings Call and Acquisition of Esselte Group Holdings AB scheduled for 8:30 am ET today","publication_date":"2016-10-24 12:30:00 +0000","url":"http://biz.yahoo.com/cc/1/154091.html","summary":"ACCO Brands Corp Earnings Call and Acquisition of Esselte Group Holdings AB scheduled for 8:30 am ET today"},{"title":"ACCO Brands Corporation Reports Third Quarter 2016 Results","publication_date":"2016-10-24 11:41:10 +0000","url":"http://www.publicnow.com/view/A1D041094B2220F924C67A15D3C55761DD10FA8E","summary":"[at noodls] - LAKE ZURICH, Ill., Oct. 24, 2016 /PRNewswire/ -- ACCO Brands Corporation (NYSE: ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, ..."},{"title":"ACCO BRANDS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial","publication_date":"2016-10-24 11:40:33 +0000","url":"http://biz.yahoo.com/e/161024/acco8-k.html","summary":"ACCO BRANDS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial"},{"title":"Acco beats 3Q profit forecasts","publication_date":"2016-10-24 11:24:37 +0000","url":"http://sg.finance.yahoo.com/news/acco-beats-3q-profit-forecasts-112437565.html","summary":"Acco beats 3Q profit forecasts"},{"title":"Q3 2016 ACCO Brands Corp Earnings Release - Before Market Open","publication_date":"2016-10-24 11:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20161024.html?t=acco","summary":"Q3 2016 ACCO Brands Corp Earnings Release - Before Market Open"},{"title":"ACCO Brands Corporation To Acquire Esselte Group Holdings AB","publication_date":"2016-10-24 11:01:04 +0000","url":"http://www.publicnow.com/view/8EDDC15869AD226DE4FC1071F8E12EA21005FC87","summary":"[at noodls] - LAKE ZURICH, Ill., Oct. 24, 2016 /PRNewswire/ -- ACCO Brands Corporation (NYSE: ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, ..."},{"title":"ACCO Brands To Acquire Esselte Group - Quick Facts","publication_date":"2016-10-24 06:58:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cf_fuNUM0E4/acco-brands-to-acquire-esselte-group--quick-facts-20161024-01070","summary":"ACCO Brands To Acquire Esselte Group - Quick Facts"},{"title":"Pre-Market Earnings Report for October 24, 2016 : KMB, VFC, QSR, BEAV, WAL, EXP, BOH, SOHU, ACCO, BCC, OPB, CYOU","publication_date":"2016-10-23 20:13:54 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y6ajy3T46ts/pre-market-earnings-report-for-october-24-2016-kmb-vfc-qsr-beav-wal-exp-boh-sohu-acco-bcc-opb-cyou-cm696900","summary":"The following companies are expected to report earnings prior to market open on 10 24 2016 Visit our Earnings Calendar for a full list of expected earnings releases Kimberly Clark Corporation KMB is reporting for the quarter ending September 30 2016"},{"title":"Pre-Market Earnings Report for October 24, 2016 : KMB, VFC, QSR, BEAV, WAL, EXP, BOH, SOHU, ACCO, BCC, OPB, CYOU","publication_date":"2016-10-21 20:13:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FeGdfMLd_Z8/pre-market-earnings-report-for-october-24-2016-kmb-vfc-qsr-beav-wal-exp-boh-sohu-acco-bcc-opb-cyou-cm696736","summary":"The following companies are expected to report earnings prior to market open on 10 24 2016 Visit our Earnings Calendar for a full list of expected earnings releases Kimberly Clark Corporation KMB is reporting for the quarter ending September 30 2016"},{"title":"MRC Global's Growth Prospects Bright Despite Macro Issues","publication_date":"2016-10-14 14:43:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wr7qFeh9U88/mrc-globals-growth-prospects-bright-despite-macro-issues-cm693354","summary":"On Oct 14 2016 we issued an updated research report on MRC Global Inc MRC Scopes of Improvement MRC Global has been steadily bolstering its upstream midstream and downstream sales through product portfolio solidification and superior customer relationship Moreover the company"},{"title":"MRC Global's Growth Prospects Bright Despite Macro Issues","publication_date":"2016-10-14 12:55:12 +0000","url":"http://finance.yahoo.com/news/mrc-globals-growth-prospects-bright-125512044.html","summary":"MRC Global's Growth Prospects Bright Despite Macro Issues"},{"title":"Owens-Illinois (OI) Upgraded to Buy on Estimate Revisions","publication_date":"2016-10-13 23:40:40 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0J5efgWYZcE/owens-illinois-oi-upgraded-to-buy-on-estimate-revisions-cm693197","summary":"On Oct 13 2016 Zacks Investment Research upgraded Owens Illinois Inc OI to a Zacks Rank 2 Buy Going by the Zacks model companies holding a Zacks Rank 2 have strong chances of outperforming the broader market over the next few quarters With positive estimate revisions over the"},{"title":"Jacobs Engineering's Contracts from Olin to Drive Growth","publication_date":"2016-10-07 22:43:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nyi9hFI5670/jacobs-engineerings-contracts-from-olin-to-drive-growth-cm690589","summary":"Jacobs Engineering Group Inc JEC recently clinched a multiple year contract from Olin Corp OLN which underpins the company s organic growth trajectory Financial details of the deal have not been disclosed yet Olin Corporation is a renowned American manufacturer of chlorine ammunition"},{"title":"ACCO Brands to Report Third Quarter 2016 Results Monday, October 24, 2016","publication_date":"2016-10-06 17:49:02 +0000","url":"http://www.publicnow.com/view/30C507A7B696C2ECC04247D4345F5CBF3A115F83","summary":"[at noodls] - LAKE ZURICH, Ill., Oct. 06, 2016 (GLOBE NEWSWIRE) -- ACCO Brands Corporation (NYSE:ACCO) will release third quarter 2016 financial results at approximately 7:00 a.m. Eastern Time on Monday, October 24, ..."},{"title":"Actaunt (ATU) Faces Headwind Perils: Time to Sell the Stock?","publication_date":"2016-10-03 21:43:07 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6FREc2dYo2U/actaunt-atu-faces-headwind-perils-time-to-sell-the-stock-cm688112","summary":"On Oct 3 2016 we issued an updated research report on Actuant Corporation ATU The stock currently carries a Zacks Rank 5 Strong Sell indicating that indicating that the stock will underperform the broader market in the near term Why Should You Shun Actaunt 160 Dismal"},{"title":"Actaunt (ATU) Faces Headwind Perils: Time to Sell the Stock?","publication_date":"2016-10-03 19:54:07 +0000","url":"http://finance.yahoo.com/news/actaunt-atu-faces-headwind-perils-195407390.html","summary":"Actaunt (ATU) Faces Headwind Perils: Time to Sell the Stock?"},{"title":"ACCO Brands Corporation to Present at Investor Conference","publication_date":"2016-09-21 14:11:08 +0000","url":"http://www.publicnow.com/view/97F01E7C2449EADD07A2D3D560F8CF13147EEB55","summary":"[at noodls] - LAKE ZURICH, Ill., Sept. 21, 2016 /PRNewswire/ -- ACCO Brands Corporation (NYSE: ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, ..."},{"title":"Avery Dennison (AVY) & BD Launch New Vascular Dressings","publication_date":"2016-09-19 14:24:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wvSmlF7iGQE/avery-dennison-avy-bd-launch-new-vascular-dressings-cm681198","summary":"Avery Dennison Corporation s AVY Vancive Medical Technologies business in association with Becton Dickinson and Company BDX BD has launched a line of transparent vascular dressings with chlorhexidine gluconate CHG antimicrobial preservative The dressings will enhance patient care"},{"title":"The GBC® Ultima® 65, the Most Popular School Laminator in the Market, is Now Easier to Use","publication_date":"2016-09-19 14:10:00 +0000","url":"http://finance.yahoo.com/news/gbc-ultima-65-most-popular-141000607.html","summary":"[PR Newswire] - LAKE ZURICH, Ill., Sept. 19, 2016 /PRNewswire/ -- The GBC® Ultima® 65, which is known as \"THE School Laminator,\" is now better than ever. The new and improved GBC Ultima 65 is packed with features found on no other laminator in the educational environment."},{"title":"Milacron (MCRN) Poised to Grow Despite Segmental Concern","publication_date":"2016-09-16 00:18:01 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OvDRqMaPZpQ/milacron-mcrn-poised-to-grow-despite-segmental-concern-cm680303","summary":"On Sept 14 2016 we issued an updated research report on Milacron Holdings Corp MCRN Milacron Holdings is a global leader in the manufacture distribution and service of highly engineered and customized systems used in the plastic technology and processing industry Looking back"},{"title":"Grainger's (GWW) August Sales Up 4% on Cromwell Buyout","publication_date":"2016-09-14 14:49:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KwBv_MSjpcU/graingers-gww-august-sales-up-4-on-cromwell-buyout-cm679422","summary":"W W Grainger Inc GWW sales increased 4 year over year for Aug 2016 The sales growth was mainly attributed to the positive contribution from the Cromwell acquisition 3 percentage points and 1 percentage point increment from favorable foreign exchange Sales improvement in August"},{"title":"MRC Global's Growth Scenario Bright Despite Macro Risks","publication_date":"2016-09-12 22:46:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U1S1w4Jru94/mrc-globals-growth-scenario-bright-despite-macro-risks-cm678333","summary":"On Sep 12 2016 we issued an updated research report on MRC Global Inc MRC Scopes for Improvement MRC Global intends to drive growth on the back of superior customer relationship The company s products offered in the upstream midstream and downstream markets are rare and non"},{"title":"ACCO Brands Corp. – Value Analysis (NYSE:ACCO) : September 9, 2016","publication_date":"2016-09-09 17:50:18 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-value-analysis-nyseacco-september-9-2016/","summary":"ACCO Brands Corp. – Value Analysis (NYSE:ACCO) : September 9, 2016"},{"title":"ETF’s with exposure to ACCO Brands Corp. : September 9, 2016","publication_date":"2016-09-09 14:19:32 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acco-brands-corp-september-9-2016/","summary":"ETF’s with exposure to ACCO Brands Corp. : September 9, 2016"},{"title":"ACCO Brands Corp. breached its 50 day moving average in a Bullish Manner : ACCO-US : September 8, 2016","publication_date":"2016-09-08 12:02:15 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-breached-its-50-day-moving-average-in-a-bullish-manner-acco-us-september-8-2016/","summary":"ACCO Brands Corp. breached its 50 day moving average in a Bullish Manner : ACCO-US : September 8, 2016"},{"title":"Sonoco's Unit Buys Cold Chain Solutions Assets from AAR","publication_date":"2016-09-07 15:21:50 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HlvZU-G7D40/sonocos-unit-buys-cold-chain-solutions-assets-from-aar-cm675582","summary":"Sonoco Products Co s SON unit Sonoco ThermoSafe has acquired the PharmaPort 360 assets licenses trademarks and manufacturing rights from AAR This buyout will help Sonoco to enter the active temperature controlled cargo containers market Per the deal Sonoco ThermoSafe will own"},{"title":"Sonoco to Divest Rigid Plastics Blow Molding Operations","publication_date":"2016-09-02 14:20:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gos3xx-ZWMM/sonoco-to-divest-rigid-plastics-blow-molding-operations-cm673928","summary":"The maker of consumer and industrial packaging products Sonoco Products Co SON has entered into a definitive agreement to sell its rigid plastics blow molding operations to Amcor an Australian packaging company for 280 million The transaction is subject to regulatory approvals in the U"},{"title":"iRobot's Business Initiatives Impressive, Risks Remain","publication_date":"2016-08-30 14:16:25 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nlOFbojP43w/irobots-business-initiatives-impressive-risks-remain-cm672100","summary":"We issued an updated research report on premium appliances company iRobot CorporationIRBT on Aug 29, 2016. The company designs and sells mechanized robots worldwide for defensive, household and security related purposes. Scope for Growth iRobot"},{"title":"Sonoco (SON) Hits 52-Week High on Improved Q2 Earnings","publication_date":"2016-08-29 16:13:20 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JafGZD4Ev0Y/sonoco-son-hits-52-week-high-on-improved-q2-earnings-cm671671","summary":"Shares of Sonoco Products Co.SON reached a fresh 52 week high of $52.27 on Aug 26, before closing lower at $51.47. This new high was boosted by strong second quarter 2016 results and an elevated 2016 guidance."},{"title":"Sonoco (SON) Hits 52-Week High on Improved Q2 Earnings","publication_date":"2016-08-29 14:32:02 +0000","url":"http://finance.yahoo.com/news/sonoco-son-hits-52-week-143202555.html","summary":"Sonoco (SON) Hits 52-Week High on Improved Q2 Earnings"},{"title":"Actuant Poised for Growth Despite Macroeconomic Headwinds","publication_date":"2016-08-29 13:13:33 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BkIAJNcS8Yw/actuant-poised-for-growth-despite-macroeconomic-headwinds-cm671392","summary":"On Aug 29, 2016, we issued an updated research report on Actuant CorporationATU . The company is involved in designing, manufacturing and distribution of various industrial products and systems, with operations in more than 30 countries. Despite"},{"title":"Actuant Poised for Growth Despite Macroeconomic Headwinds","publication_date":"2016-08-29 11:35:11 +0000","url":"http://finance.yahoo.com/news/actuant-poised-growth-despite-macroeconomic-113511772.html","summary":"Actuant Poised for Growth Despite Macroeconomic Headwinds"},{"title":"Berry Plastics to Expand in North America with AEP Buyout","publication_date":"2016-08-26 15:31:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/muDq2TmjKnE/berry-plastics-to-expand-in-north-america-with-aep-buyout-cm670746","summary":"In a bid to expand its presence in North America, Berry Plastics Group, Inc . BERY has decided to acquire leading plastic packaging films manufacturer, AEP Industries Inc., for $765 million (including debt). The share price of"},{"title":"Raven Industries (RAVN) Q2 Earnings Up Y/Y, Shares Soar","publication_date":"2016-08-24 19:45:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ldqmziPJCJQ/raven-industries-ravn-q2-earnings-up-yy-shares-soar-cm669716","summary":"Shares of Raven Industries Inc.RAVN surged around 11.6% to close at $24.00 yesterday, after it reported second quarter fiscal 2017 (ended Jul 31, 2016) results. Earnings per share increased around 9% to 12 cents per share from"},{"title":"Deere (DE) Tops Q3 Earnings, Misses Sales, Revises View","publication_date":"2016-08-19 16:49:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_2dzabdsYcc/deere-de-tops-q3-earnings-misses-sales-revises-view-cm667843","summary":"Deere & Company 's DE third quarter fiscal 2016 (ended Jul 31, 2016) earnings increased around 1.3% year over year to $1.55 per share. Earnings also topped the Zacks Consensus Estimate of 95 cents.Operational Update Net"},{"title":"Briggs & Stratton (BGG) Misses on Q4 Earnings & Revenues","publication_date":"2016-08-18 22:46:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UYV4gVit40c/briggs-stratton-bgg-misses-on-q4-earnings-revenues-cm667394","summary":"Briggs & Stratton CorporationBGG reported fourth quarter fiscal 2016 (ended Jul 3, 2016) adjusted earnings of 46 cents per share, down 9.8% from 51 cents earned in the prior year quarter. Results also missed the Zacks Consensus"},{"title":"Briggs & Stratton (BGG) Misses on Q4 Earnings & Revenues","publication_date":"2016-08-18 20:52:08 +0000","url":"http://finance.yahoo.com/news/briggs-stratton-bgg-misses-q4-205208299.html","summary":"Briggs & Stratton (BGG) Misses on Q4 Earnings & Revenues"},{"title":"Sealed Air (SEE) Poised to Grow Despite Weak Resin Prices","publication_date":"2016-08-18 00:42:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g9QSgE8_Vfg/sealed-air-see-poised-to-grow-despite-weak-resin-prices-cm666873","summary":"We issued an updated research report on Sealed Air CorporationSEE on Aug 16, 2016. The company is set to benefit from focus on innovation, acquisitions, increased demand and effective cost management. However, unfavorable foreign currency translation, political"},{"title":"Kensington Launches MicroSaver® 2.0 Keyed Laptop Lock Designed to Secure the Thinnest Devices","publication_date":"2016-08-16 15:01:03 +0000","url":"http://www.publicnow.com/view/9A14279F9289EF84AF7EBB2787D1B50663CACF04","summary":"[at noodls] - SAN MATEO, Calif., Aug. 16, 2016 /PRNewswire/ -- Kensington, a worldwide leader of desktop productivity and mobility solutions for IT, business and home office professionals and The Professionals' Choice ..."},{"title":"Kensington Launches MicroSaver® 2.0 Keyed Laptop Lock Designed to Secure the Thinnest Devices","publication_date":"2016-08-16 14:46:00 +0000","url":"http://finance.yahoo.com/news/kensington-launches-microsaver-2-0-144600115.html","summary":"[PR Newswire] - SAN MATEO, Calif., Aug. 16, 2016 /PRNewswire/ -- Kensington®, a worldwide leader of desktop productivity and mobility solutions for IT, business and home office professionals and The Professionals' Choice for device security for nearly 25 years, today announced the launch of the MicroSaver® 2.0 Keyed Laptop Lock. The MicroSaver 2.0 — which was engineered under strict specifications by Kensington to work with the thinnest laptops without compromising strength — represents the next generation of laptop security. The latest in Kensington's long legacy of providing IT professionals with maximum anti-theft protection for laptops and other devices, the MicroSaver 2.0 Keyed Laptop Lock is only 10 millimeters in diameter and provides the same strength as the world renowned MicroSaver Keyed Laptop Lock that has been the industry leader for more than 20 years."},{"title":"EnerSys (ENS) Q1 Earnings Beat, Revenues Miss, Stock Up","publication_date":"2016-08-12 15:56:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lNWUSHxM4eo/enersys-ens-q1-earnings-beat-revenues-miss-stock-up-cm664692","summary":"Shares of premium battery maker EnerSysENS surged 7.9% on Aug 11, following the company's first quarter 2017 results, which surpassed its guided range. The company reported first quarter fiscal 2017 adjusted net earnings of $1.14 per share, beating the"},{"title":"EnerSys (ENS) Q1 Earnings Beat, Revenues Miss, Stock Up","publication_date":"2016-08-12 13:18:01 +0000","url":"http://finance.yahoo.com/news/enersys-ens-q1-earnings-beat-131801665.html","summary":"EnerSys (ENS) Q1 Earnings Beat, Revenues Miss, Stock Up"},{"title":"Zacks Value Investor Highlights: Vanguard Small Cap Value ETF, Guggenheim S&P Small Cap 600 Pure Value ETF, ACCO Brands, Columbus McKinnon and Ferro","publication_date":"2016-08-12 08:52:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P1gbyqZX5aI/zacks-value-investor-highlights-vanguard-small-cap-value-etf-guggenheim-sp-small-cap-600-pure-value-etf-acco-brands-columbus-mckinnon-and-ferro-cm664093","summary":"For Immediate Release Chicago, IL August 11, 2016 Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds"},{"title":"ETF’s with exposure to ACCO Brands Corp. : August 11, 2016","publication_date":"2016-08-11 16:25:25 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acco-brands-corp-august-11-2016/","summary":"ETF’s with exposure to ACCO Brands Corp. : August 11, 2016"},{"title":"Berry Plastics (BERY) Hits 52-Week High on Solid Q3 Results","publication_date":"2016-08-11 15:55:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w1kwh5F9RZ8/berry-plastics-bery-hits-52-week-high-on-solid-q3-results-cm664106","summary":"Shares of Berry Plastics Group, Inc.BERY scaled a 52 week high of $42.70 on Aug 10. This stock price appreciation came on the back of robust third quarter fiscal 2016 results and raised guidance. Berry Plastics has a market"},{"title":"Lincoln Electric Announces Promotion of 2 Top Executives","publication_date":"2016-08-11 15:55:06 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uUTEiuC4A9c/lincoln-electric-announces-promotion-of-2-top-executives-cm664087","summary":"Lincoln Electric Holdings Inc.LECO announced that the President of Lincoln Electric Canada Michael J. Whitehead has been promoted as the Senior Vice President, Strategy and Business Development. On the other hand, the Director of Operations of Lincoln Canada Adel"},{"title":"Lincoln Electric Announces Promotion of 2 Top Executives","publication_date":"2016-08-11 13:39:01 +0000","url":"http://finance.yahoo.com/news/lincoln-electric-announces-promotion-2-133901451.html","summary":"Lincoln Electric Announces Promotion of 2 Top Executives"},{"title":"Small Cap Value Stocks for the Win","publication_date":"2016-08-10 22:51:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yhp5rZO97aM/small-cap-value-stocks-for-the-win-cm663715","summary":"Welcome to Episode #4 of the Value Investor Podcast Every week, Zacks value stock strategist and the Editor of Zacks Value Investor portfolio service, Tracey Ryniec, talks about all things happening in the value stock universe,"},{"title":"Manitowoc (MTW) Q2 Earnings Beat, Sales Miss Estimates","publication_date":"2016-08-10 16:49:43 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z6NPl4pky40/manitowoc-mtw-q2-earnings-beat-sales-miss-estimates-cm663481","summary":"The Manitowoc Company, Inc.MTW reported second quarter 2016 adjusted earnings of 4 cents per share that beat the Zacks Consensus Estimate by a penny. Notably the company has swung to profit from the prior year quarter loss of 4"},{"title":"Avery Dennison (AVY) Hits 52-Week High on Solid Q2 Earnings","publication_date":"2016-08-10 15:55:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M5DE7Nj9rfU/avery-dennison-avy-hits-52-week-high-on-solid-q2-earnings-cm663401","summary":"Shares of Avery Dennison CorporationAVY reached a fresh 52 week high of $79.09 on Aug 9, before closing lower at $78.73. This new high was boosted by strong second quarter 2016 results and an elevated 2016 guidance. Pasadena, CA"},{"title":"ACCO Brands Corp. :ACCO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016","publication_date":"2016-08-09 15:55:33 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-acco-us-earnings-analysis-q2-2016-by-the-numbers-august-9-2016/","summary":"ACCO Brands Corp. :ACCO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016"},{"title":"Ball Corporation (BLL) Q2: Tops Earnings, View Positive","publication_date":"2016-08-04 21:55:19 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nyxtw6Uv2D0/ball-corporation-bll-q2-tops-earnings-view-positive-cm660757","summary":"Ball CorporationBLL reported second quarter 2016 adjusted earnings of $1.05 per share, surpassing the Zacks Consensus Estimate of 99 cents. Earnings also increased around 18% on a year over year basis, driven by the completion of legacy metal packaging"},{"title":"ACCO BRANDS CORP Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-08-03 19:56:08 +0000","url":"http://biz.yahoo.com/e/160803/acco8-k.html","summary":"ACCO BRANDS CORP Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"ACCO Brands Corp. breached its 50 day moving average in a Bearish Manner : ACCO-US : August 3, 2016","publication_date":"2016-08-03 14:25:30 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-breached-its-50-day-moving-average-in-a-bearish-manner-acco-us-august-3-2016/","summary":"ACCO Brands Corp. breached its 50 day moving average in a Bearish Manner : ACCO-US : August 3, 2016"},{"title":"Edited Transcript of ACCO earnings conference call or presentation 2-Aug-16 12:30pm GMT","publication_date":"2016-08-02 17:44:04 +0000","url":"http://finance.yahoo.com/news/edited-transcript-acco-earnings-conference-174404759.html","summary":"Edited Transcript of ACCO earnings conference call or presentation 2-Aug-16 12:30pm GMT"},{"title":"ACCO Brands Corp Earnings Call scheduled for 8:30 am ET today","publication_date":"2016-08-02 12:30:00 +0000","url":"http://biz.yahoo.com/cc/4/152644.html","summary":"ACCO Brands Corp Earnings Call scheduled for 8:30 am ET today"},{"title":"ACCO BRANDS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits","publication_date":"2016-08-02 11:54:44 +0000","url":"http://biz.yahoo.com/e/160802/acco8-k.html","summary":"ACCO BRANDS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"},{"title":"Acco tops Street 2Q forecasts","publication_date":"2016-08-02 11:33:25 +0000","url":"http://sg.finance.yahoo.com/news/acco-tops-street-2q-forecasts-113325855.html","summary":"Acco tops Street 2Q forecasts"},{"title":"ACCO Brands Corporation Reports Second Quarter 2016 Results","publication_date":"2016-08-02 11:21:08 +0000","url":"http://www.publicnow.com/view/99FF89701D0CB9B695185DDF5B6711EA7FD841CE","summary":"[at noodls] - LAKE ZURICH, Ill., Aug. 2, 2016 /PRNewswire/ -- ACCO Brands Corporation (NYSE: ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, ..."},{"title":"Q2 2016 ACCO Brands Corp Earnings Release - Before Market Open","publication_date":"2016-08-02 11:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20160802.html?t=acco","summary":"Q2 2016 ACCO Brands Corp Earnings Release - Before Market Open"},{"title":"It's Time for Lesser-Known Names to Take Earnings Center Stage","publication_date":"2016-08-01 19:54:00 +0000","url":"http://realmoney.thestreet.com/articles/08/01/2016/its-time-lesser-known-names-take-earnings-center-stage?puc=yahoo&cm_ven=YAHOO","summary":"It's Time for Lesser-Known Names to Take Earnings Center Stage"},{"title":"ACCO Brands to Report Second Quarter 2016 Results Tuesday, August 2, 2016","publication_date":"2016-07-11 16:43:08 +0000","url":"http://www.publicnow.com/view/57A9D7316196270184D1E02F7B3D400D7919DC70","summary":"[at noodls] - LAKE ZURICH, Ill., July 11, 2016 (GLOBE NEWSWIRE) -- ACCO Brands Corporation (NYSE:ACCO) will release second quarter 2016 financial results at approximately 7:00 a.m. Eastern Time on Tuesday, August 2, ..."},{"title":"ACCO Brands Corp. breached its 50 day moving average in a Bearish Manner : ACCO-US : June 28, 2016","publication_date":"2016-06-28 12:06:27 +0000","url":"http://www.capitalcube.com/blog/index.php/acco-brands-corp-breached-its-50-day-moving-average-in-a-bearish-manner-acco-us-june-28-2016/","summary":"ACCO Brands Corp. breached its 50 day moving average in a Bearish Manner : ACCO-US : June 28, 2016"},{"title":"Raven Industries (RAVN) Poised to Combat Market Weakness","publication_date":"2016-06-24 14:38:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Frv4w4wZYtc/raven-industries-ravn-poised-to-combat-market-weakness-cm640207","summary":"On Jun 23, 2016, we issued an updated research report on Raven Industries Inc.RAVN , a manufacturer of a variety of products for customers in the industrial, construction and military aerospace markets. Raven's estimates have remained stable ahead of"},{"title":"Avery Dennison (AVY) Hits 52-Week High, Gains from Buyouts","publication_date":"2016-06-24 14:06:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xFOgohFnsF0/avery-dennison-avy-hits-52-week-high-gains-from-buyouts-cm640135","summary":"Shares of Avery Dennison CorporationAVY crafted a 52 week high of $77.38 on Jun 23. The fresh high came on the back of expected benefits from its focus on productivity, acquisitions and performance of Pressure sensitive materials. The stock"},{"title":"Apogee (APOG) Tops Q1 Earnings, Revenues; Raises View","publication_date":"2016-06-23 15:05:21 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SFO-up7JxrA/apogee-apog-tops-q1-earnings-revenues-raises-view-cm639561","summary":"Apogee Enterprises, Inc.APOG posted earnings per share of 61 cents in first quarter fiscal 2017 (ended May 28, 2016) that surged 49% from earnings of 41 cents per share in the prior year quarter. Earnings surpassed the Zacks Consensus"},{"title":"3 Undervalued Zacks Strong Buy Stocks","publication_date":"2016-06-22 20:58:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sxNM09R0DM8/3-undervalued-zacks-strong-buy-stocks-cm639240","summary":"Many investors know that screening is a very powerful way to find the best stocks, but creating your own screens can be difficult and time consuming. However, with Zacks Premium Screens, finding the best stocks is just a few"},{"title":"3 Undervalued Zacks Strong Buy Stocks","publication_date":"2016-06-22 18:59:06 +0000","url":"http://finance.yahoo.com/news/3-undervalued-zacks-strong-buy-185906684.html","summary":"3 Undervalued Zacks Strong Buy Stocks"},{"title":"Kensington SmartFit Laptop Risers Optimize User Comfort Level While Working at the Desktop","publication_date":"2016-06-22 16:48:00 +0000","url":"http://finance.yahoo.com/news/kensington-smartfit-laptop-risers-optimize-164800459.html","summary":"[PR Newswire] - NEW YORK, June 22, 2016 /PRNewswire/ -- CE Week – Kensington®, a worldwide leader of desktop computing and mobility solutions for IT, business and home office professionals, today announced two SmartFit® Laptop Risers designed to improve user productivity and comfort levels at the desktop. Kensington's SmartFit Laptop Riser and award-winning SmartFit Laptop Riser with Wireless Phone Charging Pad allow users to find their personal laptop height setting for optimal comfort to reduce neck and back strain while working. The riser with Wireless Phone Charging Pad simplifies the process of charging a smart phone by eliminating the need for any cable."},{"title":"Kensington Extends USB-C Product Line to Enhance the Professional's Desktop Performance for Greater Productivity","publication_date":"2016-06-22 16:35:00 +0000","url":"http://finance.yahoo.com/news/kensington-extends-usb-c-product-163500265.html","summary":"[PR Newswire] - NEW YORK, June 22, 2016 /PRNewswire/ -- CE WEEK – Kensington ® , a worldwide leader of desktop computing and mobility solutions for IT, business and home office professionals, has expanded its line of ..."},{"title":"Featured Research Report on Consumer Goods Stocks","publication_date":"2016-06-20 12:53:33 +0000","url":"http://news.investornetwork.com/2016/06/20/featured-research-report-on-consumer-goods-stocks/?1=1&1466427213","summary":"Featured Research Report on Consumer Goods Stocks"},{"title":"Will Rise in Beverage Cans Demand Benefit Crown Holdings?","publication_date":"2016-06-16 21:03:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Frb80pS2MyE/will-rise-in-beverage-cans-demand-benefit-crown-holdings-cm636653","summary":"We issued an updated research report on Crown Holdings Inc.CCK on Jun 15, 2016. The manufacturer of packaging products for consumer goods is expected to benefit from rise in global beverage can demand. The acquisition of EMPAQUE, increased investments"},{"title":"Should Lincoln Electric Be in Your Portfolio Right Now?","publication_date":"2016-06-16 17:08:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7DOg_fsN7k8/should-lincoln-electric-be-in-your-portfolio-right-now-cm636502","summary":"We issued an updated research report on Lincoln Electric Holdings Inc.LECO on Jun 15, 2016. The company is poised to gain from continuous focus on cost reduction, acquisitions, strength of its product pipeline and new launches. However, foreign exchange"},{"title":"Is this the Right Time to Buy Avery Dennison (AVY) Stock?","publication_date":"2016-06-16 16:09:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8d0rNWy7DI8/is-this-the-right-time-to-buy-avery-dennison-avy-stock-cm636398","summary":"On Jun 15, we issued an updated research report on Avery Dennison CorporationAVY , a producer of pressure sensitive materials, and variety of tickets, tags, labels and other converted products. In the first quarter of 2016, both of Avery"},{"title":"Five Star® Backpacks Created with Students in Mind","publication_date":"2016-05-17 13:00:00 +0000","url":"http://finance.yahoo.com/news/five-star-backpacks-created-students-130000614.html","summary":"[PR Newswire] - KETTERING, Ohio, May 17, 2016 /PRNewswire/ -- The newest Five Star® backpack line, based on the latest school supply research, incorporates highly innovative and lasting solutions from a trusted brand that is known to withstand the test of time. The unique features, such as insulated food storage and tech ports, help students carry more than just books. Five Star® Backpack + Insulated Storage – Students often take their lunches, snacks, and drinks on-the-go to help power through their busy schedules."},{"title":"Five Star® Delivers Unmatched Innovation to Create Reliable Supplies for Students","publication_date":"2016-05-17 13:00:00 +0000","url":"http://finance.yahoo.com/news/five-star-delivers-unmatched-innovation-130000517.html","summary":"[PR Newswire] - KETTERING, Ohio, May 17, 2016 /PRNewswire/ -- Although school supplies have been around for a long time, Five Star ® continues to be the industry leader in creating new and innovative solutions that help ..."},{"title":"Boris Elisman Named Chairman Of ACCO Brands Corporation","publication_date":"2016-05-11 21:07:03 +0000","url":"http://www.publicnow.com/view/09234F96E1AF3E75528AAF55E58D306654D3CF09","summary":"[at noodls] - LAKE ZURICH, Ill., May 11, 2016 /PRNewswire/ -- ACCO Brands Corporation (NYSE:ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, ..."},{"title":"ACCO Brands Corporation Completes Acquisition Of Pelikan Artline","publication_date":"2016-05-02 11:20:12 +0000","url":"http://www.publicnow.com/view/C0B3B5166FE896D6EBADB4F52384FF613BBFBD0F","summary":"[at noodls] - LAKE ZURICH, Ill., May 2, 2016 /PRNewswire/ -- ACCO Brands Corporation (NYSE:ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, ..."},{"title":"Acco tops Street 1Q forecasts","publication_date":"2016-04-27 11:34:39 +0000","url":"http://sg.finance.yahoo.com/news/acco-tops-street-1q-forecasts-113439451.html","summary":"Acco tops Street 1Q forecasts"},{"title":"ACCO Brands Corporation Reports First Quarter 2016 Results","publication_date":"2016-04-27 11:11:33 +0000","url":"http://www.publicnow.com/view/85B84F5040888ED00456CEECA108ADF2CEE50F7A","summary":"[at noodls] - LAKE ZURICH, Ill., April 27, 2016 /PRNewswire/ -- ACCO Brands Corporation (NYSE: ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, ..."},{"title":"ACCO Brands to Report First Quarter 2016 Results Wednesday, April 27, 2016","publication_date":"2016-04-12 15:39:21 +0000","url":"http://www.publicnow.com/view/7CAD9DD5520FF0425BC7925918B67DAE9A41B578","summary":"[at noodls] - LAKE ZURICH, Ill., April 12, 2016 (GLOBE NEWSWIRE) -- ACCO Brands Corporation (NYSE:ACCO) will release first quarter 2016 financial results at approximately 7:00 a.m. Eastern Time on Wednesday, April 27, ..."},{"title":"ACCO Brands Corporation To Acquire Remaining 50% Of Its Australian Joint Venture, Pelikan Artline","publication_date":"2016-03-21 20:13:09 +0000","url":"http://www.publicnow.com/view/A4274C1E2042F5DF2C9B6FD9AACA8CDF9AE6FD81","summary":"[at noodls] - LAKE ZURICH, Ill., March 21, 2016 /PRNewswire/ -- ACCO Brands Corporation (NYSE:ACCO), one of the world's largest designers, marketers and manufacturers of branded business, academic and consumer products, ..."},{"title":"Acco beats Street 4Q forecasts","publication_date":"2016-02-10 12:19:26 +0000","url":"http://sg.finance.yahoo.com/news/acco-beats-street-4q-forecasts-121926467.html","summary":"Acco beats Street 4Q forecasts"},{"title":"ACCO Brands to Report Fourth Quarter 2015 Results Wednesday, February 10, 2016","publication_date":"2016-01-20 16:25:10 +0000","url":"http://www.noodls.com/view/DA47CB27D008ADAB9E77CAD572787E13AF35C77A","summary":"[at noodls] - , (GLOBE NEWSWIRE) -- (NYSE:ACCO) will release fourth quarter and fiscal year 2015 financial results at approximately on . At the Company will host a conference call to discuss the results. The call will ..."},{"title":"Acco tops 3Q profit forecasts","publication_date":"2015-10-28 11:31:36 +0000","url":"http://sg.finance.yahoo.com/news/acco-tops-3q-profit-forecasts-113136020.html","summary":"Acco tops 3Q profit forecasts"},{"title":"ACCO Brands Corporation Reports Third Quarter 2015 Results; Announces Additional $100 Million Share Repurchase Authorization","publication_date":"2015-10-28 11:27:05 +0000","url":"http://www.noodls.com/view/CA69ABB8339F9F7B46E837907BC023CD43BF0C6C","summary":"[at noodls] - LAKE ZURICH, Ill., Oct. 28, 2015 /PRNewswire/ -- ACCO Brands Corporation (NYSE: ACCO), a world leader in branded school, office and consumer products, today reported its third quarter results for the period ..."},{"title":"ACCO Brands to Webcast Third Quarter Results Call Wednesday, October 28, 2015","publication_date":"2015-09-30 17:08:03 +0000","url":"http://www.noodls.com/view/ADFE860A891993244989622C7F0E60414C9BCC55","summary":"[at noodls] - LAKE ZURICH, Ill., Sept. 30, 2015 (GLOBE NEWSWIRE) -- ACCO Brands Corporation (NYSE:ACCO) will release third quarter 2015 financial results at approximately 7:00 a.m. Eastern Time on Wednesday, October ..."},{"title":"3.3 million dry erase boards recalled after due to cut risk","publication_date":"2015-07-30 16:33:16 +0000","url":"http://sg.finance.yahoo.com/news/3-3-million-dry-erase-163316180.html","summary":"3.3 million dry erase boards recalled after due to cut risk"},{"title":"Acco reports 1Q loss","publication_date":"2015-04-29 11:21:41 +0000","url":"http://sg.finance.yahoo.com/news/acco-reports-1q-loss-112141878.html","summary":"Acco reports 1Q loss"},{"title":"Acco beats 4Q profit forecasts","publication_date":"2015-02-11 12:57:49 +0000","url":"http://sg.finance.yahoo.com/news/acco-beats-4q-profit-forecasts-125749454.html","summary":"Acco beats 4Q profit forecasts"},{"title":"Acco beats Street 3Q forecasts","publication_date":"2014-10-29 14:07:20 +0000","url":"http://sg.finance.yahoo.com/news/acco-beats-street-3q-forecasts-140720086--finance.html","summary":"Acco beats Street 3Q forecasts"}],"result_count":250,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1}},
{"id":"2","chart":[{"values":[{"x":"1489156200","y":"4.2321"},{"x":"1489156500","y":"4.28"},{"x":"1489156800","y":"4.29"},{"x":"1489157100","y":"4.2301"},{"x":"1489157400","y":"4.2698"},{"x":"1489157700","y":"4.265"},{"x":"1489158000","y":"4.3"},{"x":"1489158300","y":"4.3"},{"x":"1489158600","y":"4.3"},{"x":"1489158900","y":"4.31"},{"x":"1489159200","y":"4.31"},{"x":"1489159500","y":"4.3"},{"x":"1489159800","y":"4.3"},{"x":"1489160100","y":"4.32"},{"x":"1489160400","y":"4.319"},{"x":"1489160700","y":"4.306"},{"x":"1489161000","y":"4.3"},{"x":"1489161600","y":"4.3"},{"x":"1489161900","y":"4.3133"},{"x":"1489162200","y":"4.32"},{"x":"1489162500","y":"4.305"},{"x":"1489162800","y":"4.32"},{"x":"1489163100","y":"4.31"},{"x":"1489163400","y":"4.3199"},{"x":"1489163700","y":"4.32"},{"x":"1489164000","y":"4.35"},{"x":"1489164300","y":"4.37"},{"x":"1489164600","y":"4.37"},{"x":"1489164900","y":"4.44"},{"x":"1489165200","y":"4.52"},{"x":"1489165800","y":"4.467"},{"x":"1489166100","y":"4.414"},{"x":"1489166400","y":"4.44"},{"x":"1489166700","y":"4.3699"},{"x":"1489167000","y":"4.4"},{"x":"1489167300","y":"4.37"},{"x":"1489167600","y":"4.38"},{"x":"1489167900","y":"4.35"},{"x":"1489168200","y":"4.2965"},{"x":"1489168500","y":"4.33"},{"x":"1489168800","y":"4.34"},{"x":"1489169100","y":"4.33"},{"x":"1489170300","y":"4.43"},{"x":"1489170900","y":"4.4"},{"x":"1489171200","y":"4.388"},{"x":"1489171500","y":"4.3865"},{"x":"1489171800","y":"4.41"},{"x":"1489172100","y":"4.3982"},{"x":"1489172400","y":"4.37"},{"x":"1489172700","y":"4.4"},{"x":"1489173000","y":"4.4"},{"x":"1489173300","y":"4.4"},{"x":"1489173600","y":"4.42"},{"x":"1489173900","y":"4.42"},{"x":"1489174200","y":"4.42"},{"x":"1489174500","y":"4.46"},{"x":"1489175100","y":"4.46"},{"x":"1489175400","y":"4.5159"},{"x":"1489175700","y":"4.59"},{"x":"1489176000","y":"4.57"},{"x":"1489176300","y":"4.542"},{"x":"1489176600","y":"4.54"},{"x":"1489176900","y":"4.55"},{"x":"1489177200","y":"4.585"},{"x":"1489177500","y":"4.57"},{"x":"1489177800","y":"4.5841"},{"x":"1489178100","y":"4.55"},{"x":"1489178400","y":"4.5564"},{"x":"1489178700","y":"4.54"},{"x":"1489179000","y":"4.54"},{"x":"1489179300","y":"4.63"},{"x":"1489179600","y":"4.61"},{"x":"1489180500","y":"4.8100000000000005"},{"x":"1489181400","y":"4.8"},{"x":"1489182600","y":"4.8100000000000005"},{"x":"1489182900","y":"4.8100000000000005"},{"x":"1489183200","y":"4.8100000000000005"},{"x":"1489185000","y":"4.71"},{"x":"1489186200","y":"4.71"},{"x":"1489186500","y":"4.71"},{"x":"1489189200","y":"4.82"},{"x":"1489192200","y":"4.71"}
],"color":"#03a9f4"}],"list":"Market Movers","symbol": "ADAP","name": "Adaptimmune Therapeu","price": 4.5347,"dollarChange": 0.31,"percentChange": 7.21,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/ADAP-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/ADAP-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/ADAP-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/ADAP-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/ADAP-1yr.php","open": 4.29,"high": 4.54,"low":4.22,"volume": 444157,"avgVol": 121491.510638,"sharesShort": 340567,"shortPercent": 0.481127,"marketCap": 285264823,"float": 70785316,"headlines":{"data":[{"title":"Adaptimmune to Report Fourth Quarter and Full Year 2016 Financial Results on March 13, 2017","publication_date":"2017-03-08 13:00:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-report-fourth-quarter-full-130000034.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, March 08, 2017-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, will announce financial results for the fourth quarter and full year ..."},{"title":"European ADRs Edge Lower as Miners Head South","publication_date":"2017-03-06 16:32:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zsQQqUfkgA0/european-adrs-edge-lower-as-miners-head-south-cm756640","summary":"American depository receipts of European stocks were 0 8 lower at 124 42 on the Bank of New York Mellon Europe ADR Index on Monday morning American depository receipts of European stocks were 0 8 lower at 124 42 on the Bank of New York Mellon Europe ADR Index on Monday morning Decliners"},{"title":"Adaptimmune Therapeutics (ADAP) Jumps: Stock Rises 10.5%","publication_date":"2017-03-06 16:18:21 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/no5-aAFKEtI/adaptimmune-therapeutics-adap-jumps-stock-rises-105-cm756608","summary":"Adaptimmune Therapeutics plc ADAP was a big mover last session as the company saw its shares rise over 10 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above"},{"title":"Adaptimmune Therapeutics (ADAP) Jumps: Stock Rises 10.5%","publication_date":"2017-03-06 13:45:01 +0000","url":"http://finance.yahoo.com/news/adaptimmune-therapeutics-adap-jumps-stock-134501147.html","summary":"Adaptimmune Therapeutics (ADAP) Jumps: Stock Rises 10.5%"},{"title":"Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference","publication_date":"2017-03-02 13:00:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-present-cowen-company-37th-130000884.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, March 02, 2017-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced that James Noble, Adaptimmune’ s Chief Executive Officer, ..."},{"title":"Adaptimmune Cuts Ribbon on U.S. Headquarters at the Navy Yard in Philadelphia","publication_date":"2017-03-01 13:30:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-cuts-ribbon-u-headquarters-133000482.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, March 01, 2017-- Adaptimmune Therapeutics plc., a leader in T-cell therapy to treat cancer, today announced it will host a ribbon cutting ceremony this morning ..."},{"title":"European ADRs Fractionally Higher as Telecom Stocks See Mixed Fortunes","publication_date":"2017-02-27 16:29:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DPhc17N4hV0/european-adrs-fractionally-higher-as-telecom-stocks-see-mixed-fortunes-cm753647","summary":"American depository receipts of European stocks were 0 2 higher at 124 27 on the Bank of New York Mellon Europe ADR Index on Monday morning American depository receipts of European stocks were 0 2 higher at 124 27 on the Bank of New York Mellon Europe ADR Index on Monday morning Gainers"},{"title":"Adaptimmune to Participate in Upcoming Investor Conference","publication_date":"2017-02-09 19:00:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-participate-upcoming-investor-conference-190000035.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, U.K., Feb. 09, 2017-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced that Adrian Rawcliffe, Adaptimmune’ s Chief Financial Officer, will ..."},{"title":"European ADRs Edge Lower as Financial Stocks Contract","publication_date":"2017-02-08 15:57:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G5qjq2tyjdY/european-adrs-edge-lower-as-financial-stocks-contract-cm744888","summary":"American depository receipts of European stocks were 0 6 lower at 121 39 on the Bank of New York Mellon Europe ADR Index on Wednesday morning American depository receipts of European stocks were 0 6 lower at 121 39 on the Bank of New York Mellon Europe ADR Index on Wednesday morning Decliners"},{"title":"European ADRs Fractionally Lower Despite Banking Gains","publication_date":"2017-01-17 16:16:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r3OLxff39Qw/european-adrs-fractionally-lower-despite-banking-gains-cm734248","summary":"American depository receipts of European stocks were 0 2 lower at 122 91 on the Bank of New York Mellon Europe ADR Index on Tuesday morning American depository receipts of European stocks were 0 2 lower at 122 91 on the Bank of New York Mellon Europe ADR Index on Tuesday morning Decliners"},{"title":"European ADRs Edge Higher as Pharma Stocks, Manufacturers See Mixed Fortunes","publication_date":"2017-01-13 16:56:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I6-Ri6FKvkM/european-adrs-edge-higher-as-pharma-stocks-manufacturers-see-mixed-fortunes-cm733320","summary":"American depository receipts of European stocks were 0 3 higher at 123 10 on the Bank of New York Mellon Europe ADR Index on Friday morning American depository receipts of European stocks were 0 3 higher at 123 10 on the Bank of New York Mellon Europe ADR Index on Friday morning Gainers"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2017-01-09 17:15:04 +0000","url":"http://biz.yahoo.com/e/170109/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Adaptimmune Announces New Senior Vice President of Global Bio-Process and Development","publication_date":"2017-01-09 13:01:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-announces-senior-vice-president-130100744.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Jan. 09, 2017-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced that Mark E. Dudley, Ph.D. has joined the company as Senior ..."},{"title":"Adaptimmune confirms GSK Nomination of Second Adaptimmune Target under Strategic Multi-Target Collaboration","publication_date":"2017-01-09 13:01:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-confirms-gsk-nomination-second-130100929.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Jan. 09, 2017-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced that GlaxoSmithKline plc has nominated a second target, ..."},{"title":"Adaptimmune Announces FDA Acceptance of IND Application for Affinity Enhanced T-Cell Therapy Targeting MAGE-A4 in Multiple Solid Tumors","publication_date":"2017-01-09 13:00:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-announces-fda-acceptance-ind-130000710.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Jan. 09, 2017-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced that the US Food and Drug Administration has accepted ..."},{"title":"8:00 am Adaptimmune Therapeutics announces that the FDA has accepted its IND application for autologous genetically modified T-cells expressing an affinity optimized T-cell receptor specific for MAGE-A4 in patients with multiple malignant s","publication_date":"2017-01-09 13:00:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#adap","summary":"8:00 am Adaptimmune Therapeutics announces that the FDA has accepted its IND application for autologous genetically modified T-cells expressing an affinity optimized T-cell receptor specific for MAGE-A4 in patients with multiple malignant s"},{"title":"These 5 Stocks Under $10 Could Make You a Lot of Money","publication_date":"2017-01-05 18:37:00 +0000","url":"https://www.thestreet.com/story/13943826/1/these-5-stocks-under-10-could-make-you-a-lot-of-money.html?puc=yahoo&cm_ven=YAHOO","summary":"These 5 Stocks Under $10 Could Make You a Lot of Money"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial","publication_date":"2016-12-19 22:02:14 +0000","url":"http://biz.yahoo.com/e/161219/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial"},{"title":"Adaptimmune and Bellicum Pharmaceuticals Enter a Strategic Collaboration to Evaluate Next-Generation T-Cell Therapies","publication_date":"2016-12-19 12:41:07 +0000","url":"http://www.publicnow.com/view/AC341DCC6BC953300C238F776BD0D642A438513B","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom and HOUSTON, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, and Bellicum Pharmaceuticals, ..."},{"title":"Is Adaptimmune Therapeutics PLC (ADAP) A Good Stock To Buy?","publication_date":"2016-12-17 21:52:48 +0000","url":"http://www.insidermonkey.com/blog/is-adaptimmune-therapeutics-plc-adap-a-good-stock-to-buy-509224/","summary":"Is Adaptimmune Therapeutics PLC (ADAP) A Good Stock To Buy?"},{"title":"How Verso Corporation (VRS) Stacks Up Against Its Peers","publication_date":"2016-12-14 11:03:44 +0000","url":"http://www.insidermonkey.com/blog/how-verso-corporation-vrs-stacks-up-against-its-peers-508485/","summary":"How Verso Corporation (VRS) Stacks Up Against Its Peers"},{"title":"European ADRs Rally as Telecommunications Stocks Advance","publication_date":"2016-12-13 16:16:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1S-pyqLlYEQ/european-adrs-rally-as-telecommunications-stocks-advance-cm720726","summary":"American depository receipts of European stocks were 1 2 higher at 120 75 on the Bank of New York Mellon Europe ADR Index on Tuesday morning American depository receipts of European stocks were 1 2 higher at 120 75 on the Bank of New York Mellon Europe ADR Index on Tuesday morning Gainers"},{"title":"European ADRs Advance as Biopharmaceutical Stocks Rally","publication_date":"2016-12-09 16:36:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pt9xgokOD6g/european-adrs-advance-as-biopharmaceutical-stocks-rally-cm719362","summary":"American depository receipts of European stocks were 0 16 higher at 119 09 on the Bank of New York Mellon Europe ADR Index on Friday morning American depository receipts of European stocks were 0 16 higher at 119 09 on the Bank of New York Mellon Europe ADR Index on Friday morning Gainers"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-12-05 12:49:25 +0000","url":"http://biz.yahoo.com/e/161205/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Adaptimmune Announces Initiation of Myxoid/Round Cell Liposarcoma Study","publication_date":"2016-12-05 12:32:01 +0000","url":"http://finance.yahoo.com/news/adaptimmune-announces-initiation-myxoid-round-123201454.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Dec. 05, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has initiated ..."},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Termination of a Material Definitive Agreement","publication_date":"2016-11-25 21:31:25 +0000","url":"http://biz.yahoo.com/e/161125/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Termination of a Material Definitive Agreement"},{"title":"What''s In The Offing For These Biotech Stocks?","publication_date":"2016-11-22 11:23:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Aodj8q9A-uA/whats-in-the-offing-for-these-biotech-stocks-20161122-00774","summary":"What''s In The Offing For These Biotech Stocks?"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Financials","publication_date":"2016-11-18 18:04:10 +0000","url":"http://finance.yahoo.com/q/is?s=adap","summary":"ADAPTIMMUNE THERAPEUTICS PLC Financials"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-11-14 11:17:28 +0000","url":"http://biz.yahoo.com/e/161114/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Adaptimmune Announces Update on Clinical Data from NY-ESO SPEAR™ T-cell Synovial Sarcoma Study at the 2016 Annual Meeting of the Connective Tissue Oncology Society (CTOS)","publication_date":"2016-11-11 16:18:55 +0000","url":"http://finance.yahoo.com/news/adaptimmune-announces-clinical-data-ny-161855335.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Nov. 11, 2016-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced an oral presentation with updated data on its study of ..."},{"title":"Edited Transcript of ADAP earnings conference call or presentation 10-Nov-16 1:00pm GMT","publication_date":"2016-11-11 16:16:20 +0000","url":"http://finance.yahoo.com/news/edited-transcript-adap-earnings-conference-161620551.html","summary":"Edited Transcript of ADAP earnings conference call or presentation 10-Nov-16 1:00pm GMT"},{"title":"Adaptimmune Presents Preclinical Data from a New, Wholly-owned SPEAR™ T-cell and a Second Generation SPEAR T-cell at the 31st Annual Meeting of the Society for Immunotherapy for Cancer (SITC)","publication_date":"2016-11-11 13:30:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-presents-preclinical-data-wholly-133000812.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Nov. 11, 2016-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced the presentation of data at the 2016 Society for Immunotherapy ..."},{"title":"Q3 2016 Adaptimmune Therapeutics PLC Earnings Release - Before Market Open","publication_date":"2016-11-10 12:07:09 +0000","url":"http://biz.yahoo.com/research/earncal/20161110.html?t=adap","summary":"Q3 2016 Adaptimmune Therapeutics PLC Earnings Release - Before Market Open"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements","publication_date":"2016-11-10 11:45:07 +0000","url":"http://biz.yahoo.com/e/161110/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements"},{"title":"Adaptimmune Reports Third Quarter 2016 Financial Results","publication_date":"2016-11-10 11:41:08 +0000","url":"http://www.publicnow.com/view/6028ABBFB33DC24162D60E744B193F9000C8E4DC","summary":"[at noodls] - - U.S. Food and Drug Administration (FDA) lifted partial clinical hold of myxoid/round cell liposarcoma (MRCLS) study of NY-ESO SPEAR™ T-cell therapy; initiation of screening expected in 4Q 2016 - - Initiated ..."},{"title":"ADAP Surges As FDA Lifts Clinical Hold, OCUL Catches Eyes, RegeneRx On The Rise","publication_date":"2016-11-10 01:57:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dQSDgHm_C-g/adap-surges-as-fda-lifts-clinical-hold-ocul-catches-eyes-regenerx-on-the-rise-20161110-00064","summary":"ADAP Surges As FDA Lifts Clinical Hold, OCUL Catches Eyes, RegeneRx On The Rise"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-11-09 21:25:39 +0000","url":"http://biz.yahoo.com/e/161109/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Adaptimmune Announces Removal of Partial Clinical Hold in Myxoid/Round Cell Liposarcoma (MRCLS)","publication_date":"2016-11-09 21:21:19 +0000","url":"http://www.publicnow.com/view/BE7AAC8216764B8F1BB147AEB8EBAFD2BA367559","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that the U.S. Food and ..."},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and","publication_date":"2016-11-08 21:43:36 +0000","url":"http://biz.yahoo.com/e/161108/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and"},{"title":"Adaptimmune Announces Appointment of Tal Zaks to Board of Directors","publication_date":"2016-11-08 21:29:14 +0000","url":"http://www.publicnow.com/view/728793F79D3CD23D27375E812270ECCC6426F8CF","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced the appointment of Tal ..."},{"title":"Adaptimmune to Present Three Posters at the 31st Annual Meeting of the Society for Immunotherapy for Cancer (SITC)","publication_date":"2016-11-08 13:00:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-present-three-posters-31st-130000614.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Nov. 08, 2016-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, announced that it will present three posters at the 2016 SITC annual meeting. ..."},{"title":"Adaptimmune to Report Third Quarter 2016 Financial Results on November 10, 2016","publication_date":"2016-11-07 18:54:19 +0000","url":"http://www.publicnow.com/view/4350AABB182EBF0E288788286FB19C94C5646FD3","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, Nov. 07, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the ..."},{"title":"Adaptimmune, Merck to Test Cancer Drug (ADAP, MRK)","publication_date":"2016-10-30 14:57:00 +0000","url":"http://www.investopedia.com/news/adaptimmune-and-merck-myeloma-deal-adap-mrk/?partner=YahooSA","summary":"Adaptimmune, Merck to Test Cancer Drug (ADAP, MRK)"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and","publication_date":"2016-10-27 20:31:13 +0000","url":"http://biz.yahoo.com/e/161027/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and"},{"title":"Adaptimmune Announces Board Changes","publication_date":"2016-10-27 20:06:07 +0000","url":"http://www.publicnow.com/view/80758D461B419114CF1E7ED2CC47CBEF6715B01D","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, Oct. 27, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) ('Adaptimmune' or the 'Company'), a leader in T-cell therapy to treat cancer, today ..."},{"title":"Adaptimmune Announces Collaboration with MSD to Evaluate KEYTRUDA® (pembrolizumab) in Combination with NY-ESO SPEAR® T-Cell Therapy in Multiple Myeloma","publication_date":"2016-10-27 14:22:02 +0000","url":"http://finance.yahoo.com/news/adaptimmune-announces-collaboration-msd-evaluate-142202619.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Oct. 27, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has entered into ..."},{"title":"European ADRs Edge Lower as Miners Head South","publication_date":"2016-10-26 15:09:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qGeU8FTWDJE/european-adrs-edge-lower-as-miners-head-south-cm698517","summary":"American depository receipts of European stocks were 0 7 lower at 117 65 on the Bank of New York Mellon Europe ADR Index on Wednesday morning American depository receipts of European stocks were 0 7 lower at 117 65 on the Bank of New York Mellon Europe ADR Index on Wednesday morning Decliners"},{"title":"Adaptimmune Therapeutics downgraded by BofA/Merrill","publication_date":"2016-10-24 11:19:35 +0000","url":"http://finance.yahoo.com/q/ud?s=ADAP","summary":"Adaptimmune Therapeutics downgraded by BofA/Merrill"},{"title":"[$$] Clinical Development News, Oct. 17-21","publication_date":"2016-10-21 22:45:30 +0000","url":"http://www.wsj.com/articles/clinical-development-news-oct-17-21-1477089923?mod=yahoo_hs","summary":"[$$] Clinical Development News, Oct. 17-21"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-10-18 12:17:22 +0000","url":"http://biz.yahoo.com/e/161018/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Adaptimmune Announces Initiation of Triple Tumor Study to Evaluate its SPEAR® T-Cell Therapy Targeting MAGE-A10","publication_date":"2016-10-18 12:13:07 +0000","url":"http://www.publicnow.com/view/629BD450DEFBC4D7080DDD8A53D6FAE46D2C04B4","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, Oct. 18, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has initiated ..."},{"title":"Here’s What We Want To See From Adaptimmune Therapeutics PLC – ADR (ADAP)","publication_date":"2016-10-13 14:40:29 +0000","url":"http://www.insidermonkey.com/blog/heres-what-we-want-to-see-from-adaptimmune-therapeutics-plc-adr-adap-481062/","summary":"Here’s What We Want To See From Adaptimmune Therapeutics PLC – ADR (ADAP)"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-10-12 20:42:15 +0000","url":"http://biz.yahoo.com/e/161012/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"European ADRs Edge Lower as Telecom Stocks Slide","publication_date":"2016-10-12 15:20:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-X2zLOzCXuw/european-adrs-edge-lower-as-telecom-stocks-slide-cm692410","summary":"American depository receipts of European stocks were 0 4 lower at 119 05 on the Bank of New York Mellon Europe ADR Index on Wednesday morning American depository receipts of European stocks were 0 4 lower at 119 05 on the Bank of New York Mellon Europe ADR Index on Wednesday morning Decliners"},{"title":"Adaptimmune Provides Update on Clinical Study Evaluating its SPEAR® T-Cell Therapy Targeting NY-ESO-1 in Ovarian Cancer","publication_date":"2016-10-12 13:37:10 +0000","url":"http://www.publicnow.com/view/F4F19125EB794FD7D331C1C092DC7500C9DC8EA8","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, Oct. 12, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that its amended protocol ..."},{"title":"European ADRs Edge Higher as Pharma Gains Offset Banking Losses","publication_date":"2016-10-10 15:58:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HAD_zvVNNbQ/european-adrs-edge-higher-as-pharma-gains-offset-banking-losses-cm691135","summary":"American depository receipts of European stocks were 0 5 higher at 121 78 on the Bank of New York Mellon Europe ADR Index on Monday morning American depository receipts of European stocks were 0 5 higher at 121 78 on the Bank of New York Mellon Europe ADR Index on Monday morning Gainers"},{"title":"Adaptimmune Provides Update on Study of NY-ESO SPEAR® T-cell Therapy in Synovial Sarcoma at the European Society for Medical Oncology (ESMO) 2016 Congress","publication_date":"2016-10-09 14:00:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-provides-study-ny-eso-140000719.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Oct. 09, 2016-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced a poster presentation of updated data on its lead clinical ..."},{"title":"Adaptimmune to Provide Update on Study of NY-ESO SPEAR® T-cell Therapy in Synovial Sarcoma at the European Society for Medical Oncology (ESMO) 2016 Congress","publication_date":"2016-10-05 20:30:00 +0000","url":"http://finance.yahoo.com/news/adaptimmune-study-ny-eso-spear-203000485.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, Oct. 05, 2016-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, announced that it will present a poster presentation of updated data on ..."},{"title":"European ADRs Edge Higher as Manufacturers See Mixed Fortunes","publication_date":"2016-10-04 16:03:19 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/08stPe2YHtc/european-adrs-edge-higher-as-manufacturers-see-mixed-fortunes-cm688554","summary":"American depository receipts of European stocks were 0 8 higher at 123 22 on the Bank of New York Mellon Europe ADR Index on Tuesday morning American depository receipts of European stocks were 0 8 higher at 123 22 on the Bank of New York Mellon Europe ADR Index on Tuesday morning Gainers"},{"title":"European ADRs Edge Higher as Miners Log Gains","publication_date":"2016-09-28 15:41:17 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Svbl7v6wYS8/european-adrs-edge-higher-as-miners-log-gains-cm685990","summary":"American depository receipts of European stocks were 0 5 higher at 122 27 on the Bank of New York Mellon Europe ADR Index on Wednesday morning American depository receipts of European stocks were 0 5 higher at 122 27 on the Bank of New York Mellon Europe ADR Index on Wednesday morning Gainers"},{"title":"Adaptimmune, MD Anderson teaming up to tackle cancer","publication_date":"2016-09-26 13:40:11 +0000","url":"http://www.bizjournals.com/philadelphia/news/2016/09/26/adaptimmune-md-anderson-cancer-research-adap.html?ana=yahoo","summary":"Adaptimmune, MD Anderson teaming up to tackle cancer"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial","publication_date":"2016-09-26 12:13:31 +0000","url":"http://biz.yahoo.com/e/160926/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial"},{"title":"MD Anderson Cancer Center and Adaptimmune Form Strategic Alliance to Advance Development of Immunotherapies Targeting Multiple Cancers","publication_date":"2016-09-26 11:31:01 +0000","url":"http://finance.yahoo.com/news/md-anderson-cancer-center-adaptimmune-113101052.html","summary":"[GlobeNewswire] - PHILADELPHIA and HOUSTON, United States and OXFORD, United Kingdom, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, and The University ..."},{"title":"Top-Rated Stock Picks and Popular Stories on Nasdaq.com: September 11 - 17","publication_date":"2016-09-20 14:52:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DRS6ORgvIC4/top-rated-stock-picks-and-popular-stories-on-nasdaqcom-september-11-17-cm681963","summary":"Welcome to the latest installment of community stock picks and overview of some of the most-read stories of the week. We're taking a look at stocks chosen by members of the Nasdaq.com community from September 11 - 17. Bullish Stocks: Here's What You Said: Adaptimmune Theraupeutics ( ADAP ): Best cell therapy in"},{"title":"Adaptimmune Announces Strategic Manufacturing Agreement with PCT to Support Development of SPEAR® T-cell Therapies Towards Commercialization","publication_date":"2016-09-19 11:48:02 +0000","url":"http://www.publicnow.com/view/68D9B35A34C1A744B2A5F191A9FF063FFC10FEB9","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has entered into ..."},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial","publication_date":"2016-09-19 11:42:02 +0000","url":"http://biz.yahoo.com/e/160919/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial"},{"title":"Caladrius Subsidiary, PCT, Announces Five-Year Strategic Manufacturing Services Agreement with Adaptimmune","publication_date":"2016-09-19 11:30:00 +0000","url":"http://finance.yahoo.com/news/caladrius-subsidiary-pct-announces-five-113000982.html","summary":"[GlobeNewswire] - BASKING RIDGE, N.J., Sept. 19, 2016-- Caladrius Biosciences, Inc., a cell therapy company combining an industry-leading development and manufacturing services provider with a select therapeutic development ..."},{"title":"These 5 Stocks Under $10 Could Make You a Lot of Money","publication_date":"2016-09-15 12:51:00 +0000","url":"https://www.thestreet.com/story/13741089/1/these-5-stocks-under-10-could-make-you-a-lot-of-money.html?puc=yahoo&cm_ven=YAHOO","summary":"These 5 Stocks Under $10 Could Make You a Lot of Money"},{"title":"Adaptimmune to Participate in Two Upcoming Investor Conferences","publication_date":"2016-09-08 19:09:05 +0000","url":"http://www.publicnow.com/view/661CE66E6127D4DD9DABD6A6BBFD534225E14E19","summary":"[at noodls] - PHILADELPHIA, and OXFORD, United Kingdom, Sept. 08, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced ..."},{"title":"European ADRs Gain Buoyed by Banks","publication_date":"2016-08-23 16:20:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YaW2MLOk5Nc/european-adrs-gain-buoyed-by-banks-cm669094","summary":"American depository receipts of European stocks were edging 0.75% higher to 123.59 on the Bank of New York Mellon Europe ADR Index on Tuesday. In continental Europe, medical device maker Edap ( EDAP ) led decliners, slipping 1.6%, followed"},{"title":"European ADRs Edge Up Driven by Telecoms and Banks","publication_date":"2016-08-18 15:59:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5qTFXnFWjec/european-adrs-edge-up-driven-by-telecoms-and-banks-cm667132","summary":"American depository receipts of European stocks were inching 0.30% higher to 123.39 on the Bank of New York Mellon Europe ADR Index on Thursday. In continental Europe, Norwegian seafood company Marine Harvest ( MHG ) led decliners, sliding 3.5%."},{"title":"Edited Transcript of ADAP earnings conference call or presentation 8-Aug-16 12:00pm GMT","publication_date":"2016-08-17 17:22:26 +0000","url":"http://finance.yahoo.com/news/edited-transcript-adap-earnings-conference-172226279.html","summary":"Edited Transcript of ADAP earnings conference call or presentation 8-Aug-16 12:00pm GMT"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and","publication_date":"2016-08-12 20:32:53 +0000","url":"http://biz.yahoo.com/e/160812/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and"},{"title":"A Handful of Biotech Stocks Plunge After Disappointing Results","publication_date":"2016-08-08 20:51:05 +0000","url":"http://finance.yahoo.com/news/handful-biotech-stocks-plunge-disappointing-205105977.html","summary":"A Handful of Biotech Stocks Plunge After Disappointing Results"},{"title":"Adaptimmune Reports Second Quarter 2016 Financial Results","publication_date":"2016-08-08 11:18:11 +0000","url":"http://www.publicnow.com/view/3FB43D1FD5345B9B4CF9420C345F556DAFDCF452","summary":"[at noodls] - - Conference call to be held today at 8:00 AM ET (1:00 PM BST) - PHILADELPHIA and OXFORD, United Kingdom, Aug. 08, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) ('Adaptimmune' or ..."},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements","publication_date":"2016-08-08 11:08:20 +0000","url":"http://biz.yahoo.com/e/160808/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements"},{"title":"Q2 2016 Adaptimmune Therapeutics PLC Earnings Release - Before Market Open","publication_date":"2016-08-08 11:07:04 +0000","url":"http://biz.yahoo.com/research/earncal/20160808.html?t=adap","summary":"Q2 2016 Adaptimmune Therapeutics PLC Earnings Release - Before Market Open"},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-08-04 10:05:11 +0000","url":"http://biz.yahoo.com/e/160804/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"Adaptimmune Announces Partial Clinical Hold of Planned Pivotal Study of NY-ESO SPEAR® T-cell Therapy in Myxoid Round Cell Liposarcoma","publication_date":"2016-08-03 20:32:04 +0000","url":"http://www.publicnow.com/view/0C866E8EDB82B569A3F8CD84E6D0B3FCB7E2C884","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy for treatment of cancer, today announced that it has received ..."},{"title":"Adaptimmune Reports Partial Clinical Hold On NY-ESO SPEAR T-cell Therapy Study","publication_date":"2016-08-03 17:18:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4afkwjD03do/adaptimmune-reports-partial-clinical-hold-on-nyeso-spear-tcell-therapy-study-20160803-01405","summary":"Adaptimmune Reports Partial Clinical Hold On NY-ESO SPEAR T-cell Therapy Study"},{"title":"Adaptimmune to Report Second Quarter 2016 Financial Results on August 8, 2016","publication_date":"2016-08-02 12:31:10 +0000","url":"http://www.publicnow.com/view/1F1A4E54A94C6753C127965EACFBFFAB49D9C726","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the ..."},{"title":"ADAP: a Biotech Stock Using T-Cell Immunotherapy to Treat Cancer","publication_date":"2016-08-02 00:56:33 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I9ZYqNCJu38/adap-a-biotech-stock-using-t-cell-immunotherapy-to-treat-cancer-cm658501","summary":"Within the world of biotech stocks lies the potential to reap massive profits.  At the same time though, this space is full of companies who ultimately fail to live up to their ambitions.  Because of the tendency for many"},{"title":"ADAP: a Biotech Stock Using T-Cell Immunotherapy to Treat Cancer","publication_date":"2016-08-01 22:13:10 +0000","url":"http://finance.yahoo.com/news/adap-biotech-stock-using-t-221310774.html","summary":"ADAP: a Biotech Stock Using T-Cell Immunotherapy to Treat Cancer"},{"title":"Adaptimmune Gets Access To Priority Medicines Regulatory Support For Its SPEAR T-cell Therapy","publication_date":"2016-07-28 17:54:05 +0000","url":"http://finance.yahoo.com/news/adaptimmune-gets-access-priority-medicines-175405362.html","summary":"Adaptimmune Gets Access To Priority Medicines Regulatory Support For Its SPEAR T-cell Therapy"},{"title":"Adaptimmune Receives Access to Priority Medicines (PRIME) Regulatory Support for its SPEAR® T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma","publication_date":"2016-07-28 15:48:04 +0000","url":"http://www.publicnow.com/view/97ABD1DC8170EB108082902CB35972EAB421B46B","summary":"[at noodls] - PHILADELPHIA, Pa. and OXFORD, UK, July 28, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that the European Medicines Agency ..."},{"title":"Adaptimmune Receives Orphan Drug Designation in the European Union for its NY-ESO SPEAR® T-cell Therapy for Treatment of Soft Tissue Sarcoma","publication_date":"2016-07-26 12:18:05 +0000","url":"http://www.publicnow.com/view/674D460CC90BFB17CF779A8260B8EEB077203A67","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, July 26, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy for treatment of cancer, today announced that the European ..."},{"title":"4 Biotechs with Blockbuster Potential for Multiple Cancer Indications","publication_date":"2016-06-28 13:31:17 +0000","url":"http://news.investornetwork.com/2016/06/28/4-biotechs-with-blockbuster-potential-for-multiple-cancer-indications/?1=1&1467120677","summary":"4 Biotechs with Blockbuster Potential for Multiple Cancer Indications"},{"title":"European ADRs Edge Higher as Financial Services Stocks Rise, 3D Printer-Makers Post Mixed Fortunes","publication_date":"2016-06-21 15:31:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fZh_E8MSWKM/european-adrs-edge-higher-as-financial-services-stocks-rise-3d-printer-makers-post-mixed-fortunes-cm638420","summary":"American depository receipts of European stocks were 0.5% higher at 121.75 on the Bank of New York Mellon Europe ADR Index on Tuesday morning. Gainers in Continental Europe were led by Marine Harvest ( MHG ), a Norwegian seafood"},{"title":"Adaptimmune Announces Commercial Development and Supply Agreement for Thermo Fisher Scientific’s Dynabeads™ CD3/CD28 Cell Therapy System","publication_date":"2016-06-21 12:29:02 +0000","url":"http://www.publicnow.com/view/F4B58E32B079B8860AD7CF69FDD7394F3B4AB7F5","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, June 21, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has entered into ..."},{"title":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial","publication_date":"2016-06-21 11:50:43 +0000","url":"http://biz.yahoo.com/e/160621/adap8-k.html","summary":"ADAPTIMMUNE THERAPEUTICS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial"},{"title":"Adaptimmune Announces Commercial Development and Supply Agreement for Thermo Fisher Scientific's Dynabeads(TM) CD3/CD28 Cell Therapy System","publication_date":"2016-06-21 11:32:02 +0000","url":"http://finance.yahoo.com/news/adaptimmune-announces-commercial-development-supply-113202006.html","summary":"[GlobeNewswire] - PHILADELPHIA and OXFORD, United Kingdom, June 21, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has entered into ..."},{"title":"Adaptimmune to Present at the 2016 JMP Life Sciences Conference","publication_date":"2016-06-16 16:49:10 +0000","url":"http://www.publicnow.com/view/9E790CDB8AE80165F95126908DD2185229A1B987","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, June 16, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that Adrian Rawcliffe, ..."},{"title":"European ADRs Edge Higher as Diversified Mining Stocks' Gains Offset Mixed Fortunes for Pharma Companies","publication_date":"2016-06-15 15:19:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hq3kZvQackw/european-adrs-edge-higher-as-diversified-mining-stocks-gains-offset-mixed-fortunes-for-pharma-companies-cm635813","summary":"American depository receipts of European stocks were 0.7% higher at 116.08 on the Bank of New York Mellon Europe ADR Index on Wednesday morning. Gainers in Continental Europe were led by Oasmia Pharmaceuticals ( OASM ), which develops drugs"},{"title":"Adaptimmune to Present at the Jefferies 2016 Healthcare Conference","publication_date":"2016-06-02 15:45:01 +0000","url":"http://www.publicnow.com/view/6E7B1DE07E74AFAFD9683AAB9955100D2B947F68","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, June 02, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that James Noble, Chief ..."},{"title":"Adaptimmune Announces Succession Plan for Chairman at End of 2016","publication_date":"2016-05-24 11:46:07 +0000","url":"http://www.publicnow.com/view/B6D629CFEB008BE51C8E4F641F32FF7E67EBB7CF","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, May 24, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) ('Adaptimmune' or the 'Company'), a leader in T-cell therapy to treat cancer, today ..."},{"title":"Adaptimmune Strengthens Board with Appointment of Barbara Duncan","publication_date":"2016-05-24 11:46:07 +0000","url":"http://www.publicnow.com/view/1D79676F65CD61CEB6262721CE22D3570A954E71","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, May 24, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) ('Adaptimmune' or the 'Company'), a leader in T-cell therapy to treat cancer, today ..."},{"title":"European ADRs Edge Higher as Pharma Stocks Log Gains","publication_date":"2016-05-20 15:20:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gPUjJdY3zRo/european-adrs-edge-higher-as-pharma-stocks-log-gains-cm624149","summary":"American depository receipts of European stocks were trading 0.5% higher at 120.05 on the Bank of New York Mellon Europe ADR Index on Friday morning. Gainers in Continental Europe were led by Aixtron ( AIXG ), a German provider"},{"title":"Adaptimmune to Present at the 2016 UBS Global Healthcare Conference","publication_date":"2016-05-19 15:02:22 +0000","url":"http://www.publicnow.com/view/EDD8B936349ED500D12266107C0E6567C227F099","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, May 19, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that James Noble, Chief ..."},{"title":"European ADRs Marginally Lower as Pharma Stocks See Mixed Fortunes","publication_date":"2016-05-17 15:47:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vzkC36G1FZ8/european-adrs-marginally-lower-as-pharma-stocks-see-mixed-fortunes-cm622246","summary":"American depository receipts of European stocks were 0.1% lower at 120.33 on the Bank of New York Mellon Europe ADR Index on Tuesday morning. Decliners in Continental Europe were led by Cellectis ( CLLS ), a French genome engineering"},{"title":"Pfizer (PFE) Reveals Positive Phase III Data on Trumenba","publication_date":"2016-05-17 04:52:47 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V_kEm0jsdjc/pfizer-pfe-reveals-positive-phase-iii-data-on-trumenba-cm621542","summary":"Pfizer Inc.PFE announced positive results from two phase III studies (one in adolescents and one in young adults) on Trumenba (meningococcal group B vaccine), for providing protection against serogroup B meningococcal disease. The randomized, placebo controlled, observer blinded studies"},{"title":"European ADRs Climb as Manufacturers Log Gains","publication_date":"2016-05-16 15:24:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zfr3ArdUcYA/european-adrs-climb-as-manufacturers-log-gains-cm621591","summary":"American depository receipts of European stocks were 0.8% higher at 119.84 on the Bank of New York Mellon Europe ADR Index on Monday morning. Gainers in Continental Europe were led by CGG ( CGG ), a manufacturer of geophysical"},{"title":"Exelixis (EXEL) Worth a Look: Stock Up 8.1% in Session","publication_date":"2016-05-16 14:55:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UqYdwnJi2jI/exelixis-exel-worth-a-look-stock-up-81-in-session-cm621506","summary":"Exelixis, Inc.EXEL was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This"},{"title":"New Strong Buy Stocks for May 13th","publication_date":"2016-05-13 18:48:37 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ShBpTXkS-eE/new-strong-buy-stocks-for-may-13th-cm620841","summary":"Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) list today Adaptimmune Therapeutics PLCADAPBHP Billiton plcBBLCable One IncCABODean Foods CoDFGrupo Aeroportr dl Pcfco SAB de CVPACView the entire Zacks Rank #1 List . Want the latest"},{"title":"Bayer Stops Phase II Adempas Study Due to Safety Issues","publication_date":"2016-05-13 15:28:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JNB4j9wlkcI/bayer-stops-phase-ii-adempas-study-due-to-safety-issues-cm620697","summary":"Bayer AGBAYRY announced that it has terminated a phase II study on Adempas (riociguat), a soluble guanylate cyclase (sGC) stimulator, in patients with pulmonary hypertension associated with idiopathic interstitial pneumonias (PH IIP), with immediate effect. The decision followed the"},{"title":"Adaptimmune Reports First Quarter 2016 Financial Results","publication_date":"2016-05-12 11:47:03 +0000","url":"http://www.publicnow.com/view/515269E479BBE2D825E38664F5E832852185FA9A","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, May 12, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) ('Adaptimmune' or the 'Company'), a leader in T-cell therapy to treat cancer, today ..."},{"title":"Adaptimmune to Present at the Bank of America Merrill Lynch 2016 Health Care Conference","publication_date":"2016-05-03 13:30:07 +0000","url":"http://www.publicnow.com/view/6C4BC5781CDAEAF05A424334DF7EBEB8CA4458C6","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, May 03, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that Adrian Rawcliffe, ..."},{"title":"Becton, Dickinson (BDX): Stock Set to Top Earnings in Q2?","publication_date":"2016-04-28 21:04:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ySeGwLXEfGE/becton-dickinson-bdx-stock-set-to-top-earnings-in-q2-cm613448","summary":"We expect Becton, Dickinson and CompanyBDX , popularly known as BD, to beat the Zacks Consensus Estimate when it reports second quarter fiscal 2016 results on May 5.Why a Likely Positive Surprise? Our proven model shows that BD is"},{"title":"Can Weight Watchers (WTW) Pull a Surprise in Q1 Earnings?","publication_date":"2016-04-28 15:10:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bQFC0y2UsOg/can-weight-watchers-wtw-pull-a-surprise-in-q1-earnings-cm613015","summary":"Weight management service provider Weight Watchers International Inc. WTW is scheduled to release first quarter 2016 results on May 4. In the last reported quarter, the company had posted a loss of 3 cents per share as against the"},{"title":"Adaptimmune to Present at the Deutsche Bank Securities 41st Annual Health Care Conference","publication_date":"2016-04-27 17:57:17 +0000","url":"http://www.publicnow.com/view/C00E46F510C55BFCD73A2EE51F974A79BA07B271","summary":"[at noodls] - PHILADELPHIA and OXFORD, U.K., April 27, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that ..."},{"title":"Adaptimmune Presents Corporate and Clinical Updates at Investor and Analyst Day","publication_date":"2016-04-22 17:02:06 +0000","url":"http://www.publicnow.com/view/1AE1198DBDC27593C6A63D68D13BDD5C4D837555","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, April 22, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (NASDAQ:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today hosted ..."},{"title":"Health Care Sector Update for 04/22/2016: ADAP, ABUS","publication_date":"2016-04-22 13:35:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Y5syc4zTgE/health-care-sector-update-for-04222016-adap-abus-cm610044","summary":"Top Health care stocks JNJ 0.2% PFE 0.1% ABT flat MRK flat AMGN 0.3 Health care shares were just lower in pre market trade on Friday. In health care stocks news, Adaptimmune Therapeutics ( ADAP ), a company that"},{"title":"Adaptimmune Announces SPEAR T-cells™ Brand for Proprietary Technology","publication_date":"2016-04-22 12:26:17 +0000","url":"http://www.publicnow.com/view/A08A341DE58F7781D21D681BC475DA7B1CF893C7","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, April 22, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (NASDAQ:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced ..."},{"title":"Adaptimmune Appoints Leading Immunotherapy Experts from United States and Europe to Inaugural Scientific Advisory Board","publication_date":"2016-04-22 11:45:09 +0000","url":"http://www.publicnow.com/view/903BE4431FBD06A7C71293F06486C02A20C052AF","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, April 22, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced ..."},{"title":"Adaptimmune to Host Analyst and Investor Day on April 22, 2016","publication_date":"2016-04-20 13:41:13 +0000","url":"http://www.publicnow.com/view/D2494C5C463C23C999726EC7BD6556DA742C7C98","summary":"[at noodls] - PHILADELPHIA and OXFORD, U.K., April 20, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that ..."},{"title":"Adaptimmune Announces New Vice President of Business Development, Wenyong Wang","publication_date":"2016-04-18 11:51:14 +0000","url":"http://www.publicnow.com/view/66262D06D33E6DF264769B3B09DECB705033DE44","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, April 18, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (NASDAQ:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced ..."},{"title":"Adaptimmune Therapeutics (ADAP) Shares March Higher, Can It Continue?","publication_date":"2016-04-12 16:08:50 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5KDsbd9fYLc/adaptimmune-therapeutics-adap-shares-march-higher-can-it-continue-cm605202","summary":"Adaptimmune Therapeutics plcADAP has been on the move lately as the stock has risen by 14.3% in the past four weeks, and it is currently trading well above its 20 Day SMA. This is a pretty solid move higher,"},{"title":"U.S. Food and Drug Administration Grants Orphan Drug Designation to Adaptimmune’s T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma","publication_date":"2016-03-30 12:10:08 +0000","url":"http://www.publicnow.com/view/0D6D728BD0B0B7A52E34163869DE0C0F4ECB8FD5","summary":"[at noodls] - PHILADELPHIA and OXFORD, United Kingdom, March 30, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced ..."}],"result_count":117,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1}},
{"id":"3","chart":[{"values":[{"x":"1489156200","y":"2"},{"x":"1489156500","y":"1.9569999999999999"},{"x":"1489156800","y":"2.0124"},{"x":"1489157100","y":"2.1052"},{"x":"1489157400","y":"2.175"},{"x":"1489157700","y":"2.3121"},{"x":"1489158000","y":"2.35"},{"x":"1489158300","y":"2.385"},{"x":"1489158600","y":"2.4050000000000002"},{"x":"1489158900","y":"2.4699999999999998"},{"x":"1489159200","y":"2.425"},{"x":"1489159500","y":"2.355"},{"x":"1489159800","y":"2.355"},{"x":"1489160100","y":"2.365"},{"x":"1489160400","y":"2.355"},{"x":"1489160700","y":"2.355"},{"x":"1489161000","y":"2.355"},{"x":"1489161300","y":"2.3501"},{"x":"1489161600","y":"2.355"},{"x":"1489161900","y":"2.355"},{"x":"1489162200","y":"2.41"},{"x":"1489162500","y":"2.38"},{"x":"1489162800","y":"2.4"},{"x":"1489163100","y":"2.3753"},{"x":"1489163400","y":"2.3752"},{"x":"1489163700","y":"2.36"},{"x":"1489164000","y":"2.365"},{"x":"1489164300","y":"2.36"},{"x":"1489164600","y":"2.365"},{"x":"1489164900","y":"2.355"},{"x":"1489165200","y":"2.355"},{"x":"1489165500","y":"2.35"},{"x":"1489165800","y":"2.35"},{"x":"1489166100","y":"2.3512"},{"x":"1489166400","y":"2.355"},{"x":"1489166700","y":"2.355"},{"x":"1489167000","y":"2.35"},{"x":"1489167300","y":"2.35"},{"x":"1489167600","y":"2.35"},{"x":"1489167900","y":"2.35"},{"x":"1489168200","y":"2.35"},{"x":"1489168500","y":"2.35"},{"x":"1489168800","y":"2.3449999999999998"},{"x":"1489169100","y":"2.34"},{"x":"1489169400","y":"2.349"},{"x":"1489169700","y":"2.34"},{"x":"1489170000","y":"2.33"},{"x":"1489170300","y":"2.325"},{"x":"1489170600","y":"2.32"},{"x":"1489170900","y":"2.3162"},{"x":"1489171200","y":"2.3101"},{"x":"1489171500","y":"2.3001"},{"x":"1489171800","y":"2.3422"},{"x":"1489172100","y":"2.34"},{"x":"1489172400","y":"2.35"},{"x":"1489172700","y":"2.3449999999999998"},{"x":"1489173000","y":"2.35"},{"x":"1489173300","y":"2.4"},{"x":"1489173600","y":"2.49"},{"x":"1489173900","y":"2.5"},{"x":"1489174200","y":"2.465"},{"x":"1489174500","y":"2.44"},{"x":"1489174800","y":"2.4699"},{"x":"1489175100","y":"2.44"},{"x":"1489175400","y":"2.425"},{"x":"1489175700","y":"2.425"},{"x":"1489176000","y":"2.425"},{"x":"1489176300","y":"2.4201"},{"x":"1489176600","y":"2.425"},{"x":"1489176900","y":"2.415"},{"x":"1489177200","y":"2.3901"},{"x":"1489177500","y":"2.395"},{"x":"1489177800","y":"2.37"},{"x":"1489178100","y":"2.375"},{"x":"1489178400","y":"2.375"},{"x":"1489178700","y":"2.35"},{"x":"1489179000","y":"2.37"},{"x":"1489179300","y":"2.3891"},{"x":"1489179600","y":"2.39"}
],"color":"#03a9f4"}],"list":"Market Movers","symbol": "AREX","name": "Approach Resources I","price": 2.425,"dollarChange": 0.22,"percentChange": 9.73,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/AREX-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/AREX-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/AREX-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/AREX-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/AREX-1yr.php","open": 2.1,"high": 2.52,"low":1.9300000000000002,"volume": 2426429,"avgVol": 1004941.468085,"sharesShort": 10103643,"shortPercent": 12.452994,"marketCap": 215005751,"float": 81134246,"headlines":{"data":[{"title":"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Approach Resources, Inc.","publication_date":"2017-03-10 18:14:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-181400366.html","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 10, 2017 / Levi & Korsinsky announces it has commenced an investigation of Approach Resources, Inc. (NASDAQ: AREX) concerning possible breaches of fiduciary duty. To obtain ..."},{"title":"Approach Resources Inc Earnings Call scheduled for 10:00 am ET today","publication_date":"2017-03-10 15:00:00 +0000","url":"http://biz.yahoo.com/cc/0/155890.html","summary":"Approach Resources Inc Earnings Call scheduled for 10:00 am ET today"},{"title":"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Approach Resources Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors","publication_date":"2017-03-10 12:33:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-purcell-julie-lefkowitz-123300462.html","summary":"[PR Newswire] - NEW YORK, March 10, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty ..."},{"title":"Approach Resources reports 4Q loss","publication_date":"2017-03-09 22:04:59 +0000","url":"http://sg.finance.yahoo.com/news/approach-resources-reports-4q-loss-220459345.html","summary":"Approach Resources reports 4Q loss"},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, F","publication_date":"2017-03-09 21:53:28 +0000","url":"http://biz.yahoo.com/e/170309/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, F"},{"title":"4:38 pm Approach Resources misses by $0.07, beats on revs","publication_date":"2017-03-09 21:38:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#arex","summary":"4:38 pm Approach Resources misses by $0.07, beats on revs"},{"title":"Approach Resources Inc. Reports 2016 Fourth Quarter and Full-Year Financial and Operating Results and Provides 2017 Outlook","publication_date":"2017-03-09 21:34:02 +0000","url":"http://finance.yahoo.com/news/approach-resources-inc-reports-2016-213402965.html","summary":"[GlobeNewswire] - FORT WORTH, Texas, March 09, 2017-- Approach Resources Inc. today reported financial and operational results for the fourth quarter and full-year 2016 and estimated 2016 proved reserves.. Production was ..."},{"title":"Q4 2016 Approach Resources Inc Earnings Release - After Market Close","publication_date":"2017-03-09 12:07:02 +0000","url":"http://biz.yahoo.com/research/earncal/20170309.html?t=arex","summary":"Q4 2016 Approach Resources Inc Earnings Release - After Market Close"},{"title":"Conference-OGIS New York for Approach Resources, Inc.","publication_date":"2017-03-08 22:56:44 +0000","url":"http://www.companyspotlight.com/routers/headline/18319/10009/22283?cp_code=YAH1&1489013804","summary":"Conference-OGIS New York for Approach Resources, Inc."},{"title":"4 Oil Stocks to Buy Before Q4 Earnings Draws to a Close","publication_date":"2017-02-28 19:50:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/je7Vn1Q4tr4/4-oil-stocks-to-buy-before-q4-earnings-draws-to-a-close-cm754338","summary":"The fourth quarter earnings season is on its last leg with reports from the majority of the S amp P 500 members on board Most of the energy majors like ExxonMobil Corporation XOM Chevron Corporation CVX Royal Dutch Shell plc RDS A and BP plc BP have announced their respective"},{"title":"Approach Resources Inc. Schedules Fourth Quarter and Full-Year 2016 Conference Call for Friday, March 10, 2017","publication_date":"2017-02-23 22:43:42 +0000","url":"http://finance.yahoo.com/news/approach-resources-inc-schedules-fourth-224342696.html","summary":"[GlobeNewswire] - FORT WORTH, Texas, Feb. 23, 2017-- Approach Resources Inc. today announced plans to release fourth quarter and full year 2016 operational and financial results after the close of trading on Thursday, March ..."},{"title":"Approach Resources Inc. -- Moody's upgrades Approach to Caa1; stable outlook","publication_date":"2017-02-07 21:43:03 +0000","url":"http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_361794&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170207_PR_361794","summary":"Approach Resources Inc. -- Moody's upgrades Approach to Caa1; stable outlook"},{"title":"The Zacks Analyst Blog Highlights: Baker Hughes, Denbury Resources, Abraxas Petroleum, Halcon Resources and Approach Resources","publication_date":"2017-02-07 16:22:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2eJQ5R8AalY/the-zacks-analyst-blog-highlights-baker-hughes-denbury-resources-abraxas-petroleum-halcon-resources-and-approach-resources-cm744175","summary":"For Immediate Release Chicago IL February 07 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog"},{"title":"The Zacks Analyst Blog Highlights: Baker Hughes, Denbury Resources, Abraxas Petroleum, Halcon Resources and Approach Resources","publication_date":"2017-02-07 14:30:02 +0000","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-baker-143002963.html","summary":"The Zacks Analyst Blog Highlights: Baker Hughes, Denbury Resources, Abraxas Petroleum, Halcon Resources and Approach Resources"},{"title":"U.S. Rig Count Continues to Increase","publication_date":"2017-02-06 21:17:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MIJOf0pUgz8/us-rig-count-continues-to-increase-cm743816","summary":"Baker Hughes Inc BHI recently declared the rig count for the week ended Feb 3 2017 In the U S the total number of rigs increased from the previous week owing to a higher number of land rigs This represents the third consecutive increase in the U S weekly rig count and shows the"},{"title":"[$$] Approach Completes Debt Exchange With Wilks Brothers","publication_date":"2017-01-31 20:45:33 +0000","url":"http://www.wsj.com/articles/approach-completes-debt-exchange-with-wilks-brothers-1485895060?mod=yahoo_hs","summary":"[$$] Approach Completes Debt Exchange With Wilks Brothers"},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se","publication_date":"2017-01-30 22:22:50 +0000","url":"http://biz.yahoo.com/e/170130/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se"},{"title":"Approach Resources Inc. Announces Exchange Offer for Remaining 7.00% Senior Notes Due 2021","publication_date":"2017-01-30 22:01:00 +0000","url":"http://finance.yahoo.com/news/approach-resources-inc-announces-exchange-220100428.html","summary":"[GlobeNewswire] - FORT WORTH, Texas, Jan. 30, 2017-- Approach Resources Inc. today announced the commencement of an offer to exchange newly issued shares of its common stock, par value $0.01 per share for $99,768,000 of ..."},{"title":"Approach Resources Inc. Announces Executive Promotion","publication_date":"2017-01-30 22:00:00 +0000","url":"http://finance.yahoo.com/news/approach-resources-inc-announces-executive-220000115.html","summary":"[GlobeNewswire] - FORT WORTH, Texas, Jan. 30, 2017-- Approach Resources Inc. today announced that Qingming Yang has been promoted to President. Yang has been leading Approach’ s operations group as Chief Operating Officer ..."},{"title":"Approach Resources Inc. Announces Close of Strategic Alliance and Deleveraging Transaction","publication_date":"2017-01-27 17:25:07 +0000","url":"http://finance.yahoo.com/news/approach-resources-inc-announces-close-172507551.html","summary":"[GlobeNewswire] - FORT WORTH, Texas, Jan. 27, 2017-- Approach Resources Inc. today announced the successful closing of the previously announced exchange transaction with Wilks Brothers, LLC and SDW Investments, LLC, entities ..."},{"title":"Approach Resources Inc. Announces 82% Stockholder Approval of Exchange Transactions","publication_date":"2017-01-26 21:10:00 +0000","url":"http://finance.yahoo.com/news/approach-resources-inc-announces-82-211000351.html","summary":"[GlobeNewswire] - FORT WORTH, Texas, Jan. 26, 2017-- Approach Resources Inc. announced that at its special meeting held today, the Company’ s stockholders voted to approve the issuance of shares of common stock of the Company, ..."},{"title":"Approach Resources (AREX): An Off-the-Radar Potential Winner","publication_date":"2017-01-11 15:00:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jk9KklsVZ3U/approach-resources-arex-an-off-the-radar-potential-winner-cm732145","summary":"It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out Before they take the plunge others get to know the hidden potential and enter into these stocks pushing them out of reach So instead of repenting spotting"},{"title":"Is Approach Resources (AREX) Stock a Solid Choice Right Now?","publication_date":"2017-01-11 14:59:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iSWcToRHn9g/is-approach-resources-arex-stock-a-solid-choice-right-now-cm732120","summary":"One stock that might be an intriguing choice for investors right now is Approach Resources Inc AREX This is because this security in the Oil amp Gas US Exploration amp Production space is seeing solid earnings estimate revision activity and is in great company from a Zacks"},{"title":"Is Approach Resources (AREX) Stock a Solid Choice Right Now?","publication_date":"2017-01-11 13:55:01 +0000","url":"http://finance.yahoo.com/news/approach-resources-arex-stock-solid-135501186.html","summary":"Is Approach Resources (AREX) Stock a Solid Choice Right Now?"},{"title":"Approach Resources (AREX): An Off-the-Radar Potential Winner","publication_date":"2017-01-11 13:45:01 +0000","url":"http://finance.yahoo.com/news/approach-resources-arex-off-radar-134501306.html","summary":"Approach Resources (AREX): An Off-the-Radar Potential Winner"},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2017-01-09 11:33:15 +0000","url":"http://biz.yahoo.com/e/170109/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2017-01-05 13:33:22 +0000","url":"http://biz.yahoo.com/e/170105/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"},{"title":"Three Oil & Gas Stocks to Buy in 2017 (HP, RSPP)","publication_date":"2016-12-27 16:18:00 +0000","url":"http://www.investopedia.com/stock-analysis/cotd/122716/three-oil-gas-stocks-buy-2017-hp-rspp-hp-rspp-arex.aspx?partner=YahooSA","summary":"Three Oil & Gas Stocks to Buy in 2017 (HP, RSPP)"},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Right","publication_date":"2016-12-22 21:32:52 +0000","url":"http://biz.yahoo.com/e/161222/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Right"},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2016-12-20 12:33:38 +0000","url":"http://biz.yahoo.com/e/161220/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"},{"title":"Approach Resources Inc. (AREX): Are Hedge Funds Right About This Stock?","publication_date":"2016-12-12 13:45:50 +0000","url":"http://www.insidermonkey.com/blog/approach-resources-inc-arex-are-hedge-funds-right-about-this-stock-506226/","summary":"Approach Resources Inc. (AREX): Are Hedge Funds Right About This Stock?"},{"title":"ETFs with exposure to Approach Resources, Inc. : December 8, 2016","publication_date":"2016-12-08 17:12:03 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-approach-resources-inc-december-8-2016/","summary":"ETFs with exposure to Approach Resources, Inc. : December 8, 2016"},{"title":"5 U.S. Oil Stocks Up Over 10% On OPEC Production Cut","publication_date":"2016-11-30 20:53:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-2XOYy4SZrk/5-us-oil-stocks-up-over-10-on-opec-production-cut-cm715970","summary":"For the first time since 2008 OPEC has reached an agreement to cut oil production The cartel announced its decision to reduce output by 1 million barrels a day b d at its headquarters in Vienna on Wednesday sending oil prices soaring more than 7 Today s announcement marks the end of"},{"title":"5 U.S. Oil Stocks Up Over 10% On OPEC Production Cut","publication_date":"2016-11-30 18:55:06 +0000","url":"http://finance.yahoo.com/news/5-u-oil-stocks-over-185506374.html","summary":"5 U.S. Oil Stocks Up Over 10% On OPEC Production Cut"},{"title":"Mid-Morning Market Update: Markets Edge Lower; Tiffany Tops Q3 Expectations","publication_date":"2016-11-29 16:17:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t4syQRUpja0/mid-morning-market-update-markets-edge-lower-tiffany-tops-q3-expectations-cm715169","summary":"Following the market opening Tuesday the Dow traded down 0 11 percent to 19 076 23 while the NASDAQ declined 0 13 percent to 5 362 05 The S amp P also fell dropping 0 14 percent to 2 198 71 Leading and Lagging Sectors Tuesday morning non cyclical consumer goods amp"},{"title":"Mid-Day Market Update: Headwaters Surges On Acquisition News; Cubic Shares Slide","publication_date":"2016-11-21 18:03:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xopjIIEo9CU/mid-day-market-update-headwaters-surges-on-acquisition-news-cubic-shares-slide-cm712159","summary":"Midway through trading Monday the Dow traded up 0 24 percent to 18 912 55 while the NASDAQ climbed 0 58 percent to 5 352 62 The S amp P also rose gaining 0 49 percent to 2 192 59 Leading and Lagging Sectors On Monday energy shares gained by 2 2 percent Meanwhile top gainers"},{"title":"APPROACH RESOURCES INC Financials","publication_date":"2016-11-15 18:04:09 +0000","url":"http://finance.yahoo.com/q/is?s=arex","summary":"APPROACH RESOURCES INC Financials"},{"title":"Trump's Rejection of Paris Climate Accord and Energy Plan Likely Unsettled the Sector","publication_date":"2016-11-11 22:26:00 +0000","url":"https://www.thestreet.com/story/13890712/1/trump-s-rejection-of-paris-climate-accord-and-energy-plan-likely-unsettled-the-sector.html?puc=yahoo&cm_ven=YAHOO","summary":"Trump's Rejection of Paris Climate Accord and Energy Plan Likely Unsettled the Sector"},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits","publication_date":"2016-11-09 21:44:44 +0000","url":"http://biz.yahoo.com/e/161109/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"},{"title":"Approach Resources Announces Reaffirmation of Borrowing Base of $325 Million","publication_date":"2016-11-09 21:30:00 +0000","url":"http://finance.yahoo.com/news/approach-resources-announces-reaffirmation-borrowing-213000255.html","summary":"[Business Wire] - Approach Resources Inc. today announced that it has completed its fall 2016 semiannual borrowing base redetermination of its revolving credit facility. The borrowing base was unanimously reaffirmed by the bank group at $325 million and there were no changes to the existing terms or conditions of the credit agreement."},{"title":"ETF’s with exposure to Approach Resources, Inc. : November 7, 2016","publication_date":"2016-11-07 17:05:16 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-approach-resources-inc-november-7-2016/","summary":"ETF’s with exposure to Approach Resources, Inc. : November 7, 2016"},{"title":"Edited Transcript of AREX earnings conference call or presentation 3-Nov-16 3:00pm GMT","publication_date":"2016-11-04 16:00:22 +0000","url":"http://finance.yahoo.com/news/edited-transcript-arex-earnings-conference-160022124.html","summary":"Edited Transcript of AREX earnings conference call or presentation 3-Nov-16 3:00pm GMT"},{"title":"Approach Resources, Inc. :AREX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016","publication_date":"2016-11-04 15:51:38 +0000","url":"http://www.capitalcube.com/blog/index.php/approach-resources-inc-arex-us-earnings-analysis-q3-2016-by-the-numbers-november-4-2016/","summary":"Approach Resources, Inc. :AREX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016"},{"title":"Approach Resources Inc Earnings Call scheduled for 11:00 am ET today","publication_date":"2016-11-03 15:00:00 +0000","url":"http://biz.yahoo.com/cc/3/154113.html","summary":"Approach Resources Inc Earnings Call scheduled for 11:00 am ET today"},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se","publication_date":"2016-11-03 10:09:40 +0000","url":"http://biz.yahoo.com/e/161103/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se"},{"title":"Approach Resources reports 3Q loss","publication_date":"2016-11-03 09:07:43 +0000","url":"http://sg.finance.yahoo.com/news/approach-resources-reports-3q-loss-090743805.html","summary":"Approach Resources reports 3Q loss"},{"title":"Approach Resources Inc. Announces Strategic Alliance and Deleveraging Transactions","publication_date":"2016-11-02 22:24:00 +0000","url":"http://finance.yahoo.com/news/approach-resources-inc-announces-strategic-222400960.html","summary":"[Business Wire] - Approach Resources Inc. today announced an agreement to substantially reduce the Company’s long-term debt through exchange transactions anchored by a proven oil and gas industry operator and investor ."},{"title":"Approach Resources Inc. Reports Third Quarter 2016 Results","publication_date":"2016-11-02 22:22:00 +0000","url":"http://finance.yahoo.com/news/approach-resources-inc-reports-third-222200400.html","summary":"[Business Wire] - Approach Resources Inc. today reported results for third quarter 2016. Highlights for third quarter 2016 include:"},{"title":"Q3 2016 Approach Resources Inc Earnings Release - After Market Close","publication_date":"2016-11-02 11:07:04 +0000","url":"http://biz.yahoo.com/research/earncal/20161102.html?t=arex","summary":"Q3 2016 Approach Resources Inc Earnings Release - After Market Close"},{"title":"Devon Energy (DVN) Q3 Earnings: Stock Likely to Beat Again","publication_date":"2016-10-27 13:42:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MpJGGoiKGIA/devon-energy-dvn-q3-earnings-stock-likely-to-beat-again-cm699237","summary":"We expect Devon Energy Corp DVN to beat expectations when it reports third quarter 2016 results after the market closes on Nov 1 Last quarter this independent energy company reported a positive earnings surprise of 127 27 It is worth noting that Devon Energy has outperformed the"},{"title":"Approach Resources upgraded by Wunderlich and SunTrust","publication_date":"2016-10-26 11:30:47 +0000","url":"http://finance.yahoo.com/q/ud?s=AREX","summary":"Approach Resources upgraded by Wunderlich and SunTrust"},{"title":"Mid-Afternoon Market Update: Gas Natural Jumps After Merger News; Twilio Shares Drop","publication_date":"2016-10-10 20:43:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9HRorg-pEeU/mid-afternoon-market-update-gas-natural-jumps-after-merger-news-twilio-shares-drop-cm691336","summary":"Toward the end of trading Monday the Dow traded up 0 53 percent to 18 336 92 while the NASDAQ climbed 0 79 percent to 5 334 18 The S amp P also rose gaining 0 50 percent to 2 164 59 Leading and Lagging Sectors Monday afternoon energy shares climbed 1 6 percent Meanwhile"},{"title":"Monday Sector Leaders: Gas Utilities, Oil & Gas Exploration & Production Stocks","publication_date":"2016-10-10 19:18:16 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0h0kPPV0HNE/monday-sector-leaders-gas-utilities-oil-gas-exploration-production-stocks-cm691219","summary":"In trading on Monday gas utilities shares were relative leaders up on the day by about 4 5 Leading the group were shares of Gas Natural EGAS up about 64 1 and shares of Northwest Natural Gas NWN up about 2 5 on the day Also showing relative strength are oil amp"},{"title":"Mid-Day Market Update: Crude Oil Up 3%; Twitter Shares Slide","publication_date":"2016-10-10 17:07:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pP00zUTQ5TM/mid-day-market-update-crude-oil-up-3-twitter-shares-slide-cm691188","summary":"Midway through trading Monday the Dow traded up 0 75 percent to 18 378 05 while the NASDAQ climbed 0 81 percent to 5 335 08 The S amp P also rose gaining 0 67 percent to 2 168 20 Leading and Lagging Sectors On Monday energy shares climbed 2 percent Meanwhile top gainers in"},{"title":"ETF’s with exposure to Approach Resources, Inc. : October 6, 2016","publication_date":"2016-10-06 13:35:00 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-approach-resources-inc-october-6-2016/","summary":"ETF’s with exposure to Approach Resources, Inc. : October 6, 2016"},{"title":"Mid-Morning Market Update: Markets Open Higher; Constellation Brands Tops Q2 Views","publication_date":"2016-10-05 15:27:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xGfPpElS4U0/mid-morning-market-update-markets-open-higher-constellation-brands-tops-q2-views-cm689147","summary":"Following the market opening Wednesday the Dow traded up 0 59 percent to 18 275 01 while the NASDAQ climbed 0 58 percent to 5 320 38 The S amp P also rose gaining 0 46 percent to 2 160 47 Leading and Lagging Sectors Wednesday morning energy shares gained by 1 4"},{"title":"Approach Resources Inc. Schedules Third Quarter 2016 Conference Call for Thursday, November 3, 2016","publication_date":"2016-10-03 20:56:06 +0000","url":"http://www.publicnow.com/view/904B6E585A08884715FAAAB505CACB1E55CFFAE6","summary":"[at noodls] - FORT WORTH, Texas--(BUSINESS WIRE)-- Approach Resources Inc.(NASDAQ: AREX) will host a conference call on Thursday, November 3, 2016, at 10:00 AM CT (11:00 AM ET) to discuss third quarter 2016 financial ..."},{"title":"Mid-Day Market Update: Crude Oil Rises Over 2%; Intra-Cellular Therapies Shares Slide","publication_date":"2016-09-29 17:51:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3nCc9fu5HQQ/mid-day-market-update-crude-oil-rises-over-2-intra-cellular-therapies-shares-slide-cm686716","summary":"Midway through trading Thursday the Dow traded down 0 10 percent to 18 321 30 while the NASDAQ declined 0 31 percent to 5 302 09 The S amp P also fell dropping 0 11 percent to 2 169 00 Leading and Lagging Sectors On Thursday energy shares gained 1 37 percent Meanwhile"},{"title":"Mid-Afternoon Market Update: Dow Gains 80 Points; Crude Oil Up 5%","publication_date":"2016-09-28 20:31:11 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3ot2lZsSphM/mid-afternoon-market-update-dow-gains-80-points-crude-oil-up-5-cm686237","summary":"Toward the end of trading Wednesday the Dow traded up 0 44 percent to 18 308 29 while the NASDAQ rose 0 09 percent to 5 310 32 The S amp P also rose gaining 0 36 percent to 2 167 61 Leading and Lagging Sectors Wednesday afternoon energy shares gained 3 5 percent Meanwhile"},{"title":"Arnold Schneider Adds to Approach Resources","publication_date":"2016-09-17 16:20:04 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ms-_Ee-jWM/arnold-schneider-adds-to-approach-resources-cm680888","summary":"Arnold Schneider Trades Portfolio of Schneider Capital Management added to his position in Approach Resources Inc AREX on Aug Schneider is president chief investment officer and principal of Schneider Capital which he founded in 996 Schneider believes disciplined"},{"title":"Arnold Schneider Adds to Approach Resources","publication_date":"2016-09-16 17:23:27 +0000","url":"http://finance.yahoo.com/news/arnold-schneider-adds-approach-resources-172327020.html","summary":"Arnold Schneider Adds to Approach Resources"},{"title":"ETF’s with exposure to Approach Resources, Inc. : September 15, 2016","publication_date":"2016-09-15 13:46:35 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-approach-resources-inc-september-15-2016/","summary":"ETF’s with exposure to Approach Resources, Inc. : September 15, 2016"},{"title":"Tuesday Sector Laggards: Non-Precious Metals & Non-Metallic Mining, Oil & Gas Exploration & Production Stocks","publication_date":"2016-09-13 18:45:33 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ut71uGPaIC8/tuesday-sector-laggards-non-precious-metals-non-metallic-mining-oil-gas-exploration-production-stocks-cm678939","summary":"In trading on Tuesday non precious metals amp non metallic mining shares were relative laggards down on the day by about 5 1 Helping drag down the group were shares of Ryerson Holding Corporation RYI off about 10 and shares of Mechel MTL down about 9 6 on the day"},{"title":"Mid-Morning Market Update: Markets Open Lower; Renesas Electronics To Acquire Intersil For $22.50/Share","publication_date":"2016-09-13 15:25:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/caNKcsN1YoA/mid-morning-market-update-markets-open-lower-renesas-electronics-to-acquire-intersil-for-2250share-cm678804","summary":"Following the market opening Tuesday the Dow traded down 0 97 percent to 18 147 63 while the NASDAQ declined 0 83 percent to 5 168 69 The S amp P also fell dropping 1 10 percent to 2 135 35 Leading and Lagging Sectors Tuesday morning non cyclical consumer goods amp"},{"title":"Approach Resources (AREX) in Focus: Stock Up 5.6% in Session","publication_date":"2016-09-08 14:20:48 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c6TwoornOYo/approach-resources-arex-in-focus-stock-up-56-in-session-cm676131","summary":"Approach Resources Inc AREX was a big mover last session as the company saw its shares rise around 5 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 123 9"},{"title":"Approach Resources (AREX) in Focus: Stock Up 5.6% in Session","publication_date":"2016-09-08 12:35:12 +0000","url":"http://finance.yahoo.com/news/approach-resources-arex-focus-stock-123512130.html","summary":"Approach Resources (AREX) in Focus: Stock Up 5.6% in Session"},{"title":"Mid-Morning Market Update: Markets Mostly Flat; HD Supply Misses Q2 Views","publication_date":"2016-09-07 15:47:20 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jVRZ-N1qKh4/mid-morning-market-update-markets-mostly-flat-hd-supply-misses-q2-views-cm675692","summary":"Following the market opening Wednesday the Dow traded down 0 07 percent to 18 525 45 while the NASDAQ gained 0 10 percent to 5 280 95 The S amp P also fell dropping 0 03 percent to 2 185 77 Leading and Lagging Sectors Wednesday morning energy shares surged by 0 43"},{"title":"Mid-Day Market Update: Navistar Rises After Strategic Alliance With Volkswagen Truck & Bus; Tonix Shares Drop","publication_date":"2016-09-06 17:37:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/33tJV7YeF40/mid-day-market-update-navistar-rises-after-strategic-alliance-with-volkswagen-truck-bus-tonix-shares-drop-cm675138","summary":"Midway through trading Tuesday the Dow traded up 0 10 percent to 18 510 70 while the NASDAQ gained 0 34 percent to 5 267 75 The S amp P also rose gaining 0 13 percent to 2 182 87 Leading and Lagging Sectors On Tuesday energy shares surged by 0 91 percent Meanwhile top gainers"},{"title":"Mid-Morning Market Update: Markets Mostly Flat; G-III Apparel Misses Q2 Expectations","publication_date":"2016-08-30 15:46:21 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wK-ju7AsZe8/mid-morning-market-update-markets-mostly-flat-g-iii-apparel-misses-q2-expectations-cm672313","summary":"Following the market opening Tuesday, the Dow traded down 0.07 percent to 18,489.98 while the NASDAQ gained 0.06 percent to 5,235.35. The S&P also fell, dropping 0.03 percent to 2,179.81. Leading and Lagging Sectors"},{"title":"ETF’s with exposure to Approach Resources, Inc. : August 30, 2016","publication_date":"2016-08-30 14:53:57 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-approach-resources-inc-august-30-2016/","summary":"ETF’s with exposure to Approach Resources, Inc. : August 30, 2016"},{"title":"Why Approach Resources (AREX) Stock Might be a Great Pick","publication_date":"2016-08-24 12:48:20 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4iIho6H3HXE/why-approach-resources-arex-stock-might-be-a-great-pick-cm669073","summary":"One stock that might be an intriguing choice for investors right now is Approach Resources, Inc.AREX . This is because this security in the Oil & Gas US Exploration & Productionspace is seeing solid earnings"},{"title":"Why Approach Resources (AREX) Stock Might be a Great Pick","publication_date":"2016-08-23 14:31:02 +0000","url":"http://finance.yahoo.com/news/why-approach-resources-arex-stock-143102555.html","summary":"Why Approach Resources (AREX) Stock Might be a Great Pick"},{"title":"Mid-Afternoon Market Update: CIFC Rises Following Acquisition News; Marathon Oil Shares Slide","publication_date":"2016-08-22 20:09:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-BwWA89mTHM/mid-afternoon-market-update-cifc-rises-following-acquisition-news-marathon-oil-shares-slide-cm668674","summary":"Toward the end of trading Monday, the Dow traded down 0.15 percent to 18,524.97 while the NASDAQ fell 0.01 percent to 5,237.92. The S&P also fell, dropping 0.13 percent to 2,181.14. Leading and Lagging"},{"title":"Mid-Afternoon Market Update: Crude Oil Up 2%; Ruby Tuesday Shares Drop Following Weak Results","publication_date":"2016-08-17 21:56:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RjdVWPLiHFo/mid-afternoon-market-update-crude-oil-up-2-ruby-tuesday-shares-drop-following-weak-results-cm664859","summary":"Toward the end of trading Friday, the Dow traded down 0.37 percent to 18,543.87 while the NASDAQ declined 0.16 percent to 5,219.95. The S&P also fell, dropping 0.25 percent to 2,180.30. Leading and Lagging"},{"title":"Approach Resources (AREX) Catches Eye: Stock Jumps 5.2%","publication_date":"2016-08-17 14:36:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IKVhLwgbs5c/approach-resources-arex-catches-eye-stock-jumps-52-cm666476","summary":"Approach Resources, Inc.AREX was a big mover last session, as the company saw its shares rise almost 5% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This"},{"title":"Approach Resources (AREX) Catches Eye: Stock Jumps 5.2%","publication_date":"2016-08-17 12:40:12 +0000","url":"http://finance.yahoo.com/news/approach-resources-arex-catches-eye-124012170.html","summary":"Approach Resources (AREX) Catches Eye: Stock Jumps 5.2%"},{"title":"Which Upstream Stocks Lead in Short Interest?","publication_date":"2016-08-15 13:19:16 +0000","url":"http://marketrealist.com/2016/08/top-5-upstream-stocks-lead-short-interest-2/?utm_source=yahoo&utm_medium=feed","summary":"Which Upstream Stocks Lead in Short Interest?"},{"title":"ETF’s with exposure to Approach Resources, Inc. : August 11, 2016","publication_date":"2016-08-11 16:30:31 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-approach-resources-inc-august-11-2016/","summary":"ETF’s with exposure to Approach Resources, Inc. : August 11, 2016"},{"title":"Approach Resources, Inc. :AREX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016","publication_date":"2016-08-09 16:10:15 +0000","url":"http://www.capitalcube.com/blog/index.php/approach-resources-inc-arex-us-earnings-analysis-q2-2016-by-the-numbers-august-9-2016/","summary":"Approach Resources, Inc. :AREX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016"},{"title":"Edited Transcript of AREX earnings conference call or presentation 4-Aug-16 3:00pm GMT","publication_date":"2016-08-05 04:04:16 +0000","url":"http://finance.yahoo.com/news/edited-transcript-arex-earnings-conference-040416011.html","summary":"Edited Transcript of AREX earnings conference call or presentation 4-Aug-16 3:00pm GMT"},{"title":"APPROACH RESOURCES INC Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-04 20:34:14 +0000","url":"http://biz.yahoo.com/e/160804/arex10-q.html","summary":"APPROACH RESOURCES INC Files SEC form 10-Q, Quarterly Report"},{"title":"Approach Resources reports 2Q loss","publication_date":"2016-08-03 23:33:41 +0000","url":"http://sg.finance.yahoo.com/news/approach-resources-reports-2q-loss-233341327.html","summary":"Approach Resources reports 2Q loss"},{"title":"Approach Resources Inc. Reports Second Quarter 2016 Results","publication_date":"2016-08-03 20:52:09 +0000","url":"http://www.publicnow.com/view/F3352A4CBA43062F6CE4CC231154856B54952AB8","summary":"[at noodls] - FORT WORTH, Texas--(BUSINESS WIRE)-- Approach Resources Inc.(NASDAQ: AREX) today reported results for second quarter 2016. Highlights for second quarter 2016 include: Average initial production (IP) for ..."},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, F","publication_date":"2016-08-03 20:45:26 +0000","url":"http://biz.yahoo.com/e/160803/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, F"},{"title":"Q2 2016 Approach Resources Inc Earnings Release - After Market Close","publication_date":"2016-08-03 11:07:04 +0000","url":"http://biz.yahoo.com/research/earncal/20160803.html?t=arex","summary":"Q2 2016 Approach Resources Inc Earnings Release - After Market Close"},{"title":"Monday Sector Laggards: Oil & Gas Exploration & Production, Precious Metals","publication_date":"2016-07-25 18:22:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/niQQCnxMWLc/monday-sector-laggards-oil-gas-exploration-production-precious-metals-cm654321","summary":"In trading on Monday, oil & gas exploration & production shares were relative laggards, down on the day by about 3.4%. Helping drag down the group were shares of Approach Resources ( AREX ), down about 9.5% and shares"},{"title":"ETF’s with exposure to Approach Resources, Inc. : July 21, 2016","publication_date":"2016-07-21 17:46:20 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-approach-resources-inc-july-21-2016/","summary":"ETF’s with exposure to Approach Resources, Inc. : July 21, 2016"},{"title":"Approach Resources Inc. Schedules Second Quarter 2016 Conference Call for Thursday, August 4, 2016","publication_date":"2016-07-20 20:30:00 +0000","url":"http://finance.yahoo.com/news/approach-resources-inc-schedules-second-203000720.html","summary":"[Business Wire] - Approach Resources Inc. will host a conference call on Thursday, August 4, 2016, at 10:00 AM CT to discuss second quarter 2016 financial and operating results."},{"title":"Upstream Stocks with High and Low Implied Volatility","publication_date":"2016-07-04 16:47:42 +0000","url":"http://marketrealist.com/2016/07/upstream-stocks-high-low-implied-volatilities/?utm_source=yahoo&utm_medium=feed","summary":"Upstream Stocks with High and Low Implied Volatility"},{"title":"ETF’s with exposure to Approach Resources, Inc. : July 1, 2016","publication_date":"2016-07-01 21:52:57 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-approach-resources-inc-july-1-2016/","summary":"ETF’s with exposure to Approach Resources, Inc. : July 1, 2016"},{"title":"Upstream Stocks with High and Low Implied Volatilities","publication_date":"2016-06-27 20:26:53 +0000","url":"http://marketrealist.com/2016/06/identifying-upstream-stocks-high-low-implied-volatility/?utm_source=yahoo&utm_medium=feed","summary":"Upstream Stocks with High and Low Implied Volatilities"},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure","publication_date":"2016-06-21 10:03:29 +0000","url":"http://biz.yahoo.com/e/160621/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Regulation FD Disclosure"},{"title":"How Did Upstream Stocks Perform on June 17?","publication_date":"2016-06-20 19:47:27 +0000","url":"http://marketrealist.com/2016/06/upstream-stocks-returns-2/?utm_source=yahoo&utm_medium=feed&utm_content=main_permalink&utm_campaign=upstream-stocks-returns-2","summary":"How Did Upstream Stocks Perform on June 17?"},{"title":"Approach Resources Inc. to Participate in Upcoming Conferences","publication_date":"2016-06-16 20:49:02 +0000","url":"http://www.publicnow.com/view/9B6A821A325AA6D8EC48EEFFD5DA928ADFD5EA4A","summary":"[at noodls] - FORT WORTH, Texas--(BUSINESS WIRE)-- Approach Resources Inc.(NASDAQ: AREX) today announced that the Company will participate in one-on-one investor meetings at the Wells Fargo West Coast Energy Conference ..."},{"title":"Mid-Day Market Update: LDR Rises On Acquisition News; DryShips Shares Drop","publication_date":"2016-06-07 17:21:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QHs1vFIPvEU/mid-day-market-update-ldr-rises-on-acquisition-news-dryships-shares-drop-cm631800","summary":"Midway through trading Tuesday, the Dow traded up 0.44 percent to 18,000.01 while the NASDAQ climbed 0.08 percent to 4,972.72. The S&P also rose, gaining 0.39 percent to 2,117.56. Leading and Lagging Sectors Tuesday morning,"},{"title":"EnerCom to Host The Oil & Gas Conference(R) 21 in Denver on August 14-18, 2016","publication_date":"2016-06-07 16:00:00 +0000","url":"http://finance.yahoo.com/news/enercom-host-oil-gas-conference-160000025.html","summary":"[Marketwired] - EnerCom, Inc. will host The Oil & Gas Conference® 21 on August 14-18, 2016, in Denver at the Westin Denver Downtown. Investment and oil and gas professionals can register for the event through the conference ..."},{"title":"APPROACH RESOURCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote","publication_date":"2016-06-02 21:10:16 +0000","url":"http://biz.yahoo.com/e/160602/arex8-k.html","summary":"APPROACH RESOURCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote"},{"title":"ETF’s with exposure to Approach Resources, Inc. : May 26, 2016","publication_date":"2016-05-26 23:09:38 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-approach-resources-inc-may-26-2016/","summary":"ETF’s with exposure to Approach Resources, Inc. : May 26, 2016"},{"title":"Stocks Are About To Take Over","publication_date":"2016-05-26 13:01:34 +0000","url":"http://finance.yahoo.com/tumblr/blog-stocks-are-about-to-take-over-130139671.html","summary":"Stocks Are About To Take Over"},{"title":"Mid-Day Market Update: Nanosphere Jumps Following Luminex Deal; Breitburn Energy Partners Shares Drop","publication_date":"2016-05-16 17:23:58 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Iudu5WWPglI/mid-day-market-update-nanosphere-jumps-following-luminex-deal-breitburn-energy-partners-shares-drop-cm621713","summary":"Midway through trading Monday, the Dow traded up 0.64 percent to 17,647.80 while the NASDAQ surged 0.81 percent to 4,756.09. The S&P also rose, gaining 0.63 percent to 2,059.54. Leading and Lagging Sectors Basic materials"},{"title":"Approach Resources Inc. Reports First Quarter 2016 Results","publication_date":"2016-05-04 20:51:03 +0000","url":"http://www.publicnow.com/view/1915EE30CC4E2B3633566F3880EA9BB22B892B9C","summary":"[at noodls] - FORT WORTH, Texas--(BUSINESS WIRE)-- Approach Resources Inc.(NASDAQ: AREX) today reported results for first quarter 2016. Highlights for first quarter 2016 include: Production was 12.8 MBoe/d, a 10% decrease ..."},{"title":"Mid-Morning Market Update: Markets Open Lower; Boeing Earnings Miss Views","publication_date":"2016-04-27 15:29:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aEG-Iy9o8s8/mid-morning-market-update-markets-open-lower-boeing-earnings-miss-views-cm612392","summary":"Following the market opening Wednesday, the Dow traded down 0.12 percent to 17,968.03 while the NASDAQ declined 0.71 percent to 4,853.74. The S&P also fell, dropping 0.05 percent to 2,090.59. Leading and Lagging Sectors On"},{"title":"Approach Resources Inc. Schedules First Quarter 2016 Conference Call for Thursday, May 5, 2016","publication_date":"2016-04-21 20:52:17 +0000","url":"http://www.publicnow.com/view/3644E7AE757BCB27A8FA50995E9CF207B388619E","summary":"[at noodls] - FORT WORTH, Texas--(BUSINESS WIRE)-- Approach Resources Inc.(NASDAQ: AREX) will host a conference call on Thursday, May 5, 2016, at 10:00 AM CT (11:00 AM ET) to discuss first quarter 2016 financial and ..."},{"title":"Approach Resources (AREX) Shares March Higher, Can It Continue?","publication_date":"2016-04-19 06:06:22 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y4GbC6xMMoA/approach-resources-arex-shares-march-higher-can-it-continue-cm608027","summary":"As of late, it has definitely been a great time to be an investor in Approach Resources, Inc.AREX . The stock has moved higher by 9.1% in the past month, while it is also above its 20 Day SMA"},{"title":"Five Oil & Energy Stocks Surging Today","publication_date":"2016-04-12 23:00:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z82sVJfQN5Q/five-oil-energy-stocks-surging-today-cm605498","summary":"U.S. oil prices closed at the highest levels of 2016 on Tuesday following rumors that producers in Russia and Saudi Arabia have finally agreed to freeze output. The news comes ahead of a meeting of the world's top producers"},{"title":"Energy Sector Update for 03/04/2016: REXX,AREX,CLNE","publication_date":"2016-03-04 20:52:15 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j_uSyVqFbjY/energy-sector-update-for-03042016-rexxarexclne-cm588605","summary":"Top Energy Stocks XOM +0.08% CVX 0.09% COP +5.78% SLB 0.56% OXY 1.53% Energy stocks were finishing well off their session highs, with the NYSE Energy Sector Index climbing about 0.7% in late trade while shares of energy companies"},{"title":"Energy Sector Update for 03/04/2016: SDRL,AREX,REXX","publication_date":"2016-03-04 18:37:04 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7rW4ykueNYg/energy-sector-update-for-03042016-sdrlarexrexx-cm588523","summary":"Top Energy Stocks XOM 0.02% CVX +1.00% COP +7.14% SLB +1.03% OXY 0.07% Energy stocks were broadly higher today, with the NYSE Energy Sector Index climbing about 2.0% while shares of energy companies in the S&P 500 were up"},{"title":"Approach Resources reports 4Q loss","publication_date":"2016-03-03 21:57:27 +0000","url":"http://sg.finance.yahoo.com/news/approach-resources-reports-4q-loss-215727278.html","summary":"Approach Resources reports 4Q loss"},{"title":"Monday Sector Laggards: Oil & Gas Exploration & Production, Shipping Stocks","publication_date":"2016-01-11 23:14:39 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lp3Os9xwnJ4/monday-sector-laggards-oil-gas-exploration-production-shipping-stocks-cm564229","summary":"In trading on Monday, oil & gas exploration & production shares were relative laggards, down on the day by about 6.2%. Helping drag down the group were shares of Halcon Resources ( HK ), off about 24.6% and shares"},{"title":"Approach Resources Inc. Reports Third Quarter 2015 Results","publication_date":"2015-11-04 21:58:04 +0000","url":"http://www.noodls.com/view/12B600CC192A57FEBB8F41114907D0127DFA45FC","summary":"[at noodls] - FORT WORTH, Texas--(BUSINESS WIRE)-- Approach Resources Inc.(NASDAQ: AREX) today reported results for third quarter 2015. Highlights for third quarter 2015 include: Record quarterly production of 1,525 ..."},{"title":"Approach Resources Inc. Schedules Third Quarter 2015 Conference Call for Thursday, November 5, 2015","publication_date":"2015-10-19 21:31:18 +0000","url":"http://www.noodls.com/view/08F15D6F2719FDEEE0A2BD2B8638FF28961C83F6","summary":"[at noodls] - Approach Resources Inc. Schedules Third Quarter 2015 Conference Call for Thursday, November 5, 2015"},{"title":"Mid-Afternoon Market Update: Genocea Biosciences Declines Following Announcement of Suspension of Development of GEN-004; PMC-Sierra Shares Surge","publication_date":"2015-10-19 20:40:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/py-1gx7B-pw/mid-afternoon-market-update-genocea-biosciences-declines-following-announcement-of-suspension-of-development-of-gen-004-pmc-sierra-shares-surge-cm532048","summary":"Toward the end of trading Monday, the Dow traded down 0.06 percent to 17,206.25 while the NASDAQ climbed 0.21 percent to 4,897.09. The S&P also fell, dropping 0.10 percent to 2,030.99. Leading and Lagging Sectors"},{"title":"Approach Resources Announces Reaffirmation of Lender Commitments in Credit Facility at $450 Million","publication_date":"2015-09-25 11:44:02 +0000","url":"http://www.noodls.com/view/FD19087B8D33B64B9C8DCCA1574402399000E9FE","summary":"[at noodls] - Download this Press Release (PDF 178 KB ) FORT WORTH, Texas--(BUSINESS WIRE)-- Approach Resources Inc.(NASDAQ: AREX) today announced that it has completed the scheduled semiannual borrowing base redetermination ..."},{"title":"Mid-Day Market Update: Crude Oil Surges Over 5%; Paycom Software Shares Tumble","publication_date":"2015-09-16 18:34:54 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jkeFMun5cj0/mid-day-market-update-crude-oil-surges-over-5-paycom-software-shares-tumble-cm520658","summary":"Midway through trading Wednesday, the Dow traded up 0.50 percent to 16,681.96 while the NASDAQ climbed 0.20 percent to 4,870.04. The S&P also rose, gaining 0.52 percent to 1,988.40. Leading and Lagging Sectors In trading"},{"title":"After Hours Most Active for Jul 30, 2015 : CX, LNKD, FEYE, QQQ, CAT, NOK, ATR, S, EXPE, AREX, FOXA, MSFT","publication_date":"2015-07-30 21:06:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RLjq4FczZH0/after-hours-most-active-for-jul-30-2015-cx-lnkd-feye-qqq-cat-nok-atr-s-expe-arex-foxa-msft-cm503468","summary":"The NASDAQ 100 After Hours Indicator is up 3.71 to 4,602.3. The total After hours volume is currently 24,089,212 shares traded. The following are the most active stocks for the after hours session Cemex S.A.B. de C.V. ( CX"},{"title":"3 Oil Stocks with Dangerous Liquidity Ratios","publication_date":"2015-07-05 13:26:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zSwKORPb0eM/3-oil-stocks-with-dangerous-liquidity-ratios-cm493199","summary":"If there is one lesson to be learned from the deep drop in oil prices over the past year, it's that liquidity matters. We see this by digging deep into the oil stocks that were"},{"title":"10 Best Oil Stocks by Oil Reserves","publication_date":"2015-06-03 18:51:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/prH_3diXrVg/10-best-oil-stocks-by-oil-reserves-cm483197","summary":"The oil industry is in the midst of one of the steepest downturns in years as the oil price is off its peak by 45%. As is typical during a downturn, investors haven't acted rationally,"},{"title":"Approach Resources reports 1Q loss","publication_date":"2015-05-06 23:19:19 +0000","url":"http://sg.finance.yahoo.com/news/approach-resources-reports-1q-loss-231919447.html","summary":"Approach Resources reports 1Q loss"},{"title":"Approach Resources misses Street 4Q forecasts","publication_date":"2015-02-26 00:06:57 +0000","url":"http://sg.finance.yahoo.com/news/approach-resources-misses-street-4q-000657239.html","summary":"Approach Resources misses Street 4Q forecasts"},{"title":"Approach Resources tops 3Q profit forecasts","publication_date":"2014-11-05 21:51:52 +0000","url":"http://sg.finance.yahoo.com/news/approach-resources-tops-3q-profit-215152608--finance.html","summary":"Approach Resources tops 3Q profit forecasts"}],"result_count":120,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1}},
{"id":"4","chart":[{"values":[{"x":"1489156200","y":"8.1001"},{"x":"1489156500","y":"8.2128"},{"x":"1489156800","y":"8.3562"},{"x":"1489157100","y":"8.43"},{"x":"1489157400","y":"8.2699"},{"x":"1489157700","y":"8.3348"},{"x":"1489158000","y":"8.2845"},{"x":"1489158300","y":"8.2401"},{"x":"1489158600","y":"8.12"},{"x":"1489158900","y":"8.1891"},{"x":"1489159200","y":"8.21"},{"x":"1489159500","y":"8.1"},{"x":"1489159800","y":"7.95"},{"x":"1489160100","y":"8.0831"},{"x":"1489160400","y":"8.16"},{"x":"1489160700","y":"8.1247"},{"x":"1489161000","y":"8.161"},{"x":"1489161300","y":"8.23"},{"x":"1489161600","y":"8.22"},{"x":"1489161900","y":"8.2532"},{"x":"1489162200","y":"8.34"},{"x":"1489162500","y":"8.25"},{"x":"1489162800","y":"8.270199999999999"},{"x":"1489163100","y":"8.23"},{"x":"1489163400","y":"8.33"},{"x":"1489163700","y":"8.3"},{"x":"1489164000","y":"8.28"},{"x":"1489164300","y":"8.25"},{"x":"1489164600","y":"8.25"},{"x":"1489164900","y":"8.27"},{"x":"1489165200","y":"8.44"},{"x":"1489165500","y":"8.39"},{"x":"1489165800","y":"8.4123"},{"x":"1489166100","y":"8.4525"},{"x":"1489166400","y":"8.49"},{"x":"1489166700","y":"8.4"},{"x":"1489167000","y":"8.46"},{"x":"1489167300","y":"8.41"},{"x":"1489167600","y":"8.514"},{"x":"1489167900","y":"8.619"},{"x":"1489168200","y":"8.538"},{"x":"1489168500","y":"8.4351"},{"x":"1489168800","y":"8.44"},{"x":"1489169100","y":"8.4"},{"x":"1489169400","y":"8.4645"},{"x":"1489169700","y":"8.5076"},{"x":"1489170000","y":"8.53"},{"x":"1489170300","y":"8.48"},{"x":"1489170600","y":"8.48"},{"x":"1489170900","y":"8.49"},{"x":"1489171200","y":"8.5"},{"x":"1489171500","y":"8.5191"},{"x":"1489171800","y":"8.4953"},{"x":"1489172100","y":"8.46"},{"x":"1489172400","y":"8.45"},{"x":"1489172700","y":"8.46"},{"x":"1489173000","y":"8.41"},{"x":"1489173300","y":"8.45"},{"x":"1489173600","y":"8.44"},{"x":"1489173900","y":"8.4179"},{"x":"1489174200","y":"8.3319"},{"x":"1489174500","y":"8.3753"},{"x":"1489174800","y":"8.3"},{"x":"1489175100","y":"8.3"},{"x":"1489175400","y":"8.3"},{"x":"1489175700","y":"8.25"},{"x":"1489176000","y":"8.21"},{"x":"1489176300","y":"8.309"},{"x":"1489176600","y":"8.32"},{"x":"1489176900","y":"8.29"},{"x":"1489177200","y":"8.46"},{"x":"1489177500","y":"8.41"},{"x":"1489177800","y":"8.43"},{"x":"1489178100","y":"8.45"},{"x":"1489178400","y":"8.45"},{"x":"1489178700","y":"8.415"},{"x":"1489179000","y":"8.46"},{"x":"1489179300","y":"8.5"},{"x":"1489179600","y":"8.44"},{"x":"1489179900","y":"8.45"},{"x":"1489180200","y":"8.55"},{"x":"1489180500","y":"8.44"},{"x":"1489180800","y":"8.5"},{"x":"1489181100","y":"8.5"},{"x":"1489181400","y":"8.49"},{"x":"1489181700","y":"8.46"},{"x":"1489182000","y":"8.5"},{"x":"1489182300","y":"8.5"},{"x":"1489182600","y":"8.46"},{"x":"1489182900","y":"8.46"},{"x":"1489183200","y":"8.46"},{"x":"1489185600","y":"8.5"},{"x":"1489185900","y":"8.47"},{"x":"1489186200","y":"8.46"},{"x":"1489186500","y":"8.45"},{"x":"1489186800","y":"8.5"},{"x":"1489187100","y":"8.5"},{"x":"1489188000","y":"8.44"},{"x":"1489188600","y":"8.44"},{"x":"1489189200","y":"8.46"},{"x":"1489190100","y":"8.49"},{"x":"1489193400","y":"8.5"},{"x":"1489193700","y":"8.45"}
],"color":"#03a9f4"}],"list":"Market Movers","symbol": "AUPH","name": "Aurinia Pharmaceutic","price": 8.24,"dollarChange": 0.46,"percentChange": 5.92,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/AUPH-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/AUPH-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/AUPH-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/AUPH-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/AUPH-1yr.php","open": 7.98,"high": 8.64,"low":7.91,"volume": 19206194,"avgVol": 5846407.638298,"sharesShort": 3382446,"shortPercent": 6.558715,"marketCap": 183595519,"float": 51571775,"headlines":{"data":[{"title":"Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session","publication_date":"2017-03-10 13:15:01 +0000","url":"http://finance.yahoo.com/news/aurinia-auph-catches-eye-stock-131501134.html","summary":"Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session"},{"title":"Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps","publication_date":"2017-03-10 12:37:00 +0000","url":"https://www.thestreet.com/story/14036467/1/biotech-stock-mailbag-puma-s-rebound-explained-tg-therapeutics-approval-debate-aurinia-next-steps.html?puc=yahoo&cm_ven=YAHOO","summary":"Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps"},{"title":"Here's Why Aurinia Pharmaceuticals Rose as Much as 15.6% Today","publication_date":"2017-03-09 23:14:16 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/450M_SF040Q/heres-why-aurinia-pharmaceuticals-rose-as-much-as-156-today-cm758893","summary":"What happened Shares of clinical stage drug developer Aurinia Pharmaceuticals NASDAQ AUPH rose over 15 today after the company announced fourth quarter and full year 2016 earnings Today s move marks the second time this week that the stock has risen by double digits The"},{"title":"Here's Why Aurinia Pharmaceuticals Rose as Much as 15.6% Today","publication_date":"2017-03-09 21:42:00 +0000","url":"http://www.fool.com/investing/2017/03/09/heres-why-aurinia-pharmaceuticals-rose-as-much-as.aspx","summary":"Here's Why Aurinia Pharmaceuticals Rose as Much as 15.6% Today"},{"title":"Aurinia reports 4Q loss","publication_date":"2017-03-09 14:22:24 +0000","url":"http://sg.finance.yahoo.com/news/aurinia-reports-4q-loss-142224293.html","summary":"Aurinia reports 4Q loss"},{"title":"Aurinia Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Operational Highlights","publication_date":"2017-03-09 13:30:00 +0000","url":"http://finance.yahoo.com/news/aurinia-reports-fourth-quarter-full-133000640.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. has released its financial results for the fourth quarter and year ended December 31, 2016. Amounts, unless specified otherwise, are expressed in U.S."},{"title":"Answering The Important Aurinia Pharmaceuticals Inc (AUPH) Questions","publication_date":"2017-03-08 15:59:43 +0000","url":"http://www.insidermonkey.com/blog/answering-the-important-aurinia-pharmaceuticals-inc-auph-questions-564599/","summary":"Answering The Important Aurinia Pharmaceuticals Inc (AUPH) Questions"},{"title":"Today's Research Reports on Trending Tickers: MeetMe and Aurinia Pharmaceuticals","publication_date":"2017-03-08 14:30:00 +0000","url":"http://finance.yahoo.com/news/todays-research-reports-trending-tickers-143000261.html","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 8, 2017 / U.S. markets slipped Tuesday as investors await more details on the upcoming Federal Reserve meeting as well as the U.S. monthly jobs report released on Friday. ..."},{"title":"Pre-Market Most Active for Mar 8, 2017 : PCRX, BAC, TSL, SNAP, UBS, VOD, TOT, COTV, AUPH, AAPL, URBN, TVIX","publication_date":"2017-03-08 13:52:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XLX4ZuI3qVQ/pre-market-most-active-for-mar-8-2017-pcrx-bac-tsl-snap-ubs-vod-tot-cotv-auph-aapl-urbn-tvix-cm757729","summary":"The NASDAQ 100 Pre Market Indicator is down 1 34 to 5 349 94 The total Pre Market volume is currently 9 271 872 shares traded The following are the most active stocks for the pre market session Pacira Pharmaceuticals Inc PCRX is unchanged at 48 65 with 1 295"},{"title":"Gainers & Losers Of Mar.7: AUPH, KURA, TEAR, AXSM, AKBA...","publication_date":"2017-03-07 21:48:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IORgSPuHlE4/gainers--losers-of-mar7-auph-kura-tear-axsm-akba-20170307-01544","summary":"Gainers & Losers Of Mar.7: AUPH, KURA, TEAR, AXSM, AKBA..."},{"title":"Here's Why Aurinia Pharmaceuticals Stock Is Soaring Today","publication_date":"2017-03-07 18:14:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ro7EbLiimMU/heres-why-aurinia-pharmaceuticals-stock-is-soaring-today-cm757330","summary":"What happened Shares of Aurinia Pharmaceuticals NASDAQ AUPH rose as much as 20 Tuesday morning after the company announced that it will present phase 2b data for its lead drug voclosporin at the National Kidney Foundation 2017 Spring Clinical Meetings in April As of 11 36 a"},{"title":"Here's Why Aurinia Pharmaceuticals Stock Is Soaring Today","publication_date":"2017-03-07 16:53:18 +0000","url":"http://www.fool.com/investing/2017/03/07/heres-why-aurinia-pharmaceuticals-rose-as-much-as.aspx","summary":"Here's Why Aurinia Pharmaceuticals Stock Is Soaring Today"},{"title":"Woe to Those Who Are Trapped When the Daily Pattern Is Broken","publication_date":"2017-03-07 15:38:00 +0000","url":"http://realmoney.thestreet.com/articles/03/07/2017/woe-those-who-are-trapped-when-daily-pattern-broken?puc=yahoo&cm_ven=YAHOO","summary":"Woe to Those Who Are Trapped When the Daily Pattern Is Broken"},{"title":"Pre-Market Most Active for Mar 7, 2017 : NMBL, WFT, GLBL, SNAP, MOMO, DKS, DISH, BAC, STAY, AUPH, XIV, TVIX","publication_date":"2017-03-07 13:52:51 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bkukCB2VOXI/pre-market-most-active-for-mar-7-2017-nmbl-wft-glbl-snap-momo-dks-dish-bac-stay-auph-xiv-tvix-cm757040","summary":"The NASDAQ 100 Pre Market Indicator is down 1 66 to 5 358 65 The total Pre Market volume is currently 4 563 057 shares traded The following are the most active stocks for the pre market session Nimble Storage Inc NMBL is 3 9 at 12 50 with 10 547 359 shares"},{"title":"4:06 pm Aurinia Pharma will present AURA-LV Phase IIb 48-week data of voclosporin for the treatment of lupus nephritis on April 20, 2017","publication_date":"2017-03-06 21:06:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#auph","summary":"4:06 pm Aurinia Pharma will present AURA-LV Phase IIb 48-week data of voclosporin for the treatment of lupus nephritis on April 20, 2017"},{"title":"Aurinia Announces Acceptance of Voclosporin Late-Breaking Presentation at the National Kidney Foundation 2017 Spring Clinical Meetings","publication_date":"2017-03-06 21:05:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-acceptance-voclosporin-breaking-210500572.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced that its late-breaking abstract for voclosporin has been accepted for oral presentation at the National Kidney Foundation 2017 Spring Clinical Meetings taking place April 18-22, 2017 in Orlando, FL."},{"title":"Gainers & Losers Of Mar.6: TGTX, CNCE, DXTR, KURA, ARGS...","publication_date":"2017-03-06 20:00:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-FtD2qL1YxA/gainers--losers-of-mar6-tgtx-cnce-dxtr-kura-args-20170306-01394","summary":"Gainers & Losers Of Mar.6: TGTX, CNCE, DXTR, KURA, ARGS..."},{"title":"Pre-Market Most Active for Mar 6, 2017 : SNAP, DB, BAC, TVIX, GM, CS, UN, MU, AUPH, GPRO, PTCT, CNCE","publication_date":"2017-03-06 13:52:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rnKICrFGIDk/pre-market-most-active-for-mar-6-2017-snap-db-bac-tvix-gm-cs-un-mu-auph-gpro-ptct-cnce-cm756479","summary":"The NASDAQ 100 Pre Market Indicator is down 6 38 to 5 367 1 The total Pre Market volume is currently 2 528 513 shares traded The following are the most active stocks for the pre market session Snap Inc SNAP is 1 26 at 28 35 with 1 772 973 shares traded following"},{"title":"Market Action Is Boring but Necessary","publication_date":"2017-03-03 16:54:00 +0000","url":"http://realmoney.thestreet.com/articles/03/03/2017/market-action-boring-necessary?puc=yahoo&cm_ven=YAHOO","summary":"Market Action Is Boring but Necessary"},{"title":"Biotech Industry Rally Grows as Trump Vows to Cut Regulations: Today's Reports on Aurinia Pharmaceuticals and Nektar Therapeutics","publication_date":"2017-03-03 14:30:00 +0000","url":"http://finance.yahoo.com/news/biotech-industry-rally-grows-trump-143000696.html","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 3, 2017 / The Biotech's Post-Election rally gained some steam this week after President Trump labeled the U.S. Food and Drug Administration's drug approval process as ..."},{"title":"Pre-Market Most Active for Mar 3, 2017 : SNAP, BAC, MU, NTNX, TVIX, SNE, AUPH, DB, UN, BIG, OCLR, IMMR","publication_date":"2017-03-03 13:52:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CPqN9rjgoYc/pre-market-most-active-for-mar-3-2017-snap-bac-mu-ntnx-tvix-sne-auph-db-un-big-oclr-immr-cm755841","summary":"The NASDAQ 100 Pre Market Indicator is down 4 5 to 5 358 76 The total Pre Market volume is currently 6 110 646 shares traded The following are the most active stocks for the pre market session Snap Inc SNAP is 0 86 at 25 34 with 1 513 887 shares traded Bank"},{"title":"Company Spotlight: Aurinia Pharma","publication_date":"2017-03-02 23:10:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JX4l6FaiGjM/company-spotlight-aurinia-pharma-20170302-01809","summary":"Company Spotlight: Aurinia Pharma"},{"title":"Health Care Sector Update for 03/02/2017: PTCT, AUPH, ADPT","publication_date":"2017-03-02 20:52:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_02j012rG4M/health-care-sector-update-for-03022017-ptct-auph-adpt-cm755634","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 06 JNJ 0 06 PFE 0 3 PFE 0 3 MRK 0 2 MRK 0 2 ABT 0 2 ABT 0 2 AMGN 0 4 AMGN 0 4 Health care stocks were little changed with the NYSE Health Care Index NYP edging up 0 04 while shares of health care companies in the S amp P"},{"title":"Thursday Sector Leaders: Music & Electronics Stores, Biotechnology Stocks","publication_date":"2017-03-02 19:13:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/szytH5UniDY/thursday-sector-leaders-music-electronics-stores-biotechnology-stocks-cm755564","summary":"In trading on Thursday music amp electronics stores shares were relative leaders up on the day by about 1 9 Leading the group were shares of Best Buy up about 5 9 and shares of Systemax up about 4 2 on the day Also showing relative strength are biotechnology shares up on the day"},{"title":"Patient Death Fears Allayed For Aurinia Pharmaceuticals Inc (AUPH), What’s Next?","publication_date":"2017-03-02 18:15:01 +0000","url":"http://www.insidermonkey.com/blog/patient-death-fears-allayed-for-aurinia-pharmaceuticals-inc-auph-whats-next-563256/","summary":"Patient Death Fears Allayed For Aurinia Pharmaceuticals Inc (AUPH), What’s Next?"},{"title":"Health Care Sector Update for 03/02/2017: PBYI,AUPH,ADPT","publication_date":"2017-03-02 18:12:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mgEExCKZi4A/health-care-sector-update-for-03022017-pbyiauphadpt-cm755546","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 13 JNJ 0 13 PFE 0 78 PFE 0 78 MRK 0 25 MRK 0 25 ABT 0 02 ABT 0 02 AMGN 0 22 AMGN 0 22 Health care stocks were little changed on Thursday with the NYSE Health Care Index declining less than 0 1 while shares of health care"},{"title":"Midday Update: Stocks Trim Gains on Profit-Taking","publication_date":"2017-03-02 18:12:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/115YBODKxQ0/midday-update-stocks-trim-gains-on-profit-taking-cm755545","summary":"Shares were trading lower on Thursday as profit taking was introduced amid expectations for another interest rate increase this month and signs of a tightening labor market Selling pressure has been heaviest in the financial sector despite rate hike forecasts followed by losses in industrials"},{"title":"Aurinia to Present at Cowen and Company 37th Annual Healthcare Conference","publication_date":"2017-03-02 18:12:00 +0000","url":"http://finance.yahoo.com/news/aurinia-present-cowen-company-37th-181200416.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc., today announced that its Chief Executive Officer, Richard M. Glickman, will present at the Cowen and Company 37th Annual Healthcare Conference in Boston, MA on March 6, 2017 at 1:20pm ET."},{"title":"Thursday’s Top Biopharma Movers","publication_date":"2017-03-02 17:20:16 +0000","url":"http://finance.yahoo.com/news/thursday-top-biopharma-movers-172016640.html","summary":"Thursday’s Top Biopharma Movers"},{"title":"Aurinia Pharma Spikes on Lupus Drug Safety","publication_date":"2017-03-02 16:39:00 +0000","url":"http://www.investopedia.com/news/aurinia-pharma-spikes-lupus-drug-safety-auph/?partner=YahooSA","summary":"Aurinia Pharma Spikes on Lupus Drug Safety"},{"title":"Biotech Premarket Movers: Aurinia, Puma, PTC, Juno","publication_date":"2017-03-02 14:32:00 +0000","url":"https://www.thestreet.com/story/14023878/1/biotech-premarket-movers-aurinia-puma-ptc-juno.html?puc=yahoo&cm_ven=YAHOO","summary":"Biotech Premarket Movers: Aurinia, Puma, PTC, Juno"},{"title":"Pre-Market Most Active for Mar 2, 2017 : AUPH, JD, PTCT, TOT, NOK, BAC, PBYI, SFR, PKX, TVIX, ARES, IBKC","publication_date":"2017-03-02 13:52:18 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NiRAciN0Hlo/pre-market-most-active-for-mar-2-2017-auph-jd-ptct-tot-nok-bac-pbyi-sfr-pkx-tvix-ares-ibkc-cm755245","summary":"The NASDAQ 100 Pre Market Indicator is up 8 84 to 5 399 83 The total Pre Market volume is currently 6 698 994 shares traded The following are the most active stocks for the pre market session Aurinia Pharmaceuticals Inc AUPH is 2 19 at 5 90 with 1 567 075"},{"title":"Aurinia's lupus drug shows no new safety concerns","publication_date":"2017-03-01 21:12:58 +0000","url":"http://finance.yahoo.com/news/aurinias-lupus-drug-shows-no-211258324.html","summary":"Aurinia's lupus drug shows no new safety concerns"},{"title":"Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints, Achieving Highest Complete Remission Rate of Any Global Lupus Nephritis Study","publication_date":"2017-03-01 21:05:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-voclosporin-meets-48-210500865.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced top-line results from its Phase IIb AURA-LV study in lupus nephritis ."},{"title":"Aurinia Pharma Kidney Drug Exits Study Update with Clean Safety Profile","publication_date":"2017-03-01 21:05:00 +0000","url":"https://www.thestreet.com/story/14022152/1/aurinia-pharma-kidney-drug-exits-study-update-with-clean-safety-profile.html?puc=yahoo&cm_ven=YAHOO","summary":"Aurinia Pharma Kidney Drug Exits Study Update with Clean Safety Profile"},{"title":"Gainers & Losers Of The Day: CEMP, IPCI, OREX, RNVA, ARGS...","publication_date":"2017-02-24 21:15:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q5MCTUpROhs/gainers--losers-of-the-day-cemp-ipci-orex-rnva-args-20170224-01164","summary":"Gainers & Losers Of The Day: CEMP, IPCI, OREX, RNVA, ARGS..."},{"title":"Aurinia Pharmaceuticals (AUPH) Shares March Higher, Can It Continue?","publication_date":"2017-02-22 14:09:16 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QgMhOiuQAzk/aurinia-pharmaceuticals-auph-shares-march-higher-can-it-continue-cm751129","summary":"Aurinia Pharmaceuticals Inc AUPH has been on the move lately as the stock has risen by 41 8 in the past four weeks and it is currently trading well above its 20 Day SMA This is a pretty solid move higher but the question that has to be on investors minds right now is can this"},{"title":"Aurinia Pharmaceuticals (AUPH) Shares March Higher, Can It Continue?","publication_date":"2017-02-22 13:20:01 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-auph-shares-march-132001854.html","summary":"Aurinia Pharmaceuticals (AUPH) Shares March Higher, Can It Continue?"},{"title":"Health Care Sector Update for 02/14/2017: AUPH","publication_date":"2017-02-14 14:38:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sxdEGgJ3_vQ/health-care-sector-update-for-02142017-auph-cm747548","summary":"Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 3 PFE 0 3 ABT flatABT flat MRK 0 2 MRK 0 2 AMGN 0 3 AMGN 0 3 Health care shares were mixed in pre market trade on Tuesday Health care shares were mixed in pre market trade on Tuesday In health care"},{"title":"Aurinia Announces Results from Japanese Phase I Ethnic Bridging Study for Voclosporin","publication_date":"2017-02-14 12:00:00 +0000","url":"http://au.finance.yahoo.com/news/aurinia-announces-results-japanese-phase-120000449.html","summary":"[Business Wire] - VICTORIA, British Columbia--(BUSINESSWIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global immunology market, today announced the results of a supportive Phase I safety, pharmacokinetic (PK) and pharmacodynamic (PD) study in healthy Japanese patients which supports further development of voclosporin in this patient population. Based on evaluations comparing the Japanese ethno-bridging data vs. previous PK and PD studies in non-Japanese patients, voclosporin demonstrated no statistically significant differences in exposure with respect to Area Under the Curve (AUC) measurements. Furthermore, the PK parameters in Japanese patients were generally consistent with previously evaluated PK parameters in non-Japanese volunteers."},{"title":"Gainers & Losers Of The Day: ZSAN, PLSE, XOMA, SAGE, CBIO...","publication_date":"2017-02-13 21:55:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kp9aiqfn-V0/gainers--losers-of-the-day-zsan-plse-xoma-sage-cbio-20170213-01457","summary":"Gainers & Losers Of The Day: ZSAN, PLSE, XOMA, SAGE, CBIO..."},{"title":"Aurinia’s New CEO, Richard Glickman, to Present at Leerink Partners 6th Annual Global Healthcare Conference","publication_date":"2017-02-10 19:44:00 +0000","url":"http://finance.yahoo.com/news/aurinia-ceo-richard-glickman-present-194400878.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc., today announced that its newly appointed Chief Executive Officer, Richard M. Glickman and Celia Economides, Associate Vice President, Investor Relations will participate in a Fireside Chat at the Leerink Partners 6th Annual Global Healthcare Conference on February 16th at 11:30am ET."},{"title":"Aurinia Announces Appointment of Company Founder, Dr. Richard M. Glickman, as its New Chief Executive Officer","publication_date":"2017-02-06 22:15:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-appointment-company-founder-221500645.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced its Board of Directors has appointed Dr."},{"title":"Can The Uptrend Continue for Aurinia Pharmaceuticals (AUPH)?","publication_date":"2017-02-03 16:34:32 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mUzJGVeVAdQ/can-the-uptrend-continue-for-aurinia-pharmaceuticals-auph-cm742867","summary":"Investors certainly have to be happy with Aurinia Pharmaceuticals Inc AUPH and its short term performance After all the stock has jumped by 48 1 in the past 4 weeks and it is also above its 20 Day Simple Moving Average as well This is certainly a good trend but investors are"},{"title":"Can The Uptrend Continue for Aurinia Pharmaceuticals (AUPH)?","publication_date":"2017-02-03 14:35:02 +0000","url":"http://finance.yahoo.com/news/uptrend-continue-aurinia-pharmaceuticals-auph-143502515.html","summary":"Can The Uptrend Continue for Aurinia Pharmaceuticals (AUPH)?"},{"title":"Aurinia Pharmaceuticals (AUPH) Jumps: Stock Rises 5.6%","publication_date":"2017-01-30 15:36:31 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MIkLIwQWJ-8/aurinia-pharmaceuticals-auph-jumps-stock-rises-56-cm740100","summary":"Aurinia Pharmaceuticals Inc AUPH was a big mover last session as its shares rose almost 6 on the day The move came after the company announced that it has selected Worldwide Clinical Trials as its Clinical Research Organization for the AURORA Phase 3 study of volcosporin for the treatment"},{"title":"Aurinia Pharmaceuticals (AUPH) Jumps: Stock Rises 5.6%","publication_date":"2017-01-30 13:25:01 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-auph-jumps-stock-132501025.html","summary":"Aurinia Pharmaceuticals (AUPH) Jumps: Stock Rises 5.6%"},{"title":"Blog Coverage Aurinia Chooses Worldwide Clinical Trials as CRO for AURORA Phase-3 Study of Voclosporin","publication_date":"2017-01-30 13:15:00 +0000","url":"http://finance.yahoo.com/news/blog-coverage-aurinia-chooses-worldwide-131500087.html","summary":"[Accesswire] - Upcoming AWS Coverage on Incyte Post-Earnings Results LONDON, UK / ACCESSWIRE / January 30, 2017 / Active Wall St. blog coverage looks at the headline from Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH ) ..."},{"title":"Health Care Sector Update for 01/27/2017: AUPH,MATN,NOVN","publication_date":"2017-01-27 18:11:05 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f0NL0KE2Lq0/health-care-sector-update-for-01272017-auphmatnnovn-cm739516","summary":"Top Health Care StocksTop Health Care Stocks JNJ 1 32 JNJ 1 32 PFE 0 56 PFE 0 56 MRK 0 54 MRK 0 54 ABT 0 80 ABT 0 80 AMGN 2 39 AMGN 2 39 Health care stocks were helping limit losses for the broader markets Friday with the NYSE Health Care Index 0 7 while shares of health"},{"title":"Pre-Market Most Active for Jan 27, 2017 : MSFT, NVS, AZN, PCG, AUPH, HZN, PHG, CL, SBUX, AAL, INTC, FB","publication_date":"2017-01-27 13:51:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IxqMfbBMfWA/pre-market-most-active-for-jan-27-2017-msft-nvs-azn-pcg-auph-hzn-phg-cl-sbux-aal-intc-fb-cm739188","summary":"The NASDAQ 100 Pre Market Indicator is up 9 to 5 157 82 The total Pre Market volume is currently 4 701 761 shares traded The following are the most active stocks for the pre market session Microsoft Corporation MSFT is 0 91 at 65 18 with 497 598 shares"},{"title":"Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix","publication_date":"2017-01-27 13:13:00 +0000","url":"https://www.thestreet.com/story/13968673/1/biotech-stock-mailbag-trump-aurinia-immunomedics-cellceutix.html?puc=yahoo&cm_ven=YAHOO","summary":"Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix"},{"title":"Aurinia Selects Worldwide Clinical Trials as its CRO for Phase 3 Lupus Nephritis Trial","publication_date":"2017-01-27 13:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-selects-worldwide-clinical-trials-130000360.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced that it has selected Worldwide Clinical Trials as its Clinical Research Organization for the AURORA Phase 3 study of volcosporin for the treatment of active lupus nephritis ."},{"title":"Aurinia Pharmaceuticals to Participate in Upcoming Conferences","publication_date":"2017-01-26 21:05:00 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-participate-upcoming-conferences-210500599.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc., today announced that Michael Martin, Chief Operating Officer, and Celia Economides, Associate VP of Investor Relations, will participate in the Canaccord Genuity Rare Disease Biopharma 1x1 Day on February 7th in New York City and the Leerink Partners 6th Annual Global Healthcare Conference on February 16th at 11:30am ET."},{"title":"Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA...","publication_date":"2017-01-25 00:26:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7IkfIqdddxg/gainers--losers-of-the-day-gnvc-nviv-clrb-aqb-bioa-20170125-00009","summary":"Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA..."},{"title":"3 Microcaps With Recent 13-D Activist Investors","publication_date":"2017-01-09 20:03:55 +0000","url":"http://finance.yahoo.com/news/3-microcaps-recent-13-d-200355554.html","summary":"3 Microcaps With Recent 13-D Activist Investors"},{"title":"Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options","publication_date":"2017-01-05 15:40:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tAgURaSMT-M/implied-volatility-surging-for-aurinia-pharmaceuticals-auph-stock-options-cm729735","summary":"Investors in 160 Aurinia Pharmaceuticals Inc AUPH need to pay close attention to the stock based on moves in the options market lately That is because the January 20th 2017 5 Put had some of the highest implied volatility of all equity options today What is Implied"},{"title":"Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options","publication_date":"2017-01-05 13:42:01 +0000","url":"http://finance.yahoo.com/news/implied-volatility-surging-aurinia-pharmaceuticals-134201148.html","summary":"Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options"},{"title":"These Biotech Stocks Could Run in 2017","publication_date":"2017-01-04 16:52:38 +0000","url":"http://finance.yahoo.com/news/biotech-stocks-could-run-2017-165238899.html","summary":"These Biotech Stocks Could Run in 2017"},{"title":"Aurinia Closes US$28 Million Financing","publication_date":"2016-12-28 22:56:00 +0000","url":"http://finance.yahoo.com/news/aurinia-closes-us-28-million-225600852.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced that it has closed its previously announced US$28.75 million financing , for the sale of 12,777,775 units of the Company at a price of US$2.25 per Unit."},{"title":"Wall Street Sees Muted Open Amid Deluge of Economic Reports","publication_date":"2016-12-22 14:37:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uZWQvedHZe4/wall-street-sees-muted-open-amid-deluge-of-economic-reports-cm725030","summary":"U S stocks were pointing to a muted open on Thursday in a typically quiet trading period before the holiday season and as investors stayed on the sidelines amid a deluge of economic data U S stocks were pointing to a muted open on Thursday in a typically quiet trading period before the"},{"title":"US Futures Roughly Flat as Traders Await Data","publication_date":"2016-12-22 13:57:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MQEGmY1lGAg/us-futures-roughly-flat-as-traders-await-data-cm724963","summary":"U S stock futures were practically flat on Thursday in a typically quiet trading period before the holiday season and as investors stayed on the sidelines and looked ahead to the release of a deluge of economic data U S stock futures were practically flat on Thursday in a typically quiet"},{"title":"Pre-Market Most Active for Dec 22, 2016 : SMFG, MU, AZN, AC, RAD, AUPH, MTU, PKX, QQQ, TVIX, FRED, AAPL","publication_date":"2016-12-22 13:57:16 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m82XDQ7_v2M/pre-market-most-active-for-dec-22-2016-smfg-mu-azn-ac-rad-auph-mtu-pkx-qqq-tvix-fred-aapl-cm724965","summary":"The NASDAQ 100 Pre Market Indicator is up 3 83 to 4 952 73 The total Pre Market volume is currently 9 428 019 shares traded The following are the most active stocks for the pre market session Sumitomo Mitsui Financial Group Inc SMFG is 0 1496 at 7 72 with 1 626"},{"title":"Aurinia Announces US$25.0 Million Bought Deal Financing","publication_date":"2016-12-22 11:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-us-25-0-110000625.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced that it has entered into an underwriting agreement with H.C."},{"title":"Aurinia Announces Long-Term Manufacturing Collaboration Agreement with Lonza for Clinical and Commercial Supply of Voclosporin","publication_date":"2016-12-19 21:05:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-long-term-manufacturing-210500033.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced it has entered into a long-term agreement with Lonza for the manufacture of voclosporin active pharmaceutical ingredient ."},{"title":"Is Attunity Ltd (ATTU) A Good Stock To Buy?","publication_date":"2016-12-15 10:39:22 +0000","url":"http://www.insidermonkey.com/blog/is-attunity-ltd-attu-a-good-stock-to-buy-510232/","summary":"Is Attunity Ltd (ATTU) A Good Stock To Buy?"},{"title":"How Gastar Exploration Inc (GST) Stacks Up Against Its Peers","publication_date":"2016-12-15 01:33:45 +0000","url":"http://www.insidermonkey.com/blog/how-gastar-exploration-inc-gst-stacks-up-against-its-peers-509866/","summary":"How Gastar Exploration Inc (GST) Stacks Up Against Its Peers"},{"title":"Aurinia Confirms Receipt of FDA End of Phase 2 Meeting Minutes","publication_date":"2016-12-13 13:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-confirms-receipt-fda-end-130000979.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced that it has received the final End of Phase II meeting minutes from the U.S."},{"title":"Aurinia Announces Appointment of Biotech Industry Leader Jeffry Randall to its Board of Directors and Audit Committee","publication_date":"2016-12-12 21:05:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-appointment-biotech-industry-210500254.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced the appointment of Lorin Jeffry “Jeff” Randall to its board of directors and Chairman of the Audit Committee."},{"title":"Aurinia Highlights Renal Function Data from Global Phase IIb AURA Study of Voclosporin for Lupus Nephritis at American Society of Nephrology Kidney Week 2016","publication_date":"2016-11-21 14:27:00 +0000","url":"http://finance.yahoo.com/news/aurinia-highlights-renal-function-data-142700818.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced highlights from its global Phase IIb AURA study of voclosporin in the treatment of lupus nephritis presented at the American Society of Nephrology Kidney Week 2016 on November 19, 2016."},{"title":"Aurinia Aligns with FDA on Lupus Drug (AUPH)","publication_date":"2016-11-17 16:43:00 +0000","url":"http://www.investopedia.com/news/aurinia-aligns-fda-lupus-drug-auph/?partner=YahooSA","summary":"Aurinia Aligns with FDA on Lupus Drug (AUPH)"},{"title":"Aurinia Pharmaceuticals Rises on Positive Mid-Stage Update","publication_date":"2016-11-16 16:35:58 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-rises-positive-mid-163558524.html","summary":"Aurinia Pharmaceuticals Rises on Positive Mid-Stage Update"},{"title":"Aurinia Highlights Speed of Remission from Global Phase IIb AURA Study of Voclosporin in LN","publication_date":"2016-11-16 13:18:07 +0000","url":"http://www.publicnow.com/view/9D5B8DE34AA71931E4E034C99AA82A8CBA3C228D","summary":"[at noodls] - NEWS RELEASE AURINIA HIGHLIGHTS SPEED OF REMISSION FROM GLOBAL PHASE IIB AURA STUDY OF VOCLOSPORIN IN LUPUS NEPHRITIS AT 2016 AMERICAN COLLEGE OF RHEUMATOLOGY ANNUAL MEETING - Late breaking abstract showcases ..."},{"title":"Aurinia Highlights Speed of Remission from Global Phase IIb AURA Study of Voclosporin in Lupus Nephritis at 2016 American College of Rheumatology Annual Meeting","publication_date":"2016-11-16 13:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-highlights-speed-remission-global-130000626.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today highlighted additional findings from its global Phase IIb AURA study of voclosporin in the treatment of lupus nephritis ."},{"title":"Aurinia Pharmaceuticals to Present at Stifel 2016 Healthcare Conference","publication_date":"2016-11-10 18:35:00 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-present-stifel-2016-183500257.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc., today announced that its Chief Operating Officer, Michael Martin, will present a corporate overview of the Company at the Stifle 2016 Healthcare Conference taking place November 15-16, 2016 at the Lotte New York Palace Hotel."},{"title":"Aurinia Establishes At-The-Market Facility","publication_date":"2016-11-09 22:05:00 +0000","url":"http://finance.yahoo.com/news/aurinia-establishes-market-facility-220500109.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. today announced that it has entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co."},{"title":"Aurinia Pharmaceuticals, Inc. :AUPH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016","publication_date":"2016-11-08 16:00:03 +0000","url":"http://www.capitalcube.com/blog/index.php/aurinia-pharmaceuticals-inc-auph-us-earnings-analysis-q3-2016-by-the-numbers-november-8-2016/","summary":"Aurinia Pharmaceuticals, Inc. :AUPH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016"},{"title":"Aurinia reports 3Q loss","publication_date":"2016-11-04 23:50:46 +0000","url":"http://sg.finance.yahoo.com/news/aurinia-reports-3q-loss-235046062.html","summary":"Aurinia reports 3Q loss"},{"title":"Aurinia Reports Third Quarter 2016 Financial Results and Operational Highlights","publication_date":"2016-11-04 22:55:00 +0000","url":"http://finance.yahoo.com/news/aurinia-reports-third-quarter-2016-225500548.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. has released its financial results for the third quarter ended September 30, 2016. Amounts, unless specified otherwise, are expressed in U.S."},{"title":"Aurinia Pharmaceuticals Jumps on Phase 3 Trial Plans","publication_date":"2016-11-03 14:45:35 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-jumps-phase-3-144535126.html","summary":"Aurinia Pharmaceuticals Jumps on Phase 3 Trial Plans"},{"title":"CEMP Loses Big As D-Day Nears, AVXS Catches Investors'' Eyes, No Respite For OPXA","publication_date":"2016-11-03 02:18:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HYQ7fJGCKSc/cemp-loses-big-as-dday-nears-avxs-catches-investors-eyes-no-respite-for-opxa-20161103-00039","summary":"CEMP Loses Big As D-Day Nears, AVXS Catches Investors'' Eyes, No Respite For OPXA"},{"title":"Aurinia Announces Plans for Single Phase III Clinical Trial for Voclosporin in the Treatment of Lupus Nephritis Following Successful Completion of End of Phase II Meeting With FDA","publication_date":"2016-11-02 20:42:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-plans-single-phase-204200510.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , today announced its plans for a single Phase III clinical trial for voclosporin in the treatment of lupus nephritis ."},{"title":"Aurinia Pharma Merits Speculative Buy On M&A Appeal; Phase 3 Study Remains Paramount","publication_date":"2016-11-02 16:05:54 +0000","url":"http://finance.yahoo.com/news/aurinia-pharma-merits-speculative-buy-160554922.html","summary":"Aurinia Pharma Merits Speculative Buy On M&A Appeal; Phase 3 Study Remains Paramount"},{"title":"Aurinia Announces Acceptance of Late-Breaking Voclosporin Abstracts for Oral Presentation at Upcoming Medical Meetings","publication_date":"2016-10-24 21:15:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-acceptance-breaking-voclosporin-211500543.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced that two late-breaking abstracts for voclosporin were accepted for oral presentations at the ACR/ARHP Annual Meeting taking place in Washington, D.C."},{"title":"Aurinia Pharmaceuticals to Present at the 2016 BIO Investor Forum in San Francisco on October 18, 2016","publication_date":"2016-10-11 12:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-present-2016-bio-120000036.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc., today announced that its Chief Executive Officer, Charles Rowland, will present a corporate overview of the Company at the 2016 BIO Investor Forum, taking place October 18-19 at the Westin St."},{"title":"Aurinia Pharmaceuticals Inc Shoots Higher on Aurion Data (AUPH)","publication_date":"2016-10-07 13:46:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TfMG92rj_mU/aurinia-pharmaceuticals-inc-shoots-higher-on-aurion-data-auph-cm689964","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Aurinia Pharmaceuticals Inc 160 NASDAQ AUPH stock is up 33 in early trading Thursday after announcing positive open label data surrounding its Aurion"},{"title":"Pre-Market Most Active for Oct 7, 2016 : LYG, BAC, ACIA, QQQ, TVIX, XIV, RBS, TWTR, NOK, BCS, AUPH, SQQQ","publication_date":"2016-10-07 12:53:06 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dqevjupr7x4/pre-market-most-active-for-oct-7-2016-lyg-bac-acia-qqq-tvix-xiv-rbs-twtr-nok-bcs-auph-sqqq-cm690181","summary":"The NASDAQ 100 Pre Market Indicator is up 3 7 to 4 877 62 The total Pre Market volume is currently 7 785 732 shares traded The following are the most active stocks for the pre market session Lloyds Banking Group Plc LYG is 0 11 at 2 71 with 586 930 shares"},{"title":"Close Update: Wall Street Little Changed in Mixed Trade as Job Data Awaited","publication_date":"2016-10-06 20:43:35 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TlIa3SRRz2Q/close-update-wall-street-little-changed-in-mixed-trade-as-job-data-awaited-cm690033","summary":"Stocks in the U S traded in mixed directions but didn t make any significant moves on Thursday as investors awaited the release of key jobs data that may give indications as to when the Federal Reserve will next hike interest rates Stocks in the U S traded in mixed directions but didn t make"},{"title":"Here’s Why Aurinia Pharmaceuticals, Georgetown Bancorp, and Three Other Stocks Are on the Move Today","publication_date":"2016-10-06 16:35:08 +0000","url":"http://www.insidermonkey.com/blog/heres-why-aurinia-pharmaceuticals-georgetown-bancorp-and-three-other-stocks-are-on-the-move-today-479063/","summary":"Here’s Why Aurinia Pharmaceuticals, Georgetown Bancorp, and Three Other Stocks Are on the Move Today"},{"title":"Aurinia Pharma Skyrockets on Positive Data From Lupus Study","publication_date":"2016-10-06 14:20:21 +0000","url":"http://247wallst.com/healthcare-business/2016/10/06/aurinia-pharma-skyrockets-on-positive-data-from-lupus-study/","summary":"Aurinia Pharma Skyrockets on Positive Data From Lupus Study"},{"title":"Pre-Market Most Active for Oct 6, 2016 : TWTR, KLAC, AUPH, SNY, CRM, ALNY, RDS/B, NOK, LRCX, WMT, MDCO, JD","publication_date":"2016-10-06 12:53:01 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5k1OPsId62M/pre-market-most-active-for-oct-6-2016-twtr-klac-auph-sny-crm-alny-rdsb-nok-lrcx-wmt-mdco-jd-cm689589","summary":"The NASDAQ 100 Pre Market Indicator is up 19 to 4 877 94 The total Pre Market volume is currently 11 202 484 shares traded The following are the most active stocks for the pre market session Twitter Inc TWTR is 3 97 at 20 90 with 7 159 866 shares traded TWTR"},{"title":"Aurinia Releases Open-Label AURION Data Demonstrating Increased Remission Rates over Time for Voclosporin in the Treatment of Lupus Nephritis","publication_date":"2016-10-06 12:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-releases-open-label-aurion-120000867.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. a clinical stage biopharmaceutical company focused on the global immunology market, today announced 24-week data in all 10 patients from the AURION study, an open-label exploratory study to assess the short-term predictors of response using voclosporin in combination with mycophenolate mofetil and oral corticosteroids in patients with active lupus nephritis ."},{"title":"Health Care Sector Update for 09/30/2016: DCTH,AUPH,VEC","publication_date":"2016-09-30 20:41:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-HdxCSCUSYE/health-care-sector-update-for-09302016-dcthauphvec-cm687354","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 95 JNJ 0 95 PFE 1 74 PFE 1 74 MRK 2 43 MRK 2 43 ABT 0 99 ABT 0 99 AMGN 1 17 AMGN 1 17 Health care stocks were gaining this afternoon with the NYSE Health Care Index rising over 0 9 while shares of health care companies in"},{"title":"Aurinia Pharmaceuticals Inc (AUPH) Makes Comeback on Encouraging Trial Data","publication_date":"2016-09-30 19:23:04 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6bgX7VeWRMs/aurinia-pharmaceuticals-inc-auph-makes-comeback-on-encouraging-trial-data-cm687315","summary":"InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Aurinia Pharmaceuticals Inc 160 NASDAQ AUPH a clinical stage biotech is back in the game Friday after announcing positive topline data from its Phase 2b"},{"title":"Health Care Sector Update for 09/30/2016: THLD,AUPH,VEC","publication_date":"2016-09-30 18:41:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iWLSh7R9shA/health-care-sector-update-for-09302016-thldauphvec-cm687286","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 83 JNJ 0 83 PFE 1 97 PFE 1 97 MRK 1 86 MRK 1 86 ABT 0 82 ABT 0 82 AMGN 1 08 AMGN 1 08 Health care stocks were gaining this afternoon with the NYSE Health Care Index rising more than 0 7 while shares of health care companies in"},{"title":"Midday Update: Deutsche Bank Takes Pressure off Wall Street, Dow Races Higher","publication_date":"2016-09-30 17:21:43 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o0P8l4cCmck/midday-update-deutsche-bank-takes-pressure-off-wall-street-dow-races-higher-cm687242","summary":"Stocks have reversed Thursday s losses and were gaining altitude in Friday s midday trade as concerns about Germany s Deutsche Bank faded following reports of a settlement with the U S government Agence France tweeted earlier this morning that the bank is nearing a 5 4 billion settlement"},{"title":"Here’s Why Aurinia Pharmaceuticals, Alphabet, and Three Other Stocks Are in Spotlight on Friday","publication_date":"2016-09-30 15:40:53 +0000","url":"http://www.insidermonkey.com/blog/heres-why-aurinia-pharmaceuticals-alphabet-and-three-other-stocks-are-in-spotlight-on-friday-477763/","summary":"Here’s Why Aurinia Pharmaceuticals, Alphabet, and Three Other Stocks Are in Spotlight on Friday"},{"title":"Health Care Sector Update for 09/30/2016: JNJ, PFE, ABT, MRK, AMGN, AUPH, THLD","publication_date":"2016-09-30 13:41:40 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/89G0AfCsppI/health-care-sector-update-for-09302016-jnj-pfe-abt-mrk-amgn-auph-thld-cm687033","summary":"Top Health care stocks Top Health care stocks JNJ 0 5 JNJ 0 5 PFE 0 2 PFE 0 2 ABT flatABT flat MRK 1 7 MRK 1 7 AMGN flatAMGN flat Health care shares were mostly higher in pre market trade Friday Health care shares were mostly higher in pre market trade Friday In health"},{"title":"Pre-Market Most Active for Sep 30, 2016 : DB, NVO, LXK, UBS, AUPH, MT, NXPI, BAC, XIV, OPHT, QCOM, TVIX","publication_date":"2016-09-30 12:51:19 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K3lXQ5a15ZQ/pre-market-most-active-for-sep-30-2016-db-nvo-lxk-ubs-auph-mt-nxpi-bac-xiv-opht-qcom-tvix-cm686982","summary":"The NASDAQ 100 Pre Market Indicator is down 4 09 to 4 871 18 The total Pre Market volume is currently 8 467 595 shares traded The following are the most active stocks for the pre market session Deutsche Bank AG DB is 0 41 at 11 89 with 2 032 097 shares traded DB"},{"title":"AUPH Regains Aura, THLD Slumps On Quitting Tarloxotinib Program, CEMP Abuzz","publication_date":"2016-09-30 00:42:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3PLk73LlvF4/auph-regains-aura-thld-slumps-on-quitting-tarloxotinib-program-cemp-abuzz-20160930-00814","summary":"AUPH Regains Aura, THLD Slumps On Quitting Tarloxotinib Program, CEMP Abuzz"},{"title":"AUPH Regains Aura, THLD Slumps On Quitting Tarloxotinib Program, CEMP Abuzz","publication_date":"2016-09-30 00:42:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sUcrCCYrSvM/auph-regains-aura-thld-slumps-on-quitting-tarloxotinib-program-cemp-abuzz-20160930-00008","summary":"AUPH Regains Aura, THLD Slumps On Quitting Tarloxotinib Program, CEMP Abuzz"},{"title":"Aurinia Announces That Voclosporin Achieves Primary and All Pre-Specified Secondary Endpoints in Its Phase IIb AURA-LV Study for Lupus Nephritis (LN)","publication_date":"2016-09-29 20:54:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-voclosporin-achieves-primary-205400424.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. a clinical stage biopharmaceutical company focused on the global immunology market, today announced that in addition to voclosporin achieving its primary endpoint of Complete Remission at 24 weeks, both doses of voclosporin when added to the current standard of care of Mycophenolate Mofetil and a forced oral corticosteroid taper have met all 24-week pre-specified secondary ..."},{"title":"Aurinia Pharmaceuticals to Present at the Leerink Partners Roundtable Series in New York September 28, 2016","publication_date":"2016-09-22 12:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-present-leerink-partners-120000003.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc., , a clinical stage biopharmaceutical company focused on the global immunology market, today announced that its Chief Executive Officer, Charles Rowland, will participate in a Fireside Chat at the Leerink Partners Roundtable Series: Rare Disease and Immuno-Oncology on September 28, 2016 at 11:05am ET in New York."},{"title":"Aurinia Pharmaceuticals to Host Lupus Nephritis (LN) Breakfast and Webcast on September 30th in New York","publication_date":"2016-09-21 12:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-host-lupus-nephritis-120000118.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc., today announced that it will host a Lupus Nephritis expert breakfast on Friday, September 30th from 8:00am to 9:30am EDT in New York."},{"title":"5 Stocks Under $10 That Could Make You a Lot of Money","publication_date":"2016-09-08 13:21:00 +0000","url":"https://www.thestreet.com/story/13698364/1/5-stocks-under-10-that-could-make-you-a-lot-of-money.html?puc=yahoo&cm_ven=YAHOO","summary":"5 Stocks Under $10 That Could Make You a Lot of Money"},{"title":"Aurinia Pharmaceuticals to Present at the 2016 Rodman & Renshaw 18th Annual Global Investment Conference","publication_date":"2016-09-07 12:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-present-2016-rodman-120000102.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc., today announced that its Chief Operating Officer, Michael R. Martin, will present a corporate overview of the Company at the 2016 Rodman & Renshaw 18th Annual Global Investment Conference, taking place September 11th-13th at the Lotte New York Palace Hotel in New York City."},{"title":"The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen","publication_date":"2016-08-18 16:49:17 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L2jQfLGz1Fo/the-zacks-analyst-blog-highlights-vertex-aurinia-aveo-and-amgen-cm667214","summary":"For Immediate Release Chicago, IL August 18, 2016 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events"},{"title":"The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen","publication_date":"2016-08-18 13:30:01 +0000","url":"http://finance.yahoo.com/news/zacks-analyst-blog-highlights-vertex-133001411.html","summary":"The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen"},{"title":"Pre-Market Most Active for Aug 17, 2016 : SO, VRX, AEO, SCYX, LOW, TGT, SMFG, AUPH, ERIC, QQQ, URBN, CREE","publication_date":"2016-08-17 21:39:54 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i2HCWe979lo/pre-market-most-active-for-aug-17-2016-so-vrx-aeo-scyx-low-tgt-smfg-auph-eric-qqq-urbn-cree-cm666405","summary":"The NASDAQ 100 Pre Market Indicator is up .2 to 4,797.39. The total Pre Market volume is currently 7,922,700 shares traded. The following are the most active stocks for the pre market session Southern Company (The) ( SO )"},{"title":"Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data","publication_date":"2016-08-17 19:49:07 +0000","url":"http://finance.yahoo.com/news/biotech-stock-roundup-vertex-slips-194907118.html","summary":"Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data"},{"title":"Aurinia (AUPH) Stock Falls on Poor Phase II Lupus Study Data","publication_date":"2016-08-16 17:38:25 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yPVs30xAiAs/aurinia-auph-stock-falls-on-poor-phase-ii-lupus-study-data-cm666060","summary":"Shares of Aurinia Pharmaceuticals Inc.AUPH crashed 55% after the company reported results from a phase IIb study, AURA LV, on its pipeline candidate, voclosporin, in patients with active lupus nephritis (LN). The randomized, controlled, double blind study compared the"},{"title":"Aurinia (AUPH) Stock Falls on Poor Phase II Lupus Study Data","publication_date":"2016-08-16 15:08:03 +0000","url":"http://finance.yahoo.com/news/aurinia-auph-stock-falls-poor-150803768.html","summary":"Aurinia (AUPH) Stock Falls on Poor Phase II Lupus Study Data"},{"title":"Tuesday’s Top Health Care Movers","publication_date":"2016-08-16 14:55:19 +0000","url":"http://247wallst.com/healthcare-business/2016/08/16/tuesdays-top-health-care-movers/","summary":"Tuesday’s Top Health Care Movers"},{"title":"AUPH Loses Aura, PETX Scores Hat Trick, ACRX Meets Trial Goal","publication_date":"2016-08-16 01:07:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eh3__MF4fz8/auph-loses-aura-petx-scores-hat-trick-acrx-meets-trial-goal-20160816-00013","summary":"AUPH Loses Aura, PETX Scores Hat Trick, ACRX Meets Trial Goal"},{"title":"Health Care Sector Update for 08/15/2016: TBIO,AAC,AUPH","publication_date":"2016-08-15 20:34:59 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p73HTMG7wLU/health-care-sector-update-for-08152016-tbioaacauph-cm665544","summary":"Top Health Care Stocks JNJ 0.58% PFE +0.47% MRK +0.25% ABT 0.08% AMGN +0.82% Health care stocks turned mostly positive this afternoon, with the NYSE Health Care Index reversing earlier declines to post a 0.2% advance while shares of"},{"title":"Health Care Sector Update for 08/15/2016: RTTR,AAC,AUPH","publication_date":"2016-08-15 18:51:07 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5e7aefDJ3c8/health-care-sector-update-for-08152016-rttraacauph-cm665495","summary":"Top Health Care Stocks JNJ 0.59% PFE +0.19% MRK +0.38% ABT +0.32% AMGN +0.87% Health care stocks have turned solidly positive this afternoon, with the NYSE Health Care Index climbing to a 0.3% gain, reversing an earlier decline, while"},{"title":"Aurinia Pharmaceuticals (AUPH) Stock Tumbles on Lupus Drug Trial Deaths","publication_date":"2016-08-15 15:35:00 +0000","url":"https://www.thestreet.com/story/13675182/1/aurinia-pharmaceuticals-auph-stock-tumbles-on-lupus-drug-trial-deaths.html?puc=yahoo&cm_ven=YAHOO","summary":"Aurinia Pharmaceuticals (AUPH) Stock Tumbles on Lupus Drug Trial Deaths"},{"title":"Why These Five Stocks Are in Spotlight on Monday","publication_date":"2016-08-15 14:58:30 +0000","url":"http://www.insidermonkey.com/blog/why-these-five-stocks-are-in-spotlight-on-monday-3-469052/","summary":"Why These Five Stocks Are in Spotlight on Monday"},{"title":"Why Aurinia Pharma Is Getting Slaughtered","publication_date":"2016-08-15 14:40:40 +0000","url":"http://247wallst.com/healthcare-business/2016/08/15/why-aurinia-pharma-is-getting-slaughtered/","summary":"Why Aurinia Pharma Is Getting Slaughtered"},{"title":"Pre-Market Most Active for Aug 15, 2016 : BABA, AUPH, YHOO, TWTR, CHK, VRX, X, TWLO, ACRX, XIV, ACIA, AAPL","publication_date":"2016-08-15 13:00:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tvjcBCIkHMA/pre-market-most-active-for-aug-15-2016-baba-auph-yhoo-twtr-chk-vrx-x-twlo-acrx-xiv-acia-aapl-cm665203","summary":"The NASDAQ 100 Pre Market Indicator is up 7.89 to 4,814.97. The total Pre Market volume is currently 3,068,948 shares traded. The following are the most active stocks for the pre market session Alibaba Group Holding Limited ( BABA"},{"title":"Aurinia Pharmaceuticals Announces Voclosporin Meets Primary Endpoint in Phase IIB AURA-LV Study in Lupus Nephritis","publication_date":"2016-08-15 10:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-announces-voclosporin-meets-100000140.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage biopharmaceutical company focused on the global immunology market, today announced positive top-line results from the Phase 2b AURA-LV clinical study in patients with active lupus nephritis ."},{"title":"DVAX To Face FDA Panel, BMY's Opdivo Disappoints, MRK Scores Big With FDA Nod","publication_date":"2016-08-07 21:55:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gyDgXustNhc/dvax-to-face-fda-panel-bmys-opdivo-disappoints-mrk-scores-big-with-fda-nod-20160807-00048","summary":"DVAX To Face FDA Panel, BMY's Opdivo Disappoints, MRK Scores Big With FDA Nod"},{"title":"Aurinia reports 2Q loss","publication_date":"2016-08-05 13:31:42 +0000","url":"http://sg.finance.yahoo.com/news/aurinia-reports-2q-loss-133142754.html","summary":"Aurinia reports 2Q loss"},{"title":"Aurinia Reports Second Quarter 2016 Financial Results and Operational Highlights","publication_date":"2016-08-05 13:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-reports-second-quarter-2016-130000033.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. has released its financial results for the second quarter ended June 30, 2016. Amounts, unless specified otherwise, are expressed in U.S."},{"title":"Aurinia Pharmaceuticals to Host Lupus Nephritis Expert Breakfast and Webcast on August 4th in New York","publication_date":"2016-07-28 23:56:00 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-host-lupus-nephritis-235600754.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. today announced it will host a Lupus Nephritis expert breakfast on Thursday, August 4th from 8:00am to 9:30am EDT in New York."},{"title":"Aurinia Establishes At-The-Market Facility","publication_date":"2016-07-22 21:18:00 +0000","url":"http://finance.yahoo.com/news/aurinia-establishes-market-facility-211800077.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. today announced that it has entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co."},{"title":"Aurinia Announces Appointment of Head of Communications & Advocacy","publication_date":"2016-07-11 14:50:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-appointment-head-communications-145000889.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a clinical stage pharmaceutical company focused on the global nephrology market, today announced that it has appointed Celia Economides to the newly created position of Associate Vice President, Corporate Communications & Patient Advocacy."},{"title":"Coverage initiated on Aurinia Pharma by H.C. Wainwright","publication_date":"2016-06-30 11:16:39 +0000","url":"http://finance.yahoo.com/q/ud?s=AUPH","summary":"Coverage initiated on Aurinia Pharma by H.C. Wainwright"},{"title":"ANTH Dims On BRIGHT-SC Data, CYAD Fails To Chart, LLY Gets FDA Panel Nod","publication_date":"2016-06-29 01:31:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WG94V3NZokQ/anth-dims-on-brightsc-data-cyad-fails-to-chart-lly-gets-fda-panel-nod-20160629-00015","summary":"ANTH Dims On BRIGHT-SC Data, CYAD Fails To Chart, LLY Gets FDA Panel Nod"},{"title":"Aurinia Announces 24 Week Remission Rates from the First Seven Patients in its Open Label AURION Study in Lupus Nephritis (LN)","publication_date":"2016-06-28 22:45:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-24-week-remission-224500295.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. announced today that it has completed an analysis of the first 7 patients to complete 24 weeks in its open-label AURION study."},{"title":"Aurinia Announces Closing of US$7 Million Private Placement","publication_date":"2016-06-22 21:15:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-closing-us-7-211500983.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. has completed its previously announced private placement of 3,000,000 units of the Company at US$2.36 per unit for total gross proceeds of US$7,080,000 ."},{"title":"Aurinia Announces Private Placement","publication_date":"2016-06-15 11:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-private-placement-110000046.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. today announced that it intends to complete a private placement of units of the Company at a price of US$2.36 per unit, and has received commitments to purchase units totalling US$7,080,000 ."},{"title":"Aurinia Announces Results of Annual General Meeting","publication_date":"2016-06-09 23:29:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-results-annual-general-232900571.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. is pleased to announce that the six incumbent directors of the Company were re-elected at the Company’s annual general meeting held on June 8, 2016 ."},{"title":"Aurinia Pharmaceuticals, Inc. :AUPH-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016","publication_date":"2016-06-01 16:27:04 +0000","url":"http://www.capitalcube.com/blog/index.php/aurinia-pharmaceuticals-inc-auph-us-earnings-analysis-q1-2016-by-the-numbers-june-1-2016/","summary":"Aurinia Pharmaceuticals, Inc. :AUPH-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016"},{"title":"Aurinia Announces Presentations at the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Meeting","publication_date":"2016-05-12 22:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-presentations-european-renal-220000718.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. announced three presentations including the first scientific abstract of multi-targeted therapy utilizing voclosporin in the treatment of lupus nephritis at the 53rd Annual ERA-EDTA congress to be held in Vienna, Austria from May 21st – 24th, 2016."},{"title":"Aurinia reports 1Q loss","publication_date":"2016-05-11 21:42:31 +0000","url":"http://sg.finance.yahoo.com/news/aurinia-reports-1q-loss-214231469.html","summary":"Aurinia reports 1Q loss"},{"title":"Aurinia Reports First Quarter 2016 Financial Results and Operational Highlights","publication_date":"2016-05-11 21:30:00 +0000","url":"http://finance.yahoo.com/news/aurinia-reports-first-quarter-2016-213000785.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. has released its financial results for the first quarter ended March 31, 2016. Amounts, unless specified otherwise, are expressed in U.S."},{"title":"Aurinia Initiates First Clinical Study of Voclosporin for Japan","publication_date":"2016-05-09 11:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-initiates-first-clinical-study-110000283.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. announced today that after constructive interactions with the Japanese Pharmaceuticals and Medical Devices Agency , the Company will initiate a study of voclosporin in healthy Japanese volunteers."},{"title":"Aurinia Pharmaceuticals to Present at the 2016 Bloom Burton & Co. Healthcare Investor Conference","publication_date":"2016-04-28 11:00:00 +0000","url":"http://finance.yahoo.com/news/aurinia-pharmaceuticals-present-2016-bloom-110000657.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc., today announced that its Chief Operating Officer, Michael R. Martin will present a corporate overview of the company at the 2016 Bloom Burton & Co."},{"title":"Aurinia Announces Appointment of New Chief Executive Officer","publication_date":"2016-04-11 11:30:00 +0000","url":"http://finance.yahoo.com/news/aurinia-announces-appointment-chief-executive-113000874.html","summary":"[Business Wire] - Aurinia Pharmaceuticals Inc. , a biopharmaceutical company focused on the global nephrology market, announced today that the company has appointed Mr."},{"title":"Aurinia reports 4Q loss","publication_date":"2016-03-18 21:45:44 +0000","url":"http://sg.finance.yahoo.com/news/aurinia-reports-4q-loss-214544762.html","summary":"Aurinia reports 4Q loss"},{"title":"New Strong Buy Stocks for January 11th","publication_date":"2016-01-11 16:17:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-mAs4tyNWL8/new-strong-buy-stocks-for-january-11th-cm563882","summary":"Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today Allstate Corp ( ALL )Anika Therapeutics Inc ( ANIK )Aurinia Pharmaceuticals Inc ( AUPH )Bitauto Hldg Ltd ( BITA )Bridgeline Digital Inc ( BLIN )View"},{"title":"Actinium Pharmaceuticals (ATNM) in Focus: Stock Jumps 5.3%","publication_date":"2016-01-05 17:21:43 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CtKU5lCC4uw/actinium-pharmaceuticals-atnm-in-focus-stock-jumps-53-cm561447","summary":"Actinium Pharmaceuticals, Inc.ATNM was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session."},{"title":"Dermira (DERM) Looks Good: Stock Adds 5.9% in Session","publication_date":"2015-12-15 15:45:50 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5lbm1z4Dm3E/dermira-derm-looks-good-stock-adds-59-in-session-cm554911","summary":"Dermira, Inc.DERM was a big mover last session, as the company saw its shares rise almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This"},{"title":"New Strong Buy Stocks for December 14th","publication_date":"2015-12-14 16:43:09 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0X8GsRH5gIY/new-strong-buy-stocks-for-december-14th-cm554355","summary":"Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today Alon USA Partners LP ( ALDW )Arbor Realty Trust Inc ( ABR )Arena Pharmaceuticals, Inc. ( ARNA )Aurinia Pharmaceuticals Inc ( AUPH )Beneficial Bancorp Inc"},{"title":"New Strong Buy Stocks for December 7th","publication_date":"2015-12-07 16:17:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V125cMmQD1Q/new-strong-buy-stocks-for-december-7th-cm550998","summary":"Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today Aerie Pharmaceuticals Inc ( AERI )Arena Pharmaceuticals, Inc. ( ARNA )Aurinia Pharmaceuticals Inc ( AUPH )BioTelemetry, Inc. ( BEAT )Cadence Design Systems Inc ( CDNS"},{"title":"IntelliPharmaCeutics (IPCI) in Focus: Stock Climbs 8.3%","publication_date":"2015-12-01 16:11:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kG7iUvqsB8M/intellipharmaceutics-ipci-in-focus-stock-climbs-83-cm548805","summary":"IntelliPharmaCeutics International Inc.IPCI was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session."},{"title":"New Strong Buy Stocks for November 30th","publication_date":"2015-11-30 16:38:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yjSD_VldcUk/new-strong-buy-stocks-for-november-30th-cm548289","summary":"Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) list today Alexza Pharmaceuticals, Inc. ( ALXA )American Woodmark Corporation ( AMWD )Aurinia Pharmaceuticals Inc ( AUPH )Auris Medical Holding AG ( EARS )BioTelemetry, Inc. ( BEAT"},{"title":"Ignyta (RXDX) Looks Good: Stock Jumps 7.1% in Session","publication_date":"2015-11-24 15:24:13 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tMvTHrV1Dmo/ignyta-rxdx-looks-good-stock-jumps-71-in-session-cm546598","summary":"Ignyta, Inc.RXDX was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This"},{"title":"New Strong Buy Stocks for November 23rd","publication_date":"2015-11-23 17:17:30 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hxGI_SlD2Io/new-strong-buy-stocks-for-november-23rd-cm546059","summary":"Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) list today 2U Inc ( TWOU )Antero Resources Corp ( AR )Arena Pharmaceuticals, Inc. ( ARNA )Aurinia Pharmaceuticals Inc ( AUPH )Brady Corp ( BRC ) View"},{"title":"Aurinia reports 3Q loss","publication_date":"2015-11-13 21:32:40 +0000","url":"http://sg.finance.yahoo.com/news/aurinia-reports-3q-loss-213240589.html","summary":"Aurinia reports 3Q loss"},{"title":"Is a Surprise Coming for Aurinia Pharmaceuticals (AUPH) This Earnings Season?","publication_date":"2015-11-10 16:12:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D-esUL9vgTo/is-a-surprise-coming-for-aurinia-pharmaceuticals-auph-this-earnings-season-cm541303","summary":"Investors are always looking for stocks that are poised to beat at earnings season and Aurinia Pharmaceuticals Inc.AUPH may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for"},{"title":"What's in Store for Voxeljet (VJET) This Earnings Season?","publication_date":"2015-11-09 19:05:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gwsjqgESzYc/whats-in-store-for-voxeljet-vjet-this-earnings-season-cm540988","summary":"Voxeljet AGVJET is slated to report third quarter 2015 results on Nov 12, 2015, after the closing bell. Last quarter, the company posted a positive earnings surprise of 23.53%. Let us see how things are shaping up for this"},{"title":"What's in the Cards for Model N (MODN) in Q4 Earnings?","publication_date":"2015-11-07 01:12:49 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IAc4Cq71MZs/whats-in-the-cards-for-model-n-modn-in-q4-earnings-cm540312","summary":"Model N, Inc. MODN is scheduled to report fourth quarter fiscal 2015 results on Nov 9. Last quarter, the company posted a loss per share of 19 cents, narrower than the Zacks Consensus Estimate of a loss of 20"},{"title":"What's in the Cards for Gogo this Earnings Season?","publication_date":"2015-11-04 22:20:14 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2uMePUoFXaw/whats-in-the-cards-for-gogo-this-earnings-season-cm539076","summary":"In flight connectivity provider, Gogo Inc.GOGO is slated to release third quarter 2015 results on Nov 5, before the opening bell. Last quarter, Gogo delivered a negative earnings surprise of 3.23%. However, the company has posted an average earnings"},{"title":"Is Humana (HUM) Poised to Beat Q3 Earnings Estimates?","publication_date":"2015-11-04 22:19:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PLfpM3iiUFg/is-humana-hum-poised-to-beat-q3-earnings-estimates-cm539075","summary":"We expect Humana, Inc . HUM to beat expectations when it reports third quarter 2015 earnings on Nov 6, 2015.Why a Likely Positive Surprise? Our proven model shows that Humana is likely to beat on earnings because it has"}],"result_count":155,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1}},
{"id":"5","chart":[{"values":[{"x":"1489156200","y":"1.8199999999999998"},{"x":"1489156500","y":"1.8599999999999999"},{"x":"1489156800","y":"1.79"},{"x":"1489157100","y":"1.69"},{"x":"1489157400","y":"1.8454000000000002"},{"x":"1489157700","y":"1.9708"},{"x":"1489158000","y":"1.96"},{"x":"1489158300","y":"2.03"},{"x":"1489158600","y":"1.98"},{"x":"1489158900","y":"2.03"},{"x":"1489159200","y":"1.9808"},{"x":"1489159500","y":"2.02"},{"x":"1489159800","y":"2.1499"},{"x":"1489160100","y":"2.42"},{"x":"1489160400","y":"2.4"},{"x":"1489160700","y":"2.37"},{"x":"1489161000","y":"2.5"},{"x":"1489161300","y":"2.5522"},{"x":"1489161600","y":"2.445"},{"x":"1489161900","y":"2.39"},{"x":"1489162200","y":"2.45"},{"x":"1489162500","y":"2.44"},{"x":"1489162800","y":"2.2499000000000002"},{"x":"1489163100","y":"2.2354"},{"x":"1489163400","y":"2.15"},{"x":"1489163700","y":"2.23"},{"x":"1489164000","y":"2.3199"},{"x":"1489164300","y":"2.32"},{"x":"1489164600","y":"2.41"},{"x":"1489164900","y":"2.37"},{"x":"1489165200","y":"2.3"},{"x":"1489165500","y":"2.3"},{"x":"1489165800","y":"2.24"},{"x":"1489166100","y":"2.2399"},{"x":"1489166400","y":"2.2298999999999998"},{"x":"1489166700","y":"2.2885"},{"x":"1489167000","y":"2.341"},{"x":"1489167300","y":"2.41"},{"x":"1489167600","y":"2.38"},{"x":"1489167900","y":"2.33"},{"x":"1489168200","y":"2.2773"},{"x":"1489168500","y":"2.3"},{"x":"1489168800","y":"2.36"},{"x":"1489169100","y":"2.3401"},{"x":"1489169400","y":"2.301"},{"x":"1489169700","y":"2.3247999999999998"},{"x":"1489170000","y":"2.2856"},{"x":"1489170300","y":"2.29"},{"x":"1489170600","y":"2.2917"},{"x":"1489170900","y":"2.3237"},{"x":"1489171200","y":"2.4132"},{"x":"1489171500","y":"2.3291"},{"x":"1489171800","y":"2.15"},{"x":"1489172100","y":"2.07"},{"x":"1489172400","y":"2.14"},{"x":"1489172700","y":"2.1452"},{"x":"1489173000","y":"2.0399"},{"x":"1489173300","y":"2.04"},{"x":"1489173600","y":"2.043"},{"x":"1489173900","y":"2.0599"},{"x":"1489174200","y":"2.13"},{"x":"1489174500","y":"2.1099"},{"x":"1489174800","y":"2.05"},{"x":"1489175100","y":"2.04"},{"x":"1489175400","y":"1.97"},{"x":"1489175700","y":"2.0299"},{"x":"1489176000","y":"2.06"},{"x":"1489176300","y":"1.99"},{"x":"1489176600","y":"1.98"},{"x":"1489176900","y":"1.99"},{"x":"1489177200","y":"1.96"},{"x":"1489177500","y":"2.04"},{"x":"1489177800","y":"2.0825"},{"x":"1489178100","y":"2.04"},{"x":"1489178400","y":"2.1999"},{"x":"1489178700","y":"2.107"},{"x":"1489179000","y":"2.06"},{"x":"1489179300","y":"2.0506"},{"x":"1489179600","y":"2.05"},{"x":"1489179900","y":"2.02"},{"x":"1489180200","y":"2.03"},{"x":"1489180500","y":"2.04"},{"x":"1489180800","y":"2.02"},{"x":"1489181100","y":"2.02"},{"x":"1489181400","y":"1.99"},{"x":"1489181700","y":"2.02"},{"x":"1489182000","y":"2.04"},{"x":"1489182900","y":"2.02"},{"x":"1489183200","y":"2.02"},{"x":"1489183500","y":"2.02"},{"x":"1489183800","y":"2"},{"x":"1489184100","y":"1.99"},{"x":"1489184400","y":"1.96"},{"x":"1489185000","y":"1.95"},{"x":"1489185300","y":"1.95"},{"x":"1489185600","y":"1.92"},{"x":"1489185900","y":"1.97"},{"x":"1489186200","y":"1.92"},{"x":"1489186500","y":"1.92"},{"x":"1489186800","y":"1.96"},{"x":"1489187700","y":"1.96"},{"x":"1489188000","y":"2"},{"x":"1489189500","y":"1.95"},{"x":"1489189800","y":"2"},{"x":"1489190100","y":"2.01"},{"x":"1489190700","y":"2.01"},{"x":"1489191900","y":"2.02"},{"x":"1489193100","y":"2.01"},{"x":"1489193700","y":"2.04"}
],"color":"#03a9f4"}],"list":"Market Movers","symbol": "CATB","name": "Catabasis Pharmaceut","price": 1.991,"dollarChange": 0.67,"percentChange": 49.7,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/CATB-1d.php","oneMonthNull":"","oneMonth": "http://automatedinvestmentresearch.com/CATB-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/CATB-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/CATB-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/CATB-1yr.php","open": 1.69,"high": 2.76,"low":1.58,"volume": 55722075,"avgVol": 1933239.425532,"sharesShort": 893779,"shortPercent": 4.791789,"marketCap": 22382763,"float": 18652303,"headlines":{"data":[{"title":"Catabasis Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate Developments on Thursday, March 16","publication_date":"2017-03-02 13:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-report-fourth-quarter-130000016.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, will report fourth quarter and full year 2016 financial results after the NASDAQ Global Market close on Thursday, March 16, 2017."},{"title":"Sarepta (SRPT) Q4 Loss Widens; Sales of Duchenne Drug Slow","publication_date":"2017-03-01 17:13:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SLgBT9VSx04/sarepta-srpt-q4-loss-widens-sales-of-duchenne-drug-slow-cm754878","summary":"Sarepta Therapeutics Inc SRPT reported wider than expected loss in the fourth quarter of 2016 Meanwhile the biotech company s 2017 sales outlook fell largely short of expectations as the commercial launch of its only approved drug Exondys 51 has been slower than expected Sarepta"},{"title":"Catabasis Pharmaceuticals to Present at Cowen and Company 37th Annual Health Care Conference","publication_date":"2017-03-01 13:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-present-cowen-company-130000707.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate and pipeline overview at Cowen and Company’s 37th Annual Health Care Conference on March 8, 2017 at 10:40am ET at the Boston Marriott Copley Place Hotel in Boston, MA."},{"title":"How the state’s newest Duchenne biotechs are getting a boost from patient groups","publication_date":"2017-02-27 12:50:11 +0000","url":"http://www.bizjournals.com/boston/news/2017/02/27/how-the-state-s-newest-duchenne-biotechs-are.html?ana=yahoo","summary":"How the state’s newest Duchenne biotechs are getting a boost from patient groups"},{"title":"Congressman Keating calls pricy Duchenne drug an example of 'gouging'","publication_date":"2017-02-17 19:30:08 +0000","url":"http://www.bizjournals.com/boston/news/2017/02/17/congressman-keating-calls-pricy-duchenne-drug-an.html?ana=yahoo","summary":"Congressman Keating calls pricy Duchenne drug an example of 'gouging'"},{"title":"Catabasis Pharmaceuticals Announces Promotion of Ted Hibben to Chief Business Officer","publication_date":"2017-02-17 13:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-announces-promotion-ted-130000207.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced the promotion of Ted Hibben to Chief Business Officer. Mr. Hibben has more than 20 years of experience in business and corporate development, strategy, fundraising and M&A."},{"title":"Santhera opens Mass. office as local Duchenne ecosystem grows","publication_date":"2017-02-17 12:00:11 +0000","url":"http://www.bizjournals.com/boston/news/2017/02/17/santhera-opens-mass-office-as-local-duchenne.html?ana=yahoo","summary":"Santhera opens Mass. office as local Duchenne ecosystem grows"},{"title":"SV Life Sciences Advisers, LLC Buys KalVista Pharmaceuticals, Sells Raptor Pharmaceutical","publication_date":"2017-02-08 09:17:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CFilzlAQTgo/sv-life-sciences-advisers-llc-buys-kalvista-pharmaceuticals-sells-raptor-pharmaceutical-cm744623","summary":"SV Life Sciences Advisers LLC New Purchases KALV Reduced Positions OCUL Sold Out RPTP New Purchases KALV New Purchases KALV Reduced Positions OCUL Reduced Positions OCUL Sold Out RPTP Sold Out"},{"title":"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Catabasis Pharmaceuticals, Inc.","publication_date":"2017-02-02 16:08:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-160800732.html","summary":"[Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Catabasis Pharmaceuticals, Inc. concerning possible violations of federal securities laws."},{"title":"Catabasis Hits 52-Week Low on Poor DMD Drug Study Data","publication_date":"2017-02-02 13:33:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JJpG3fc33zM/catabasis-hits-52-week-low-on-poor-dmd-drug-study-data-cm742023","summary":"Cambridge MA based Catabasis Pharmaceuticals Inc s CATB shares tumbled to a new 52 week low of 1 08 on Feb 1 after the company announced disappointing top line safety and efficacy data from part B of the MoveDMD study phase I II on edasalonexent CAT 1004 The company s shares"},{"title":"Catabasis Hits 52-Week Low on Poor DMD Drug Study Data","publication_date":"2017-02-02 12:21:12 +0000","url":"http://finance.yahoo.com/news/catabasis-hits-52-week-low-122112062.html","summary":"Catabasis Hits 52-Week Low on Poor DMD Drug Study Data"},{"title":"Catabasis Pharmaceuticals downgraded by Citigroup","publication_date":"2017-02-02 12:05:31 +0000","url":"http://finance.yahoo.com/q/ud?s=CATB","summary":"Catabasis Pharmaceuticals downgraded by Citigroup"},{"title":"Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data","publication_date":"2017-02-02 11:27:11 +0000","url":"http://finance.yahoo.com/news/biotech-stock-roundup-celgene-biogen-112711812.html","summary":"Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data"},{"title":"Gainers & Losers Of The Day: PULM, ETRM, SMMT, BVX, ARQL...","publication_date":"2017-02-01 22:29:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZB_dn9p9tLw/gainers--losers-of-the-day-pulm-etrm-smmt-bvx-arql-20170201-01814","summary":"Gainers & Losers Of The Day: PULM, ETRM, SMMT, BVX, ARQL..."},{"title":"Health Care Sector Update for 02/01/2017: BVX,SMMT,CATB","publication_date":"2017-02-01 21:31:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YxKYNAERMKw/health-care-sector-update-for-02012017-bvxsmmtcatb-cm741830","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 26 JNJ 0 26 PFE 0 38 PFE 0 38 MRK 1 15 MRK 1 15 ABT 0 15 ABT 0 15 AMGN 1 54 AMGN 1 54 Health care stocks have turned solidly higher this afternoon with the NYSE Health Care Index rising about 0 3 in value today while shares"},{"title":"Catabasis Drops After Muscular Dystrophy Drug Fails","publication_date":"2017-02-01 20:41:00 +0000","url":"http://www.investopedia.com/news/catabasis-tanks-70-dmd-drug-failure-catb/?partner=YahooSA","summary":"Catabasis Drops After Muscular Dystrophy Drug Fails"},{"title":"Health Care Sector Update for 02/01/2017: SGYP,SMMT,CATB","publication_date":"2017-02-01 18:51:31 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kAiR0L0ciDo/health-care-sector-update-for-02012017-sgypsmmtcatb-cm741745","summary":"Top Health Care StocksTop Health Care Stocks JNJ 0 47 JNJ 0 47 PFE 0 10 PFE 0 10 MRK 1 17 MRK 1 17 ABT 0 42 ABT 0 42 AMGN 1 55 AMGN 1 55 Health care stocks were little changed in afternoon trade Wednesday with the NYSE Health Care Index adding about 0 1 in value today while"},{"title":"Catabasis Pharmaceuticals Inc (CATB): What’s Next?","publication_date":"2017-02-01 15:45:59 +0000","url":"http://www.insidermonkey.com/blog/catabasis-pharmaceuticals-inc-catb-whats-next-529810/","summary":"Catabasis Pharmaceuticals Inc (CATB): What’s Next?"},{"title":"Catabasis Pharma stock sinks 69% after negative mid-stage clinical trial results for DMD drug","publication_date":"2017-02-01 12:47:30 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=ED66A940-55B5-4281-93A1-A82A53D147AC&siteid=yhoof2","summary":"Catabasis Pharma stock sinks 69% after negative mid-stage clinical trial results for DMD drug"},{"title":"Catabasis: Negative Mid-stage Clinical Trial Results For DMD Drug","publication_date":"2017-02-01 11:44:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pfJuAguT68g/catabasis-negative-midstage-clinical-trial-results-for-dmd-drug-20170201-01057","summary":"Catabasis: Negative Mid-stage Clinical Trial Results For DMD Drug"},{"title":"Catabasis shares plummet on Duchenne trial failure","publication_date":"2017-02-01 00:55:06 +0000","url":"http://www.bizjournals.com/boston/news/2017/01/31/catabasis-shares-plummet-on-duchenne-trial-failure.html?ana=yahoo","summary":"Catabasis shares plummet on Duchenne trial failure"},{"title":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure","publication_date":"2017-01-31 21:11:30 +0000","url":"http://biz.yahoo.com/e/170131/catb8-k.html","summary":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure"},{"title":"4:02 pm Catabasis Pharmaceuticals announces top-line safety and efficacy results for Part B of the MoveDMD trial of edasalonexent for the treatment of Duchenne muscular dystrophy; changes were not statistically significant (shares halted)","publication_date":"2017-01-31 21:02:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#catb","summary":"4:02 pm Catabasis Pharmaceuticals announces top-line safety and efficacy results for Part B of the MoveDMD trial of edasalonexent for the treatment of Duchenne muscular dystrophy; changes were not statistically significant (shares halted)"},{"title":"Catabasis Pharmaceuticals Announces Top-Line Results for Part B of the MoveDMD® Trial for Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy","publication_date":"2017-01-31 21:01:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-announces-top-line-210100111.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced top-line safety and efficacy results for Part B of the MoveDMD® trial of edasalonexent for the treatment of Duchenne muscular dystrophy ."},{"title":"Catabasis Muscular Dystrophy Drug Posts Early Win","publication_date":"2017-01-23 17:32:00 +0000","url":"http://www.investopedia.com/news/catabasis-reports-muscular-dystrophy-drug-data-catb/?partner=YahooSA","summary":"Catabasis Muscular Dystrophy Drug Posts Early Win"},{"title":"Gainers & Losers Of The Day: CATB, MCUR, BIOC, SSH, ZYNEâ€¦","publication_date":"2017-01-19 20:17:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dyddD7IfBA0/gainers--losers-of-the-day-catb-mcur-bioc-ssh-zyne%C3%A2%C2%A6-20170119-01587","summary":"Gainers & Losers Of The Day: CATB, MCUR, BIOC, SSH, ZYNEâ€¦"},{"title":"Thursday’s Top Biopharma Movers","publication_date":"2017-01-19 17:20:53 +0000","url":"http://finance.yahoo.com/news/thursday-top-biopharma-movers-172053849.html","summary":"Thursday’s Top Biopharma Movers"},{"title":"Health Care Sector Update for 01/19/2017: CATB","publication_date":"2017-01-19 15:17:07 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M8lMh0GZ6-c/health-care-sector-update-for-01192017-catb-cm735381","summary":"Top health care stocks Top health care stocks JNJ 0 1 JNJ 0 1 PFE 0 2 PFE 0 2 ABT 0 5 ABT 0 5 MRK 0 4 MRK 0 4 AMGN 0 1 AMGN 0 1 Health care shares were mainly lower in early trade on Thursday Health care shares were mainly lower in early trade on Thursday In health"},{"title":"Catabasis Pharma surges 17% on positive early-stage clinical trial results for DMD drug","publication_date":"2017-01-19 14:08:35 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=BEDA5CF6-7191-4B92-99E8-160018E8F2EC&siteid=yhoof2","summary":"Catabasis Pharma surges 17% on positive early-stage clinical trial results for DMD drug"},{"title":"Catabasis Pharmaceuticals Phase 1 Data on Edasalonexent (CAT-1004), a Potential Disease-Modifying Therapy Being Developed for Duchenne Muscular Dystrophy, Published in the Journal of Clinical Pharmacology","publication_date":"2017-01-19 13:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-phase-1-data-130000602.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 data on edasalonexent in adult subjects. Edasalonexent is a potential disease-modifying therapy being developed for Duchenne muscular dystrophy ."},{"title":"Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?","publication_date":"2017-01-18 13:38:05 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1iQxZmyBYpg/will-thermo-fisher-tmo-beat-earnings-estimates-in-q4-cm734637","summary":"MA based medical instruments manufacturer Thermo Fisher Scientific Inc TMO is scheduled to report fourth quarter and full year 2016 results before the opening bell on Jan 31 Last quarter the company posted a positive earnings surprise of 3 05 In the trailing four quarters the"},{"title":"Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?","publication_date":"2017-01-18 12:40:12 +0000","url":"http://finance.yahoo.com/news/thermo-fisher-tmo-beat-earnings-124012566.html","summary":"Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?"},{"title":"Zimmer Biomet (ZBH) Q4 Earnings: A Surprise in the Cards?","publication_date":"2017-01-17 13:38:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rBllWU9ptR8/zimmer-biomet-zbh-q4-earnings-a-surprise-in-the-cards-cm734050","summary":"Orthopedic reconstructive products manufacturer 160 Zimmer Biomet Holdings Inc ZBH is expected to report fourth quarter 2017 financial numbers on Jan 31 before the opening bell 160 Last quarter the company s earnings met the Zacks Consensus Estimate However the four quarter"},{"title":"Mead Johnson (MJN) Q4 Earnings: Disappointment in Store?","publication_date":"2017-01-16 14:40:03 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OEvCSdif28Y/mead-johnson-mjn-q4-earnings-disappointment-in-store-cm733823","summary":"Mead Johnson Nutrition Company MJN is scheduled to report fourth quarter 2016 results on Jan 26 before the opening bell Last quarter the company posted a positive earnings surprise of 1 16 Further Mead Johnson s earnings outpaced the Zacks Consensus Estimate in the past four quarters"},{"title":"Mead Johnson (MJN) Q4 Earnings: Disappointment in Store?","publication_date":"2017-01-16 12:15:12 +0000","url":"http://finance.yahoo.com/news/mead-johnson-mjn-q4-earnings-121512919.html","summary":"Mead Johnson (MJN) Q4 Earnings: Disappointment in Store?"},{"title":"ResMed (RMD) Q2 Earnings: Disappointment in the Cards?","publication_date":"2017-01-13 13:39:15 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G5a_YSk0ZRU/resmed-rmd-q2-earnings-disappointment-in-the-cards-cm733122","summary":"ResMed Inc RMD is slated to report second quarter fiscal 2017 results after market close on Jan 23 Last quarter the company posted a negative earnings surprise of 1 59 However ResMed s earnings outpaced the Zacks Consensus Estimate in one of the past four quarters with an average beat"},{"title":"ResMed (RMD) Q2 Earnings: Disappointment in the Cards?","publication_date":"2017-01-13 11:37:11 +0000","url":"http://finance.yahoo.com/news/resmed-rmd-q2-earnings-disappointment-113711385.html","summary":"ResMed (RMD) Q2 Earnings: Disappointment in the Cards?"},{"title":"Will Catabasis Pharmaceuticals (CATB) Continue to Surge Higher?","publication_date":"2017-01-06 16:41:19 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kLHJ-BbxmyQ/will-catabasis-pharmaceuticals-catb-continue-to-surge-higher-cm730398","summary":"As of late it has definitely been a great time to be an investor in Catabasis Pharmaceuticals Inc CATB The stock has moved higher by 26 4 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest"},{"title":"Will Catabasis Pharmaceuticals (CATB) Continue to Surge Higher?","publication_date":"2017-01-06 14:17:02 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-catb-continue-surge-141702114.html","summary":"Will Catabasis Pharmaceuticals (CATB) Continue to Surge Higher?"},{"title":"Catabasis Pharmaceuticals Research on CAT-5571, a Novel Activator of Autophagy and Potential Oral Treatment for Cystic Fibrosis, Published in Journal of Medicinal Chemistry","publication_date":"2017-01-05 13:14:10 +0000","url":"http://www.publicnow.com/view/829FC81615DDFB5280D34544E68952796A302794","summary":"[at noodls] - -- Preclinical Data Demonstrate that Fatty Acid Cysteamine Conjugates Are Autophagy Activators that Enhance the Correction of Misfolded F508del-CFTR -- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 5, 2017-- ..."},{"title":"Catabasis Pharmaceuticals Research on CAT-5571, a Novel Activator of Autophagy and Potential Oral Treatment for Cystic Fibrosis, Published in Journal of Medicinal Chemistry","publication_date":"2017-01-05 13:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-research-cat-5571-130000348.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced the publication of preclinical data on CAT-5571, a novel activator of autophagy and potential oral treatment for cystic fibrosis ."},{"title":"Positive Preclinical Research on the Edasalonexent (CAT-1004) Program, a Potential Disease-Modifying Therapy for Duchenne Muscular Dystrophy, Published in JCI Insight","publication_date":"2017-01-04 13:33:20 +0000","url":"http://www.publicnow.com/view/8EB4FA500E59B4368B840BE048D466F92A9E6F09","summary":"[at noodls] - -- Preclinical Data Demonstrate Disease Modifying Effects in Two Animal Models of Duchenne Muscular Dystrophy -- CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 4, 2017-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), ..."},{"title":"Positive Preclinical Research on the Edasalonexent (CAT-1004) Program, a Potential Disease-Modifying Therapy for Duchenne Muscular Dystrophy, Published in JCI Insight","publication_date":"2017-01-04 13:00:00 +0000","url":"http://finance.yahoo.com/news/positive-preclinical-research-edasalonexent-cat-130000986.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced the publication of preclinical data on the edasalonexent program, a potential disease-modifying therapy for Duchenne muscular dystrophy ."},{"title":"New Strong Buy Stocks for December 30th","publication_date":"2016-12-30 17:02:34 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R0G3hZoZr8o/new-strong-buy-stocks-for-december-30th-cm728032","summary":"Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today Alarm Com Holdings Inc ALRM This provider of cloud based software platform solutions has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2 6 over the last 30 days ALARM COM"},{"title":"New Strong Buy Stocks for December 30th","publication_date":"2016-12-30 13:57:01 +0000","url":"http://finance.yahoo.com/news/strong-buy-stocks-december-30th-135701206.html","summary":"New Strong Buy Stocks for December 30th"},{"title":"What's in Store for Walgreens Boots (WBA) in Q1 Earnings?","publication_date":"2016-12-28 15:02:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x243yVCzi0Q/whats-in-store-for-walgreens-boots-wba-in-q1-earnings-cm726785","summary":"Walgreens Boots Alliance Inc WBA is slated to release first quarter 2017 results before the market opens on Jan 5 Last quarter the company posted a positive earnings surprise of 8 08 In fact in the last four quarters Walgreens Boots earnings outpaced the Zacks Consensus Estimate at"},{"title":"How Five Star Quality Care, Inc. (FVE) Stacks Up Against Its Peers","publication_date":"2016-12-14 23:21:31 +0000","url":"http://www.insidermonkey.com/blog/how-five-star-quality-care-inc-fve-stacks-up-against-its-peers-509820/","summary":"How Five Star Quality Care, Inc. (FVE) Stacks Up Against Its Peers"},{"title":"Catabasis Pharmaceuticals, Inc. :CATB-US: Earnings Analysis: Q3, 2016 By the Numbers : December 6, 2016","publication_date":"2016-12-06 15:07:39 +0000","url":"http://www.capitalcube.com/blog/index.php/catabasis-pharmaceuticals-inc-catb-us-earnings-analysis-q3-2016-by-the-numbers-december-6-2016/","summary":"Catabasis Pharmaceuticals, Inc. :CATB-US: Earnings Analysis: Q3, 2016 By the Numbers : December 6, 2016"},{"title":"CATABASIS PHARMACEUTICALS INC Financials","publication_date":"2016-11-18 18:04:12 +0000","url":"http://finance.yahoo.com/q/is?s=catb","summary":"CATABASIS PHARMACEUTICALS INC Financials"},{"title":"Catabasis Pharmaceuticals Provides Edasalonexent and Rare Disease Pipeline Updates at Investor Day","publication_date":"2016-11-17 13:30:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-provides-edasalonexent-rare-133000498.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today is holding its first Investor Day and will provide an in-depth review of the Company’s strategy and pipeline in rare diseases, including edasalonexent and other programs."},{"title":"Catabasis Pharmaceuticals, Inc. (Nasdaq: CATB) to Ring The Nasdaq Stock Market Closing Bell","publication_date":"2016-11-16 18:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-inc-nasdaq-catb-180000014.html","summary":"[GlobeNewswire] - What: Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Jill C. Milne, Co-Founder and CEO, will ring ..."},{"title":"Edited Transcript of CATB earnings conference call or presentation 10-Nov-16 9:30pm GMT","publication_date":"2016-11-12 02:49:21 +0000","url":"http://finance.yahoo.com/news/edited-transcript-catb-earnings-conference-024921057.html","summary":"Edited Transcript of CATB earnings conference call or presentation 10-Nov-16 9:30pm GMT"},{"title":"Health Care Sector Update for 11/11/2016: CATB,PTCT,CRMD","publication_date":"2016-11-11 19:27:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/koZZMC6mXqU/health-care-sector-update-for-11112016-catbptctcrmd-cm708042","summary":"Top Health Care StocksTop Health Care Stocks JNJ 1 02 JNJ 1 02 PFE 2 66 PFE 2 66 MRK 1 03 MRK 1 03 ABT 1 45 ABT 1 45 AMGN 2 12 AMGN 2 12 Health care stocks were considerably lower during Friday trade with the NYSE Health Care Index sinking just more than 1 0 while shares of"},{"title":"Catabasis Pharmaceuticals posts 3Q loss","publication_date":"2016-11-10 22:58:34 +0000","url":"http://sg.finance.yahoo.com/news/catabasis-pharmaceuticals-posts-3q-loss-225834910.html","summary":"Catabasis Pharmaceuticals posts 3Q loss"},{"title":"Catabasis Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today","publication_date":"2016-11-10 21:30:00 +0000","url":"http://biz.yahoo.com/cc/7/154507.html","summary":"Catabasis Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today"},{"title":"Catabasis Pharmaceuticals Reports Third Quarter 2016 Financial Results and Recent Corporate Highlights","publication_date":"2016-11-10 21:21:14 +0000","url":"http://www.publicnow.com/view/5C63D4FFFAC1B97355BF838829C09E9FD25B0F9C","summary":"[at noodls] - -- Enrollment Complete for MoveDMD Phase 2 Trial of Edasalonexent, a Potential Disease-Modifying Treatment for Duchenne Muscular Dystrophy (DMD) -- -- Expanding Rare Disease Pipeline with CAT-5571, a Potential ..."},{"title":"Catabasis Pharmaceuticals Reports Third Quarter 2016 Financial Results and Recent Corporate Highlights","publication_date":"2016-11-10 21:10:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-reports-third-quarter-211000878.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2016 and corporate highlights."},{"title":"CATABASIS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report","publication_date":"2016-11-10 21:08:30 +0000","url":"http://biz.yahoo.com/e/161110/catb10-q.html","summary":"CATABASIS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report"},{"title":"Q3 2016 Catabasis Pharmaceuticals Inc Earnings Release - After Market Close","publication_date":"2016-11-10 12:07:08 +0000","url":"http://biz.yahoo.com/research/earncal/20161110.html?t=catb","summary":"Q3 2016 Catabasis Pharmaceuticals Inc Earnings Release - After Market Close"},{"title":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an","publication_date":"2016-11-07 21:07:54 +0000","url":"http://biz.yahoo.com/e/161107/catb8-k.html","summary":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an"},{"title":"Catabasis Pharmaceuticals to Host Investor Day in New York City on November 17","publication_date":"2016-11-03 12:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-host-investor-day-120000052.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, announced today that it will be hosting its first Investor Day and simultaneous webcast on November 17, 2016 from 8:30am to 11:30am ET in New York City."},{"title":"Catabasis Pharmaceuticals Presents Positive Data for CAT-5571, a Novel Activator of Autophagy, as a Potential Oral Treatment for Cystic Fibrosis at the 30th Annual North American Cystic Fibrosis Conference","publication_date":"2016-10-27 15:15:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-presents-positive-data-151500549.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced positive preclinical data presented at the 30th Annual North American Cystic Fibrosis Conference , which support CAT-5571 as a potential oral treatment for cystic fibrosis with potential effects on both the cystic fibrosis transmembrane conductance regulator and on bacterial clearance of Pseudomonas aeruginosa...."},{"title":"Catabasis Pharmaceuticals to Report Third Quarter 2016 Financial Results and Recent Corporate Developments on Thursday, November 10","publication_date":"2016-10-26 12:15:09 +0000","url":"http://www.publicnow.com/view/0C897DC70E6083B3BAD20284FF48F4C592F7F3AC","summary":"[at noodls] - The Company will Host a Conference Call at 4:30pm ET CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 26, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, will report ..."},{"title":"Catabasis Pharmaceuticals to Report Third Quarter 2016 Financial Results and Recent Corporate Developments on Thursday, November 10","publication_date":"2016-10-26 12:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-report-third-quarter-120000989.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, will report third quarter 2016 financial results after the NASDAQ Global Market close on Thursday, November 10, 2016."},{"title":"Catabasis Pharmaceuticals to Present CAT-5571, a Novel Activator of Autophagy, as a Potential Treatment for Cystic Fibrosis at the 30th Annual North American Cystic Fibrosis Conference","publication_date":"2016-10-20 12:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-present-cat-5571-120000433.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that CAT-5571, a novel activator of autophagy, will be presented as a potential treatment for cystic fibrosis in an oral presentation and two poster presentations at the 30th Annual North American Cystic Fibrosis Conference ."},{"title":"Why Sarepta Therapeutics Skyrocketed 131% in September","publication_date":"2016-10-11 21:18:48 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mymsv-XDjrw/why-sarepta-therapeutics-skyrocketed-131-in-september-cm692065","summary":"Image source Getty Images What happened After the FDA approved its lead drug candidate for the treatment of Duchenne muscular dystrophy DMD on Sept 19 shares in Sarepta Therapeutics NASDAQ SRPT soared an eye popping 131 last month according to S amp P Global"},{"title":"Catabasis Presents Data from DMD study on Edasalonexent","publication_date":"2016-10-11 15:21:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CgJmOAeHPw4/catabasis-presents-data-from-dmd-study-on-edasalonexent-cm691773","summary":"Catabasis Pharmaceuticals Inc CATB announced that it has presented results from the part A of the MoveDMD study phase I II on edasalonexent at the congress of the World Muscle Society Edasalonexent a molecule that inhibits a protein called NF kB is being developed for the treatment"},{"title":"Catabasis Presents Data from DMD study on Edasalonexent","publication_date":"2016-10-11 13:30:01 +0000","url":"http://finance.yahoo.com/news/catabasis-presents-data-dmd-study-133001450.html","summary":"Catabasis Presents Data from DMD study on Edasalonexent"},{"title":"Catabasis Pharmaceuticals to Present the MoveDMD® Trial of Edasalonexent (CAT-1004), a Potential Disease-Modifying Therapy for DMD, at the American Neurological Association’s 2016 Annual Meeting","publication_date":"2016-10-11 12:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-present-movedmd-trial-120000181.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that Catabasis will present the MoveDMD trial of edasalonexent for the treatment of Duchenne muscular dystrophy at the American Neurological Association’s 2016 Annual Meeting."},{"title":"Health Care Sector Update for 10/06/2016: CLRB, CATB","publication_date":"2016-10-06 13:23:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/asOA_XI_R4Y/health-care-sector-update-for-10062016-clrb-catb-cm689626","summary":"Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE flatPFE flat ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were flat in pre market trade on Thursday Health care shares were flat in pre market trade on Thursday In health care stocks"},{"title":"Catabasis Pharmaceuticals Presents Positive Data from Part A of the MoveDMD® Trial of Edasalonexent (CAT-1004), a Potential Disease-Modifying Therapy for DMD, at the World Muscle Society Congress","publication_date":"2016-10-06 12:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-presents-positive-data-120000294.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that Catabasis is presenting positive data from Part A of the MoveDMD trial of edasalonexent for the treatment of Duchenne muscular dystrophy at the World Muscle Society Congress."},{"title":"Sarepta/Summit Ink Deal for Utrophin Modulator DMD Drugs","publication_date":"2016-10-05 16:47:38 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eCmz_2tC4aQ/sareptasummit-ink-deal-for-utrophin-modulator-dmd-drugs-cm689254","summary":"Sarepta Therapeutics Inc SRPT announced that it has entered into an exclusive license and collaboration agreement with Summit Therapeutics plc SMMT for the rights to the latter s utrophin modulator pipeline for the treatment of Duchenne muscular dystrophy DMD Although Sarepta s"},{"title":"Blog Coverage Sarepta Announces Collaboration with Summit Therapeutics","publication_date":"2016-10-05 12:57:09 +0000","url":"http://news.investornetwork.com/2016/10/05/blog-coverage-sarepta-announces-collaboration-with-summit-therapeutics/?1=1&1475672229","summary":"Blog Coverage Sarepta Announces Collaboration with Summit Therapeutics"},{"title":"Catabasis Pharmaceuticals Announces Promotion of Andrew Nichols, Ph.D. to Chief Scientific Officer and Angelika Fretzen to Senior Vice President of Product Development","publication_date":"2016-10-05 12:48:09 +0000","url":"http://www.publicnow.com/view/433FCE53BBFD30F239BDF4C2A6CF3CC8C51BCE66","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 5, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB), a clinical-stage pharmaceutical company, today announced the promotion of Andrew Nichols, Ph.D. to Chief ..."},{"title":"Catabasis Pharmaceuticals Announces Promotion of Andrew Nichols, Ph.D. to Chief Scientific Officer and Angelika Fretzen to Senior Vice President of Product Development","publication_date":"2016-10-05 12:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-announces-promotion-andrew-120000498.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company, today announced the promotion of Andrew Nichols, Ph.D. to Chief Scientific Officer and Angelika Fretzen, Ph.D., to Senior Vice President of Product Development."},{"title":"CATB Data Pushed Back To Q1, SMMT At Peak, TRIB Pounded, OTIC Hits Right Notes","publication_date":"2016-10-05 01:04:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qCD762Mut_8/catb-data-pushed-back-to-q1-smmt-at-peak-trib-pounded-otic-hits-right-notes-20161005-00016","summary":"CATB Data Pushed Back To Q1, SMMT At Peak, TRIB Pounded, OTIC Hits Right Notes"},{"title":"​Analyst: Sarepta ‘removes potential competitive threat’ with $562M deal","publication_date":"2016-10-04 16:12:16 +0000","url":"http://www.bizjournals.com/boston/blog/bioflash/2016/10/analyst-sarepta-removes-potential-competitive.html?ana=yahoo","summary":"​Analyst: Sarepta ‘removes potential competitive threat’ with $562M deal"},{"title":"Catabasis Pharmaceuticals Completes Target Enrollment for Part B of the MoveDMD® Trial, a Phase 2 Trial of Edasalonexent (CAT-1004) for the Potential Treatment of Duchenne Muscular Dystrophy","publication_date":"2016-10-04 12:18:10 +0000","url":"http://www.publicnow.com/view/97FDE8A657C5E3C32AA02847473EE8EB680DF7EC","summary":"[at noodls] - Catabasis Pharmaceuticals Completes Target Enrollment for Part B of the MoveDMD® Trial, a Phase 2 Trial of Edasalonexent (CAT-1004) for the Potential Treatment of Duchenne Muscular Dystrophy The text version ..."},{"title":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-10-04 12:12:50 +0000","url":"http://biz.yahoo.com/e/161004/catb8-k.html","summary":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"BUZZ-Summit Therapeutics: Best day since 2009 on Sarepta deal","publication_date":"2016-10-04 11:52:55 +0000","url":"http://uk.finance.yahoo.com/news/buzz-summit-therapeutics-best-day-115255208.html","summary":"BUZZ-Summit Therapeutics: Best day since 2009 on Sarepta deal"},{"title":"Top 6 Biopharma Gainers of the Past Week","publication_date":"2016-10-02 14:05:42 +0000","url":"http://247wallst.com/healthcare-business/2016/10/02/top-6-biopharma-gainers-of-the-past-week/","summary":"Top 6 Biopharma Gainers of the Past Week"},{"title":"Close Update: Stocks Unravel as Deutsche Bank Spooks Wall Street","publication_date":"2016-09-29 21:01:21 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B_aGmyY0dDo/close-update-stocks-unravel-as-deutsche-bank-spooks-wall-street-cm686825","summary":"The Dow Jones Industrial Average limped into Thursday s close nearly 200 points lower after a report concerning Deutsche Bank DB spooked Wall Street The Dow Jones Industrial Average limped into Thursday s close nearly 200 points lower after a report concerning Deutsche Bank DB"},{"title":"Midday Update: Wall Street Wobbles as Fed-Speak and Data Argues For Higher Rates","publication_date":"2016-09-29 17:41:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nsCKxsR9toc/midday-update-wall-street-wobbles-as-fed-speak-and-data-argues-for-higher-rates-cm686698","summary":"Stocks are being dragged lower with the Dow Jones Industrial Average off by more than 160 points as the fallout from Deutsche Bank DB continues to reverberate through Wall Street Stocks are being dragged lower with the Dow Jones Industrial Average off by more than 160 points as the"},{"title":"Here’s Why These Five Stocks Are in the Spotlight Today","publication_date":"2016-09-29 16:46:52 +0000","url":"http://www.insidermonkey.com/blog/heres-why-these-five-stocks-are-in-the-spotlight-today-3-477590/","summary":"Here’s Why These Five Stocks Are in the Spotlight Today"},{"title":"Catabasis Skyrockets on Sarepta Partnership","publication_date":"2016-09-29 16:40:37 +0000","url":"http://finance.yahoo.com/news/catabasis-skyrockets-sarepta-partnership-164037300.html","summary":"Catabasis Skyrockets on Sarepta Partnership"},{"title":"Sarepta announces Duchenne research partnership with Cambridge's Catabasis","publication_date":"2016-09-29 15:34:14 +0000","url":"http://www.bizjournals.com/boston/blog/bioflash/2016/09/sarepta-announces-duchenne-research-partnership.html?ana=yahoo","summary":"Sarepta announces Duchenne research partnership with Cambridge's Catabasis"},{"title":"Health Care Sector Update for 09/29/2016: CATB","publication_date":"2016-09-29 13:41:24 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3J6LLA_l6Ao/health-care-sector-update-for-09292016-catb-cm686435","summary":"Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 1 PFE 0 1 ABT 0 8 ABT 0 8 MRK 0 1 MRK 0 1 AMGN flatAMGN flat Health care shares were mixed in pre market trade on Thursday Health care shares were mixed in pre market trade on Thursday In health care"},{"title":"Catabasis Pharmaceuticals and Sarepta Therapeutics Announce a Joint Research Collaboration in Duchenne Muscular Dystrophy","publication_date":"2016-09-29 13:40:00 +0000","url":"http://www.publicnow.com/view/151624850A4441D5E4103743FD944E743A435442","summary":"[at noodls] - CAMBRIDGE, MA, September 29, 2016 - Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company ('Catabasis'), and Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage ..."},{"title":"Catabasis Pharmaceuticals Announces Closing of $11.5 Million Offering of Common Stock, Including Full Exercise of Underwriter’s Option to Purchase Additional Shares","publication_date":"2016-09-28 20:29:04 +0000","url":"http://www.publicnow.com/view/904740E5E09DB0E0EA1AA59AA9998CD974B7848E","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 28, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB), a clinical-stage pharmaceutical company, today announced the closing of an underwritten offering of 2,875,000 ..."},{"title":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial","publication_date":"2016-09-23 20:28:18 +0000","url":"http://biz.yahoo.com/e/160923/catb8-k.html","summary":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial"},{"title":"What is Going on With These Falling Stocks?","publication_date":"2016-09-23 15:18:46 +0000","url":"http://www.insidermonkey.com/blog/what-is-going-on-with-these-falling-stocks-9-476533/","summary":"What is Going on With These Falling Stocks?"},{"title":"Catabasis Pharmaceuticals Announces Pricing of $10 Million Offering of Common Stock","publication_date":"2016-09-23 11:12:07 +0000","url":"http://www.publicnow.com/view/E5B6126684FDEFE88EC7E0CFBB2C07E8435498CE","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 23, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten offering of 2,500,000 ..."},{"title":"Mallinckrodt DMD Drug Gets Fast Track Status in the U.S.","publication_date":"2016-08-26 15:30:47 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bRd1jNkw7j4/mallinckrodt-dmd-drug-gets-fast-track-status-in-the-us-cm670703","summary":"Mallinckrodt Public Limited CompanyMNK announced that it has received Fast Track designation in the U.S. for its Investigational New Drug (IND) application for Synacthen Depot for the treatment of patients with Duchenne muscular dystrophy (DMD). We"},{"title":"What We’re Watching For In The Upcoming Catabasis Pharmaceuticals Inc (CATB) Data","publication_date":"2016-08-15 18:09:59 +0000","url":"http://www.insidermonkey.com/blog/what-were-watching-for-in-the-upcoming-catabasis-pharmaceuticals-inc-catb-data-469120/","summary":"What We’re Watching For In The Upcoming Catabasis Pharmaceuticals Inc (CATB) Data"},{"title":"Health Care Sector Update for 08/12/2016: CXRX,NBY,CATB","publication_date":"2016-08-12 17:48:33 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kMqCzp29r3g/health-care-sector-update-for-08122016-cxrxnbycatb-cm664793","summary":"Top Health Care Stocks JNJ 0.56% PFE 0.75% MRK 0.41% ABT 0.93% AMGN +0.21% Health care stocks were retreating Friday afternoon, with the NYSE Health Care Index posting a 0.4% decline and shares of health care companies in the"},{"title":"Edited Transcript of CATB earnings conference call or presentation 11-Aug-16 8:30pm GMT","publication_date":"2016-08-12 16:47:14 +0000","url":"http://finance.yahoo.com/news/edited-transcript-catb-earnings-conference-164714076.html","summary":"Edited Transcript of CATB earnings conference call or presentation 11-Aug-16 8:30pm GMT"},{"title":"Health Care Sector Update for 08/12/2016: ,CATB,PTX,XLV","publication_date":"2016-08-12 12:48:37 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n3XZTQrCVp8/health-care-sector-update-for-08122016-catbptxxlv-cm664495","summary":"Top Health Care Stocks JNJ Unchanged PFE +0.40% MRK Unchanged ABT Unchanged AMGN .34% Health care stocks were unchanged ahead of Friday's opening bell, with shares of health care companies in the S&P 500 as measure by the Health"},{"title":"Catabasis Pharmaceuticals Reports Second Quarter 2016 Financial Results and Recent Corporate Highlights","publication_date":"2016-08-11 20:31:03 +0000","url":"http://www.publicnow.com/view/2D1F324F92FDAB16251906C26695AC7D9CA97475","summary":"[at noodls] - -- Edasalonexent (CAT-1004) as a Potential Disease-Modifying Treatment for Duchenne Muscular Dystrophy (DMD): MoveDMD Phase 2 (Part B) Trial Progressing Well and Open-Label Extension Initiated -- CAMBRIDGE, ..."},{"title":"Catabasis Pharmaceuticals posts 2Q loss","publication_date":"2016-08-11 20:19:45 +0000","url":"http://sg.finance.yahoo.com/news/catabasis-pharmaceuticals-posts-2q-loss-201945102.html","summary":"Catabasis Pharmaceuticals posts 2Q loss"},{"title":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an","publication_date":"2016-08-11 20:10:06 +0000","url":"http://biz.yahoo.com/e/160811/catb8-k.html","summary":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an"},{"title":"CATABASIS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report","publication_date":"2016-08-11 20:04:54 +0000","url":"http://biz.yahoo.com/e/160811/catb10-q.html","summary":"CATABASIS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report"},{"title":"Q2 2016 Catabasis Pharmaceuticals Inc Earnings Release - After Market Close","publication_date":"2016-08-11 11:07:03 +0000","url":"http://biz.yahoo.com/research/earncal/20160811.html?t=catb","summary":"Q2 2016 Catabasis Pharmaceuticals Inc Earnings Release - After Market Close"},{"title":"Catabasis Pharmaceuticals to Present at 2016 Wedbush PacGrow Healthcare Conference","publication_date":"2016-08-09 12:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-present-2016-wedbush-120000398.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate and pipeline overview at the upcoming 2016 Wedbush PacGrow Healthcare Conference on Tuesday, August 16, 2016 at 1:20pm ET at the Le Parker Meridien Hotel in New York, NY."},{"title":"4 Biotech Stocks With Up to 300% Upside Potential and Upcoming Catalysts","publication_date":"2016-08-03 13:55:25 +0000","url":"http://247wallst.com/healthcare-business/2016/08/03/4-biotech-stocks-with-up-to-300-upside-potential-and-upcoming-catalysts/","summary":"4 Biotech Stocks With Up to 300% Upside Potential and Upcoming Catalysts"},{"title":"These 5 Stocks Under $10 Are Set to Soar Higher","publication_date":"2016-07-28 14:08:00 +0000","url":"https://www.thestreet.com/story/13656106/1/these-5-stocks-under-10-are-set-to-soar-higher.html?puc=yahoo&cm_ven=YAHOO","summary":"These 5 Stocks Under $10 Are Set to Soar Higher"},{"title":"Catabasis Pharmaceuticals to Report Second Quarter 2016 Financial Results and Recent Corporate Developments on Thursday, August 11","publication_date":"2016-07-28 12:18:08 +0000","url":"http://www.publicnow.com/view/ADD919202551BA76B3945FEB332A1D3D62101677","summary":"[at noodls] - The Company will Host a Conference Call at 4:30pm ET CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul. 28, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, will report ..."},{"title":"Catabasis Pharmaceuticals Names Joseph Johnston VP, Regulatory Affairs","publication_date":"2016-07-12 12:23:05 +0000","url":"http://www.publicnow.com/view/5AFBCFD435BF930FF3AB3D657B889BBCCF02A48D","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul. 12, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it has named Joseph Johnston as Vice President, ..."},{"title":"Advicent introduces Narrator® Clients powered by NaviPlan® in its latest release","publication_date":"2016-07-11 14:01:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-present-cat-1004-130000775.html","summary":"[Business Wire] - Advicent is pleased to announce that their newest financial planning portal, Narrator Clients, will now be powered by NaviPlan, as part of the financial planning tool’s latest version update."},{"title":"Catabasis' DMD Drug in Phase II Open-Label Extension Study","publication_date":"2016-07-08 16:41:21 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XKBXqnoO1iI/catabasis-dmd-drug-in-phase-ii-open-label-extension-study-cm646449","summary":"Catabasis Pharmaceuticals, Inc.CATB announced that it has initiated an open label extension (Part C) of the phase II portion of its MoveDMD study (phase I II) on edasalonexent (CAT 1004). Edasalonexent, a molecule that inhibits a protein called NF"},{"title":"Catabasis' DMD Drug in Phase II Open-Label Extension Study","publication_date":"2016-07-08 14:28:02 +0000","url":"http://finance.yahoo.com/news/catabasis-dmd-drug-phase-ii-142802916.html","summary":"Catabasis' DMD Drug in Phase II Open-Label Extension Study"},{"title":"Catabasis Pharmaceuticals Announces the Initiation of an Open-Label Extension for the MoveDMD® Trial Studying Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy","publication_date":"2016-07-07 12:21:05 +0000","url":"http://www.publicnow.com/view/8198F85B4DDE9F530A8D2FE030024CDA4EABDAD1","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul. 7, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the initiation of an open-label extension for ..."},{"title":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-07-01 20:18:13 +0000","url":"http://biz.yahoo.com/e/160701/catb8-k.html","summary":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"7 Stocks Under $10 to Trade for Big Post-Brexit Gains","publication_date":"2016-06-26 13:31:00 +0000","url":"https://www.thestreet.com/story/13619971/1/7-stocks-under-10-to-trade-for-big-post-brexit-gains.html?puc=yahoo&cm_ven=YAHOO","summary":"7 Stocks Under $10 to Trade for Big Post-Brexit Gains"},{"title":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders","publication_date":"2016-06-20 20:02:52 +0000","url":"http://biz.yahoo.com/e/160620/catb8-k.html","summary":"CATABASIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"},{"title":"Catabasis Pharmaceuticals to Present Edasalonexent (CAT-1004), an Oral Agent Targeting NF-kB: MoveDMDSM Trial in Duchenne Muscular Dystrophy (DMD) at the 2016 PPMD Annual Connect Conference","publication_date":"2016-06-20 12:00:00 +0000","url":"http://finance.yahoo.com/news/catabasis-pharmaceuticals-present-edasalonexent-cat-120000033.html","summary":"[Business Wire] - Catabasis Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that edasalonexent will be featured in an oral presentation and a poster presentation at the upcoming 2016 Parent Project Muscular Dystrophy Annual Connect Conference being held on Sunday, June 26 – Wednesday, June 29, 2016 at the Renaissance Orlando at Sea World Hotel in Orlando, FL."},{"title":"Catabasis Pharmaceuticals, Inc. :CATB-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016","publication_date":"2016-06-08 22:05:22 +0000","url":"http://www.capitalcube.com/blog/index.php/catabasis-pharmaceuticals-inc-catb-us-earnings-analysis-q1-2016-by-the-numbers-june-8-2016/","summary":"Catabasis Pharmaceuticals, Inc. :CATB-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016"},{"title":"Health Care Sector Update for 06/08/2016: FCSC,IMNP,CATB","publication_date":"2016-06-08 20:26:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XA-CBJ6GMdg/health-care-sector-update-for-06082016-fcscimnpcatb-cm632554","summary":"Top Health Care Stocks JNJ +0.04% PFE +1.09% MRK 0.02% ABT +1.07% AMGN 0.69% Health care stocks continued to rise throughout Wednesday trading, with the NYSE Health Care Index climbing 0.4% while shares of health care companies in the"},{"title":"Health Care Sector Update for 06/08/2016: EVAR,IMNP,CATB","publication_date":"2016-06-08 17:26:44 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s-ZVQ_KCnIU/health-care-sector-update-for-06082016-evarimnpcatb-cm632458","summary":"Top Health Care Stocks JNJ 0.04% PFE +1.07% MRK 0.06% ABT +1.41% AMGN 0.65% Health care stocks rose Wednesday, with the NYSE Health Care Index climbing 0.3% while shares of health care companies in the S&P 500 were ahead"},{"title":"5 Stocks That Are Getting Battered and Bruised Today","publication_date":"2016-06-08 16:09:50 +0000","url":"http://www.insidermonkey.com/blog/5-stocks-that-are-getting-battered-and-bruised-today-458542/","summary":"5 Stocks That Are Getting Battered and Bruised Today"},{"title":"Catabasis Pharmaceuticals and Parent Project Muscular Dystrophy to Host a Webinar on MoveDMDSM: A Clinical Trial of Edasalonexent (CAT-1004) in Boys with Duchenne Muscular Dystrophy","publication_date":"2016-06-08 12:28:02 +0000","url":"http://www.publicnow.com/view/946B28C32E1C50E444C10CA42AF452BB8D74908B","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 8, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, and Parent Project Muscular Dystrophy (PPMD) will host a webinar ..."},{"title":"ALDX Expects Data In Q3, CATB Tumbles On Study Data, Teva Gets FDA Panel Nod","publication_date":"2016-06-08 00:30:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xeSafRUy16Q/aldx-expects-data-in-q3-catb-tumbles-on-study-data-teva-gets-fda-panel-nod-20160608-00009","summary":"ALDX Expects Data In Q3, CATB Tumbles On Study Data, Teva Gets FDA Panel Nod"},{"title":"Catabasis Pharmaceuticals Announces Top-Line Phase 2a Results for CAT-2054","publication_date":"2016-06-07 20:48:04 +0000","url":"http://www.publicnow.com/view/548BD3C26E6E3DB7082B292B658136D56679AD9E","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 7, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced top-line results from its Phase 2a clinical ..."},{"title":"Health Care Sector Update for 05/23/2016: CATB,RNPT,CHRS","publication_date":"2016-05-23 20:24:25 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yy-JLWMKofI/health-care-sector-update-for-05232016-catbrnptchrs-cm625135","summary":"Top Health Care Stocks JNJ 0.37% PFE +0.07% MRK 0.48% ABT 0.15% AMGN 0.45% Health care stocks were moderately lower, with the NYSE Health Care Index retreating 0.1% while shares of health care companies in the S&P 500 were"},{"title":"Health Care Sector Update for 05/23/2016: CATB, VTL","publication_date":"2016-05-23 13:48:36 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KMUBbipGdgs/health-care-sector-update-for-05232016-catb-vtl-cm624781","summary":"Top Health care stocks JNJ flat PFE 0.1% ABT flat MRK flat AMGN flat Health care shares were mainly unchanged in pre market trade on Monday. In health care stocks news, Catabasis Pharmaceuticals ( CATB ) reported on Saturday"},{"title":"Catabasis Pharmaceuticals Presents Positive Pre-Clinical Data at Digestive Disease Week 2016; Data Support CAT-2054, a Phase 2 Asset, as a Potential Treatment for Nonalcoholic Steatohepatitis (NASH)","publication_date":"2016-05-21 16:53:01 +0000","url":"http://www.publicnow.com/view/3D5174FDCAB4FD01ABF11D33BEEEAF2306935AD8","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 21, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced positive pre-clinical data supporting CAT-2054 ..."},{"title":"Catabasis Pharmaceuticals to Present Pre-Clinical Data Supporting CAT-2054 as a Potential Treatment for Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week 2016","publication_date":"2016-05-16 12:32:05 +0000","url":"http://www.publicnow.com/view/FBEA1EE1DEB88D507F4A3ACF2EA7C426C11F0032","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that pre-clinical data will be presented that ..."},{"title":"Catabasis Pharmaceuticals to Present CAT-2054, a Potential Treatment for Nonalcoholic Steatohepatitis (NASH) and Hypercholesterolemia, at the National Lipid Association 2016 Scientific Sessions","publication_date":"2016-05-16 12:32:05 +0000","url":"http://www.publicnow.com/view/F55F2BF054B85BD0DAD5DF0870C11F700AB17B95","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it will present CAT-2054, a potential treatment ..."},{"title":"Catabasis Pharmaceuticals Reports First Quarter 2016 Financial Results and Recent Corporate Highlights","publication_date":"2016-05-12 21:27:10 +0000","url":"http://www.publicnow.com/view/0EA4FD9204BE861C47C317BC8DA43E6AC3DF8FC1","summary":"[at noodls] - -- Edasalonexent (CAT-1004) as a Potential Treatment for Duchenne Muscular Dystrophy (DMD): MoveDMD Part B (Phase 2) Trial Initiated Following Positive Safety, Tolerability, Pharmacokinetic and NF-kB Biomarker ..."},{"title":"Catabasis Pharmaceuticals posts 1Q loss","publication_date":"2016-05-12 20:12:46 +0000","url":"http://sg.finance.yahoo.com/news/catabasis-pharmaceuticals-posts-1q-loss-201246128.html","summary":"Catabasis Pharmaceuticals posts 1Q loss"},{"title":"Catabasis Pharmaceuticals to Report First Quarter 2016 Financial Results and Recent Corporate Developments on Thursday, May 12","publication_date":"2016-04-28 12:19:18 +0000","url":"http://www.publicnow.com/view/50545705744622A27699D9CEFCDF7D2D28CDE8AF","summary":"[at noodls] - The Company will Host a Conference Call at 4:30pm ET CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 28, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, will report ..."},{"title":"Catabasis Pharmaceuticals Initiates Part B of the MoveDMDSM Trial of CAT-1004 for the Treatment of Duchenne Muscular Dystrophy","publication_date":"2016-04-12 12:15:19 +0000","url":"http://www.publicnow.com/view/0066944969AEC8EFA6E6A22F3CE91EBCA7D50299","summary":"[at noodls] - - Positive NF-kB Biomarker Data from Part A of the MoveDMD Trial in Patients - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 12, 2016-- 'Catabasis announced that dosing of the first patient has been initiated ..."},{"title":"Catabasis Pharmaceuticals to Present at Needham and Company’s 15th Annual Healthcare Conference","publication_date":"2016-04-07 12:22:31 +0000","url":"http://www.publicnow.com/view/E020B40E2C1DCCAC1EB5E1BDD9022706965FF50E","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 7, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, ..."},{"title":"Catabasis Pharmaceuticals Announces Additions to Board of Directors and the Formation of a Science and Technology Committee","publication_date":"2016-04-06 12:20:10 +0000","url":"http://www.publicnow.com/view/0DA976C97292F97BD475486511BCC828E6255A40","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 6, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the appointment of Burt Adelman, M.D., and Michael ..."},{"title":"Catabasis Pharmaceuticals Announces Resignation of Chief Financial Officer","publication_date":"2016-04-01 20:27:18 +0000","url":"http://www.publicnow.com/view/E9BD6D4317AD9BDE878D1167557FB67A835DFA71","summary":"[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 1, 2016-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that Ian Sanderson, Chief Financial Officer, ..."},{"title":"Catabasis Pharmaceuticals Presents Positive CAT-1004 Data from Part A of the MoveDMDSM Trial at the 2016 Muscular Dystrophy Association Clinical Conference","publication_date":"2016-03-21 12:29:46 +0000","url":"http://www.publicnow.com/view/EFAA66D673FA85626946C629CA14B18F3EF93CE4","summary":"[at noodls] - - Trial Demonstrated Favorable Safety, Tolerability and Pharmacokinetics in Patients - - Results Support Initiation of Part B of Trial, Expected in First Half of 2016 - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. ..."},{"title":"Catabasis Pharmaceuticals (CATB) Jumps: Stock Up 43.9%","publication_date":"2016-03-07 15:41:57 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d6Lb-PPRWzA/catabasis-pharmaceuticals-catb-jumps-stock-up-439-cm589182","summary":"Catabasis Pharmaceuticals, Inc.CATB was a big mover last session, as its shares rose almost 44% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Friday's rally breaks"},{"title":"Catabasis Pharmaceuticals posts 4Q loss","publication_date":"2016-03-02 21:21:30 +0000","url":"http://sg.finance.yahoo.com/news/catabasis-pharmaceuticals-posts-4q-loss-212130560.html","summary":"Catabasis Pharmaceuticals posts 4Q loss"},{"title":"Catabasis Pharmaceuticals Announces Positive Top-Line Results from Part A of the MoveDMD℠ Trial, a Phase 1 / 2 Trial of CAT-1004 for the Treatment of Duchenne Muscular Dystrophy","publication_date":"2016-01-25 13:17:09 +0000","url":"http://www.publicnow.com/view/A2C8E11AB0472FE329F671A785E7F89783E342D9","summary":"[at noodls] - - Trial Demonstrated Favorable Safety, Tolerability and Pharmacokinetics in Patients - - Results Support Initiation of Part B of Trial, Expected in First Half of 2016 - --(BUSINESS WIRE)--Jan. 25, 2016-- ..."},{"title":"FARA Announces Catabasis Pharmaceuticals as the Recipient of the Kyle Bryant Translational Research Award to Evaluate CAT-4001 as a Potential Therapy for Friedreich’s Ataxia","publication_date":"2016-01-19 13:15:11 +0000","url":"http://www.noodls.com/view/0D38C33BC1AFFFA1997ABCB81D61B3C70E81B07A","summary":"[at noodls] - & --(BUSINESS WIRE)--Jan. 19, 2016-- The Friedreich's () and (NASDAQ:CATB) announce that is the recipient of the Award. Catabasis is a clinical-stage drug development company built on a pathway pharmacology ..."},{"title":"Tuesday Sector Laggards: Drugs, Diagnostics","publication_date":"2015-12-22 20:16:47 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bF_myadPxSA/tuesday-sector-laggards-drugs-diagnostics-cm557771","summary":"In trading on Tuesday, drugs shares were relative laggards, down on the day by about 1%. Helping drag down the group were shares of Bio Path Holdings ( BPTH ), down about 12.4% and shares of Catabasis Pharmaceuticals ("},{"title":"Catabasis Pharmaceuticals Completes Enrollment for Part A of the MoveDMDSM Trial, a Phase 1/2 Trial of CAT-1004 for the Treatment of Duchenne Muscular Dystrophy","publication_date":"2015-12-18 13:12:20 +0000","url":"http://www.noodls.com/view/A81D5AAA3F7183162FB242B63BC4882F0C77B88B","summary":"[at noodls] - --(BUSINESS WIRE)--Dec. 18, 2015-- (NASDAQ: CATB), a clinical-stage drug development company built on a pathway pharmacology technology platform, today announced that enrollment is complete in Part A of ..."},{"title":"Catabasis Names Deirdre Cunnane SVP, General Counsel","publication_date":"2015-12-17 13:26:29 +0000","url":"http://www.noodls.com/view/AFB66AF39641D24F19DFFC11F98874ED7870EEB4","summary":"[at noodls] - --(BUSINESS WIRE)--Dec. 17, 2015-- , a clinical-stage drug development company built on a pathway pharmacology technology platform, today announced that it has named , J.D., as senior vice president, general ..."},{"title":"Catabasis Pharmaceuticals Will Present CAT-1004, a Potential Disease-Modifying Agent in Development for the Treatment of Duchenne Muscular Dystrophy, at the Action Duchenne International Conference","publication_date":"2015-10-27 12:00:00 +0000","url":"http://uk.finance.yahoo.com/news/catabasis-pharmaceuticals-present-cat-1004-120000447.html","summary":"Catabasis Pharmaceuticals Will Present CAT-1004, a Potential Disease-Modifying Agent in Development for the Treatment of Duchenne Muscular Dystrophy, at the Action Duchenne International Conference"},{"title":"Lipid drug delivery: Sancilio Pharmaceuticals files for an $86 million IPO","publication_date":"2015-09-04 17:56:05 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x6U-bHv1el0/lipid-drug-delivery-sancilio-pharmaceuticals-files-for-an-86-million-ipo-cm515337","summary":"Sancilio Pharmaceuticals Company, which markets, licenses and develops products based on its lipid drug delivery technology, filed on Monday with the SEC to raise up to $86 million in an initial public offering. The Riviera Beach, FL based company,"},{"title":"BioMarin's Drisapersen Gets Rare Pediatric Disease Status","publication_date":"2015-08-20 21:05:43 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PJD1K3w-uq4/biomarins-drisapersen-gets-rare-pediatric-disease-status-cm511401","summary":"BioMarin Pharmaceutical Inc.BMRN announced that drisapersen has received rare pediatric disease designation from the FDA for the treatment of patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping treatment. A rare pediatric disease is one"},{"title":"Catabasis Up on Fast Track Status for DMD Drug CAT-1004 - Analyst Blog","publication_date":"2015-07-07 23:28:02 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_WOT-_ZwFdQ/catabasis-up-on-fast-track-status-for-dmd-drug-cat-1004-analyst-blog-cm494060","summary":"Catabasis Pharmaceuticals, Inc. 's CATB shares gained 10% after the company announced that it has received Fast Track designation from the FDA for its Duchenne muscular dystrophy (DMD) candidate, CAT 1004. We note that the FDA grants Fast Track"},{"title":"IPO Roundup: 7 companies make Wall Street debut Thursday","publication_date":"2015-06-25 21:01:07 +0000","url":"http://sg.finance.yahoo.com/news/ipo-roundup-7-companies-wall-194631451.html","summary":"IPO Roundup: 7 companies make Wall Street debut Thursday"},{"title":"Catabasis Pharmaceuticals prices IPO at $12, below the range","publication_date":"2015-06-25 14:28:40 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-rYPiPZGDm0/catabasis-pharmaceuticals-prices-ipo-at-12-below-the-range-cm490653","summary":"Catabasis Pharmaceuticals, which is developing combined therapies for Duchenne muscular dystrophy and high cholesterol, raised $60 million by offering 5 million shares (upsized from 4.3 million shares) at $12, below the range of $13 to $15. Catabasis Pharmaceuticals plans"},{"title":"The missing link: Catabasis Pharmaceuticals sets terms for $60 million IPO","publication_date":"2015-06-11 23:20:28 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c0yPHy7os9I/the-missing-link-catabasis-pharmaceuticals-sets-terms-for-60-million-ipo-cm486312","summary":"Catabasis Pharmaceuticals, which is developing combined therapies for Duchenne muscular dystrophy and high cholesterol, announced terms for its IPO on Thursday. The Cambridge, MA based company plans to raise $60 million by offering 4.3 million shares at a price"}],"result_count":149,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1}}]
